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ABSTRACT
COMMUNITY-BASED EVALUATION OF THE AIR TOXICS PROVISIONS
OF TITLE III OF THE 1990 CLEAN AIR ACT AMENDMENTS:
RISKS, COSTS AND BENEFITS
by
Keith C. Silverman
Hazardous air pollutants (HAPs) are those pollutants that are known or suspected to
cause cancer, serious health effects, or adverse environmental effects. People exposed to
HAPs at sufficient concentrations and durations may have an increased risk of getting
cancer or experiencing other health effects. The 1990 Amendments to the Clean Air Act
(CAAA) directed the U.S. Environmental Protection Agency (USEPA) to use
technology-based air pollution control measures to significantly reduce emissions of
HAPs from major sources of air pollution, followed by a risk-based assessment to address
any remaining or residual health risks.
This study retrospectively assessed the public health risk posed by 17 major
source facilities, located in three counties in New Jersey, in 1990, the year the Clean Air
Act was last amended. Air dispersion modeling, based on the physical characteristics and
mass emission rates of the source facilities, was used to quantitatively and spatially
estimate the community's exposure to HAPs. The estimated exposures were then used to
evaluate the public health risk posed by source facilities individually and collectively.
The risk results were used to assess what, if any, air pollution controls would be required
for the source facilities by Title III of the CAAA. The economic benefits and costs of
these pollution controls were also estimated.
The results suggest that the public health impact of the emissions was limited to
the receptors in close proximity to the source facilities. No cumulative impacts were
found in nearby residential neighborhoods even when source facilities were clustered
together. The morbidity risks from non-carcinogenic pollutants were all below
acceptable thresholds. The mortality risks from carcinogenic pollutants were all within
the USEPA acceptable risk range. No source facility posed a cancer risk to the
community greater than 1 in one hundred thousand, and only three source facilities
presented a cancer risk greater than 1 in one million. The results suggest that the addition
of technology-based air pollution controls results in relatively small reductions in
community health risk and that the residual risk, after the additional controls, is minimal.
COMMUNITY-BASED EVALUATION OF THE AIR TOXIC PROVISIONS
OF TITLE III OF THE 1990 CLEAN AIR ACT AMENDMENTS:
RISKS, COSTS AND BENEFITS
by
Keith C. Silverman
A Dissertation
Submitted to the Faculty of
New Jersey Institute of Technology
and
Rutgers, The State University of New Jersey — Newark
in Partial Fulfillment of the Requirements for the Degree of
Doctor of Philosophy in Environmental Science
Department of Chemistry and Environmental Science
January 2007
Copyright © 2007 by Keith C. Silverman
ALL RIGHTS RESERVED
APPROVAL PAGE
COMMUNITY-BASED EVALUATION OF THE AIR TOXICS PROVISIONS
OF TITLE III OF THE 1990 CLEAN AIR ACT AMENDMENTS:
RISKS, COSTS AND BENEFITS
Keith C. Silverman
Dr. Zeyuan Qiu, Dissertation Advisor
	 Date
Assistant Professor of Chemistry and Environmental Science, NJIT
Dr. Aosvh W. Bozzelli, Committee Member
	 Date
DistingVished Professor, Department of Chemistry and Environmental Science, NJIT
Dr. Some Mitra, Committee Memberdr—r-
Professor, epartment of Chemistry and Environmental Science, NJIT
Dr. Edward V. Sargent, Commit 
	 ber	 Date
Senior Director, Global Sa
	 & the Environment, Merck & Co., Inc.
Dr. Sn G. Tell, Committee Member
	 'Date
SenW Project Engineer, Global Safety & the Environment, Merck & Co., Inc.
Dr. Daniel k Watts, Committee Member
	 Date
Executive Director, York Center for Environmental Engineering & Science, NJIT
574
BIOGRAPHICAL SKETCH
Author:	 Keith Charles Silverman
Degree:	 Doctor of Philosophy
Date:	 January 2007
Undergraduate and Graduate Education:
• Doctor of Philosophy in Environmental Science,
New Jersey Institute of Technology and
Rutgers, The State University of New Jersey, Newark, NJ, January 2007
• Master of Public Health in Environmental and Occupational Health,
University of Medicine and Dentistry of New Jersey and
Rutgers, The State University of New Jersey, Piscataway, NJ, May 1999
• Bachelor of Arts in Biology,
Rutgers, The State University of New Jersey, New Brunswick, NJ, May 1989
Major:	 Environmental Science
Selected Presentations and Publications:
Silverman KC and Tell JG. (2002, December 8 — 11). Comparison of AERMOD,
ISCST3, AERMOD-PRIME, and ISCST3-PRIME: Implications for Risk
Assessment. Paper presented at the Society for Risk Analysis Annual Meeting,
New Orleans, LA.
Naumann BD, Silverman KC, Dixit R, Faria EC and Sargent EV. (2001). Case Studies of
Categorical Data-Derived Adjustment Factors. Journal of Human and Ecological
Risk Assessment, 7(1), 61-105.
Silverman KC, Naumann BD, Holder DJ, Dixit R, Faria EC, Sargent EV and Gallo MA.
(1999). Establishing Data-Derived Uncertainty Factors from Published
Pharmaceutical Clinical Trial Data. Journal of Human and Ecological Risk
Assessment, 5(5), 1059-1089.
iv
ACKNOWLEDGEMENTS
Thanks to the many people who assisted and encouraged me in so many ways during my
doctoral studies. In particular, my friends, Dr. Ellen Faria, Dr. Bruce Naumann, and
Patricia Green, whose support, wisdom, and guidance have been instrumental over the
years. I especially want to thank Dr. Edward Sargent, who has advised me throughout
my masters and doctoral programs. Ed is not only a boss, a mentor, and a true friend, but
he is also someone for whom I have the greatest respect and admiration. I have learned
so much over the years from Ed about science, business, leadership, and family. I am
truly grateful for the privilege of having worked with Ed. I also want to extend a big
thanks to Dr. Joan Tell for all the support, guidance, and friendship she has given me
over the years. Our scholarly debates have greatly shaped both my academic and
professional development.
I am especially grateful to Dr. Zeyuan Qiu, my dissertation committee
chairperson and friend. Zeyuan provided an educational experience that encouraged
scientific and scholarly interaction and contributed greatly to my academic development.
Not only did he always make time for me, but also he always read and responded to the
drafts of each chapter quickly and with detailed comments and suggestions. I am also
grateful to my committee members for their comments and suggestions. I have benefited
greatly from their advice.
I want to thank my parents for their never-ending support and encouragement
over the years, through all my endeavors. They have shown me the value of hard work
and their confidence in my abilities and in me has impressed upon me the dedication and
discipline to work hard. I also want to thank my parents and my sister, Kristen, for the
v
countless hours of childcare support they provided when my wife's schedule and mine
were hectic.
I am very grateful for the support I received from two very inspirational and
influential young women, my two daughters, Emily and Lauren. I am so proud of how
these young women handled the missed dinners, the missed goodnight kisses, and the
missed time with daddy. Their constant understanding and love was a big encouragement
to me. Finally, I cannot even begin to express how grateful I am to my wife and my best
friend, Kate. Kate has suffered more for this dissertation than anyone else has. She has
been a constant source of loving encouragement, patience, wisdom, and support
throughout this whole endeavor. Without Kate, this dissertation would have never been
possible. So, thank you, Kate, for everything!
vi
TABLE OF CONTENTS
Chapter 	 Page
1 INTRODUCTION 	  1
1.1 General Background  
	
1
1.2 Statement of the Problem 	 9
1.3 Hypothesis 	  11
1.4 Objectives 	  12
1.5 Procedure 	  14
1.6 Assumptions
	
 15
2 LITERATURE SURVEY
	
 16
2.1 Introduction 	  16
2.2 Uniform Emission Standards 	  17
2.3 Ample Margin of Safety (AMOS) 	  19
2.4 Section 812 Analysis 	  22
2.5 Human Health Risk Assessment
	
 27
2.6 Air Dispersion Modeling 	  31
2.7 Geographical Information Systems (GIS) 	
 33
2.8 Valuation of Benefits 
	
 35
2.9 National Scale Air Toxics Assessment 
	  39
3 DATA AND METHODS 	  42
3.1 Study Area and Source Facilities 	  42
3.2 Estimation of the 1990 Baseline Health Risk 
	
 57
3.2.1 Hazard Identification 
	
 57
vii
TABLE OF CONTENTS
(Continued)
Chapter 	 Page
3.2.2 Toxicity Assessment 	  65
3.2.3 Exposure Assessment 	  72
3.2.4 Risk Characterization 	  92
3.3 Estimation of Human Health Benefits 	  97
3.3.1 Air Pollution Controls Required by the MACT Standard 	  97
3.3.2 Economic Valuation of Human Health Benefits 	  99
3.3.3 Normalization of Costs and Benefits 	  104
3.4 Estimation of Cost Data for Air Pollution Controls 	  110
3.5 Benefit and Cost Assessment 	  114
4 RESULTS, ANALYSIS, and UNCERTAINITIES 	  117
4.1 Air Dispersion Modeling 	  117
4.2 Risk Characterization 	  119
4.2.1 Individual Facility Risk 	  119
4.2.2 Cumulative Risk 	  134
4.2.3 Benefit and Cost Assessment 	  134
4.3 Variability and Uncertainty 	  141
5 SUMMARY AND CONCLUSIONS 
	
 147
APPENDIX A LIST OF HAZARDOUS AIR POLLUTANTS
	
 156
APPENDIX B SOURCE INFORMATION FOR ALL FACILITIES 	  159
APPENDIX C CHRONIC TOXICITY CRITERIA 	  208
viii
TABLE OF CONTENTS
(Continued)
Chapter	 Page
APPENDIX D AERMET INPUT FILE AND SUMMARY FILE 	  214
D.1 AERMET Input File 	  215
D.2 AERMET Summary File 	  216
APPENDIX E AERMOD INPUT FILES 	  218
E.1 AERMOD Input Files 	  219
APPENDIX F EXAMPLE OF AERMOD OUTPUT FILES
	
 244
F.1 Example of AERMOD Output Files: Benzene
	
 245
F.2 Example of AERMOD Output Files: Formaldehyde 	  250
F.3 Example of AERMOD Output Files: Methylene chloride 	  255
F.4 Example of AERMOD Output Files: Methyl hydrazine 	  260
F.5 Example of AERMOD Output Files: Tetrahydrofuran 
	
 265
REFERENCES 
	
 270
ix
LIST OF TABLES
Table Page
3.1 HAPs Released by All Industries of SIC Code 28 in NJ 	 46
3.2 HAPs Released by Industries of SIC Code 28 in NJ, by County 	 48
3.3 Source Facilities Identified in the Study Area 	 52
3.4 SIC Codes and Principle Products of the Study Facilities 	 55
3.5 MACT Standards Relevant to this Study 	 56
3.6 List of Chemicals of Concern 	 61
3.7 List of Chemicals Dropped from the Study 	 62
3.8 Site-Specific Land Use Parameters Used in AERMET
	 85
3.9 Selected Annual Producer Price Indices 	 107
3.10 Selected Annual Consumer Price Indices 
	 109
4.1 Maximum Cumulative LICRs and HQs for the 17 Source Facilities 
	
120
4.2 COCs Driving Carcinogenic Risk in Children
	 133
4.3 Risk Estimates Due to COC Exposure
	 135
4.4 MACT Facilities on Record with NJDEP
	 137
4.5 Cost Estimate for MACT Controls at Two Facilities 
	
140
A.1 List of Hazardous Air Pollutants
	 157
B.1 Source Facility: Firmenich, Inc 
	 163
B.2 Source Facility: Hoechst Celanese, Inc. 
	 165
B.3 Source Facility: Hoffman LaRoche, Inc 
	 168
B.4 Source Facility: Penick Corp. 	 171
B.5 Source Facility: Sun Chemical Corp.
	 174
x
LIST OF TABLES
(Continued)
Table	 Page
B.6	 Source Facility: Troy Chemical Corp. 	  176
B.7	 Source Facility: Amerchol Corp.. 	
 178
B.8	 Source Facility: Private Formulations, Inc. 	
 180
B.9	 Source Facility: RBH Dispersions, Inc 	  181
B.10 Source Facility: Rhone-Poulenc, LP. 	
 185
B.11 Source Facility: Staflex, Inc. 
	  187
B.12 Source Facility: Union Carbide Corp. 	  189
B.13 Source Facility: Ciba-Geigy Corp. 	  192
B.14 Source Facility: Exxon Corp. 	
 197
B.15 Source Facility: Merck & Co., Inc. 
	  199
B.16 Source Facility: Schering Corp. (Kenilworth) 
	
 202
B.17 Source Facility: Schering Corp. (Union) 
	  205
C.1	 Chronic Toxicity Criteria 	
 209
xi
LIST OF FIGURES
Figure Page
3.1 Geographic location of Essex, Union, and Middlesex Counties. 
	
49
3.2 Geographic locations of the 17 selected source facilities. 	 53
3.3 Probable location of a facility's emission sources. 	 78
3.4 Land use characteristics surrounding the source facilities. 
	
84
3.5 Topography of the study area. 	 88
3.6 Boundaries of the receptor grids used in the air dispersion model. 
	
91
3.7 Components of the net social benefit. 	 116
4.1 Carcinogenic risk to children in 1990 (Hoffman LaRoche Inc.). 	 123
4.2 1990 Census block tracts of interest (Hoffman LaRoche Inc.)
	
125
4.3 Carcinogenic risk to children in 1990 (Merck & Co., Inc.). 
	
127
4.4 1990 Census block tracts of interest (Merck & Co., Inc.). 
	
128
4.5 Carcinogenic risk to children in 1990 (Union Carbide Corp.) 
	
130
4.6 1990 Census block tracts of interest (Union Carbide Corp.). 
	
131
xii
LIST OF ACRONYMS
ACCACA	 Advisory Council on Clean Air Compliance Analysis
ADD	 Average Daily Dose
AERMOD American Meteorological Society / Environmental Protection Agency
Regulatory Model
AERMET AERMOD Meteorological Preprocessor
AERMIC	 AMS/EPA Regulatory Model Improvement Committee
AMOS
	
Ample Margin of Safety
AMS	 American Meteorological Society
ARB	 Air Resources Board, Cal EPA
ATSDR	 Agency for Toxic Substances & Disease Registry
BCA	 Benefit and Cost Analysis
CAA	 Clean Air Act
CAAA	 Clean Air Act Amendments of 1990
Cal EPA	 California Environmental Protection Agency
CAPCOA	 California Air Pollution Control Officers Association, Cal EPA
CFR	 Code of Federal Regulations
COC	 Chemical of Concern
COI	 Cost of Illness
CPI	 Consumer Price Index
CV	 Contingent Valuation
DEM	 Digital Elevation Model
DOQQ	 Digital Ortho-QuarterQuad
EDF	 Environmental Defense Fund
EPCRA	 Emergency Planning and Community Right to Know Act
ESL	 Effects Screening Level
FR	 Federal Register
g/s	 grams per second
GIS	 Geographical Information System
HAP	 Hazardous Air Pollutant
HEAST	 Health Effects Assessment Summary Tables
HON	 Hazardous Organic NESHAP
HI	 Hazard Index
HQ	 Hazard Quotient
IRIS	 Integrated Risk Information System
ISC	 Industrial Source Complex Model
kg	 kilogram
LADD	 Lifetime Average Daily Dose
LICR	 Lifetime Incremental Cancer Risk
LOAEL	 Lowest-observed-adverse-effect-level
LULC	 Land Use and Land Cover
MACT	 Maximum Achievable Control Technology.
m
3 	
cubic meters
mb	 millibars
xl"
MCL	 Maximum Contaminant Level
MEI	 Maximum Exposed Individual
MIR	 Maximum Individual Risk
mg/m3 	 milligrams per cubic meter
MON	 Miscellaneous Organic NESAHP
MRL	 Minimum Risk Level
micrograms
1-tghn	 microgram per cubic meter
NAICS	 North American Industrial Classification System
NAS	 National Academy of Sciences
NATA	 National Air Toxic Assessment
NCDC	 National Climatic Data Center
NCEA	 National Center for Exposure Assessment
NESHAP	 National Emission Standards for Hazardous Air Pollutants.
NJ	 New Jersey
NJDEP	 New Jersey Department of Environmental Protection
NJDEPE	 New Jersey Department of Environmental Protection and Energy
NOAA	 National Oceanic and Atmospheric Administration
NOAEL	 No Observed Adverse Effect Level
NRC	 National Research Council
NRDC
	 National Resources Defense Council
NTI	 National Toxics Inventory
NY	 New York
OAQPS	 Office of Air Quality Planning and Standards
OEHHA	 Office of Environmental Health Hazard Assessments
OLDN
	 Organic Liquids Distribution (non-gasoline) NESHAP
OPRA	 Open Public Records Act
OSHA	 United States Occupational Safety & Health Administration
PBL	 Planetary Boundary Layer
Pharm	 Pharmaceutical NESHAP
PPI	 Producer Price Index
RBC	 Risk Based Concentration
RCRA	 Resource Conservation and Recovery Act
REL	 Reference Exposure Level
RfC	 Reference Concentration
RfD	 Reference Dose
SAB	 Science Advisory Board
SARA	 Superfund Amendments and Reauthorization Act
SCRAM	 Support Center for Regulatory Air Models
SDTS	 Spatial Data Transfer Standard
SDWA	 Safe Drinking Water Act
SIC	 Standard Industrial Classification
SF	 Slope Factor
SOCMI	 Synthetic Organic Chemical Manufacturing Industry
STF-1	 Summary Tape File - 1
TCEQ	 Texas Commission on Environmental Quality
xiv
THE	 Tetrahydrofuran
TTN	 Technology Transfer Network
TOU	 Thermal Oxidizer Unit
tpy	 Tons per year
TRI	 Toxic Release Inventory
TRIF ID	 TRI Facility Identification
OF	 Uncertainty Factor
UR	 Unit Risk
US	 United States
USC	 United States Code
USCB	 United States Census Bureau
USDOL	 United States Department of Labor
USEPA	 United States Environmental Protection Agency
USGS	 United States Geological Survey
UTM	 Universal Transverse Mercator
VAPCCI	 Vatavuk Air Pollution Control Cost Indexes
VOC	 Volatile Organic Compound
VSL	 Value of a Statistical Life
VSLY	 Value of a Statistical Life Year
WTP	 Willingness to Pay
CHAPTER 1
INTRODUCTION
1.1 General Background
Hazardous air pollutants (HAPs) are those air pollutants that are known or suspected to
cause cancer, serious health effects, or adverse environmental effects. Examples of
HAPs include benzene, methylene chloride, vinyl chloride, dioxin, and metal compounds.
Section 112(b) of the Clean Air Act (CAA) lists the 188 HAPs (USEPA, 1990a). People
exposed to HAPs at sufficient concentrations and durations may increase their chance of
getting cancer or experiencing other serious health effects. These health effects include
damage to the immune system, as well as neurological, respiratory, reproductive,
developmental, and other health problems (National Research Council, 1994; USEPA,
1990a, 1990b, 2003e). Toxic air pollutants originate primarily from two types of sources:
mobile sources and stationary sources. Mobile sources are further categorized as on-road
mobile sources (e.g., cars, trucks, and buses) and non-road mobile sources (e.g., planes,
trains, marine equipment, construction equipment, lawn and garden equipment, and
emergency generators) (USEPA, 20030. Stationary sources are further categorized as
either major sources or area sources. A major source is any stationary source or group of
stationary sources located within a contiguous area under common business control (e.g.,
an industrial facility) that emits or has the potential to emit (considering controls) in
aggregate, 10 tons per year (tpy) or more of any one HAP or 25 tpy or more of any
combination of HAP (Brownell, 2001; Martineau, 2004; USEPA, 1990a). Major sources
may release pollutants from equipment leaks, when materials are transferred from one
1
2location to another, or during discharge through stacks or vents.
Area sources are defined as any stationary source of HAPs that is not a major
source (Martineau, 2004; USEPA, 1990a). Area sources are generally smaller size
facilities (e.g., dry cleaners) that release lesser quantities of pollutants into the air. Area
sources are defined as sources that emit less than 10 tpy of a single air toxic, or less than
25 tpy of a combination of air toxics. Though emissions from individual area sources are
often relatively small, collectively their emissions can be of concern, particularly where
large numbers of sources are located in heavily populated areas. Another type of area
source is the home, where emissions originate from building materials and cleaning
activities (Brownell, 2001; Martineau, 2004; USEPA, 1990a, 20030. Motor vehicles and
non-road vehicles are not considered area sources (Martineau, 2004).
Prior to the 1990 Amendments, the 1970 and 1977 versions of the CAA required
the United States Environmental Protection Agency (USEPA) to list chemicals as HAPs
and then set National Emission Standards for HAPs (NESHAPs) based on their specific
health risks. The United States (U.S.) Congress directed the USEPA to set these health-
based limits at a level that provided an ample margin of safety (AMOS) to protect public
health [42 U.S.C. §7412(b)(1)(B) (1970)] (Martineau, 2004; USEPA, 1999c). This
health-based approach to standard setting proved difficult and minimally effective in
reducing emissions. From 1970 to 1990, the USEPA had listed only eight chemicals as
HAPs and issued NESHAPs for only seven of the listed HAPs. In addition, these
NESHAPs only covered a limited number of emission sources. The major difficulty in
listing chemicals as HAPs was the risk assessment and risk management process
necessary to set a NESHAP. The risk assessment was made difficult by the air dispersion
3modeling and human health impact assessment necessary to establish a safe level of
exposure. The risk management process attempted to balance the assessed risk against
other elements, such as technological feasibility and cost, to reduce the exposure to a
level that provided for an AMOS to protect public health (Andrews, 2000; Martineau,
2004).
A major blow to setting NESHAPs using the risk-based approach came in 1987.
In a historic case, the National Resources Defense Council (NRDC) took the USEPA to
court (National Resources Defense Council v. EPA, 1987) to challenge the USEPA's
decision to consider cost and technical feasibility in setting the vinyl chloride NESHAP.
The court concluded that the USEPA could not consider cost when establishing a safe
level of exposure to a HAP but the USEPA could consider cost and technical feasibility
when setting a level of exposure that provides for an AMOS to protect public health.
Therefore, the court ruled in favor of the USEPA and concluded that consideration of
cost, in establishing a NESHAP that provided for an AMOS, was acceptable (Martineau,
2004).
Because of all the difficulties the USEPA encountered while attempting to set
risk-based NESHAPs, Congress decided to alter the approach when drafting the 1990
CAAA. In the 1990 Amendments, Congress directed the USEPA to use a two-step
approach to control HAPs. The approach required the USEPA to first use a technology-
based approach to significantly reduce emissions of HAPs from major sources of air
pollution, followed by a risk-based approach to address any remaining or residual risks.
The approach to setting technology-based standards involved establishing a list of
emitters of HAPs then grouping the emitters on the list by industry. These groups
4became known as source categories. Congress also included a list of 188 HAPs in the
1990 CAAA. The complete list of the HAPs can be found at 42 U.S.C. §7401 et seg.
(1990) and in Appendix A of this study.
The technology-based standards of the 1990 CAAA required the maximum
achievable control technology (MACT) be applied to HAP emission sources at industrial
source facilities (Martineau, 2004; USEPA, 2000d). The MACT standard required the
installation of air pollution controls that would result in the maximum degree of reduction
that is achievable, considering cost, energy requirements, and any non-air quality health
and environmental impacts (Brownell, 2001; Martineau, 2004). For new sources, the
USEPA based the standard on the best controlled source in the source category. For
existing sources, the USEPA based the standard on the average pollution control level
achieved by the top performing existing sources in the source category (Brownell, 2001;
Martineau, 2004). The USEPA has taken the position that it will not consider costs when
setting the MACT standards (Martineau, 2004).
The MACT standards are considered the national emission standards for HAPs
(i.e., the NESHAPs) for specific source categories. For example, the Pharmaceutical
MACT standard regulates the HAP emissions from processes at pharmaceutical
manufacturing operations that meet the criteria of a major source. The final rule for
pharmaceutical production, published September 21, 1998, affected approximately 100
pharmaceutical production facilities nationwide and was expected to reduce air toxics
emissions by 24,000 tons annually which equates to a 65 percent reduction from pre-
MACT levels (USEPA, 2002c).
5Section 112(f) of the CAA now requires the USEPA to complete a report to
Congress that includes a discussion of methods the USEPA would use to evaluate the
risks remaining after the application of MACT standards. This residual risk assessment
must assess the MACT standards effectiveness at reducing the health and environmental
risks posed by HAPs. After setting a MACT standard, the USEPA has eight years (nine
years for the earliest standards) to examine the risk posed by continued emissions from
source facilities and if necessary, to issue requirements for additional controls to reduce
unacceptable residual risk (USEPA, 2000d). At the time of this study, the USEPA was
still developing its strategy for assessing and reducing residual risks and still in the
process of promulgating final residual risk standards.
In 1999, the USEPA published it's Residual Risk Report to Congress, in response
to a requirement that Congress had put in the 1990 CAAA (USEPA, 1999c). The
Residual Risk Report to Congress specifically references the benzene NESHAP which
the USEPA issued shortly after the vinyl chloride decision. In the benzene NESHAP, the
USEPA developed a two step regulatory framework. In the first step, the USEPA set an
acceptable level of risk. In the second step, the USEPA established an AMOS, which
made the NESHAP more stringent. The framework used to develop the benzene
NESHAP is one potential framework for assessing residual risk (Martineau, 2004).
In June 2006, the USEPA issued a draft of the proposed rule for the Hazardous
Organic National Emissions Standards for Hazardous Air Pollutants (HON): Residual
Risk (USEPA, 2006e). The proposed rule reviewed the technology-based standards put
in place and the estimated residual risks for the HON source category. As a result of this
review, the USEPA proposed two options. The first option would impose no further
6controls based on a proposal that the existing technology-based standards were protecting
public health with an AMOS. The second option would require further reductions of
organic HAPs by applying additional controls to emissions that are currently not
controlled by the technology-based standard. Written comments on the proposed rule
were being collected by the USEPA at the time of writing of this study. It is fairly certain
that a quantitative human health risk assessment, that considers the effects of direct
inhalation of emitted HAPs, will be a critical component of any residual risk rule.
Besides the direct health risks, the overall residual risk may also consider indirect human
risk from persistent and bioaccumulative pollutants and/or ecological risk. Residual risks
greater than a specified threshold may require the emitting industry to implement further
reductions in the emissions of HAPs (Brownell, 2001).
This study examined the impacts of uniformly applied technology-based
standards for controlling air pollution. The first part of this study presents a methodology
for assessing the health risk that industrial source facilities pose to the community. In
this part, reported data on facility emissions were used in a quantitative human health risk
assessment to evaluate the risk in 1990 from 17 major sources in NJ. The intent of this
retrospective risk assessment was to evaluate the health risk that existed in 1990, the year
the CAA was last amended and the MACT standards were established.
Quantitative human health risk assessments are commonly used as a tool to guide
regulatory decision making and policy setting. A human health risk assessment that
looks at the direct inhalation of vapor emissions requires critical pieces of information
such as site-specific data on the physical characteristics of the emission sources, accurate
estimates on the mass emission rate of the chemicals of concern (COC), good estimates
7of toxicity, predictions of the spatial and temporal distributions of these emissions, and an
estimate of human exposure. Air dispersion models are used in risk assessments to
predict the fate and transport of pollutants in the atmosphere. Once emitted, pollutants
mix with the existing air where physical processes, such as turbulence and chemical
reactions, cause the pollutants to disperse and their concentrations to decrease. Air
dispersion models predict the spatial and temporal distributions of pollutants using
mathematical equations that describe the numerous and complex meteorological
processes responsible for pollutant dispersion. As such, air dispersion models are widely
used to meet federal and state air quality regulations (USEPA, 2001). Since human
exposure is based on the air concentration of the pollutant, the concentration data
predicted by an air dispersion model is a critical step in the risk assessment process.
As mentioned earlier, a quantitative human health risk assessment that considers
the effects of direct inhalation of emitted HAPs is one component by which residual risk
will be estimated. Residual risks, greater than a specified threshold, may require source
facilities to implement further reductions in their emissions of HAPs. Therefore, if a
human health risk assessment results in an overestimate of risk then unnecessary cost
may be incurred to eliminate a risk that is already small. On the other hand, under-
estimates of risk would have detrimental effects on public health and environment.
In the second part of this study the results of the quantitative risk assessment will
be used in a benefit and cost analysis (BCA) of the MACT standards as they pertain to
the source facilities in this study. The BCA part of this study considered the cost of the
technology-based controls in relation to any benefits, in terms of protection of public
health. As mentioned earlier, decisions involving safe levels of air pollution are to be
8made solely on the basis of health and environmental effects, regardless of cost.
However, the USEPA is allowed to consider cost and technical feasibility when deciding
what level of air pollution constitutes an AMOS. This approach is similar to the Safe
Drinking Water Act (SDWA), last amended in 1996, which allowed for the consideration
of cost in setting Maximum Contaminant Levels (MCLs) (Kucera, 2001).
Regardless of whether or not economic factors are considered in setting public
health and environmental policies, policymakers should be questioning if the dollars
spent on complying with environmental regulations are having a positive impact. To
shed light on this question, economists look to see if the marginal cost of attainment of a
regulation is less than the marginal benefits produced through the regulation. Simply
speaking, is society seeing an improvement in public health or in the environment for the
money spent on the regulation? The answer to this question requires the benefits and
costs of environmental policies to be measured or estimated and then compared. A
positive net benefit would indicate that the public is getting a benefit for each dollar
spent.
The BCA in this study estimated the human health benefits derived as a result of
any air pollution controls added under the MACT standards. Any predicted reductions in
adverse human health effects were assigned a monetary value. The change in adverse
effects was assessed in terms of the magnitude decrease in morbidity (i.e., sickness) or
mortality (i.e., death) as a result of the regulation. Placing a dollar value on public health
or a human life can be quite controversial. To make the BCA meaningful and useful as a
policy making tool, the dollar estimates must be accurate and at the same time practical.
Various valuation methods have been developed and numerous studies have been
9conducted to estimate the dollar value of public health and to determine society's
willingness to pay (WTP) for risk reduction.
1.2 Statement of the Problem
Two prior cost and benefit studies of the CAA by the USEPA concluded the 1970 Act
along with the Amendments of 1977 and 1990 were beneficial in improving the air
quality of the United States. In both studies, the total implementation costs of CAA were
justified by the total benefits obtained in human health and welfare. The first study, a
retrospective study, showed the ratio of the benefits to costs for the period 1970 to 1990
was 42 to 1 (USEPA, 1997a). The second study, a prospective study, estimated the ratio
for the period 1990 to 2010 to be approximately 4 to 1 (USEPA, 1999b).
However, these studies considered the aggregate costs and benefits of
implementing the 1990 CAAA and did not evaluate each Title of the Act separately. The
1990 CAAA contained eleven Titles (USEPA, 1990b).
■ Title I: Provisions for Attainment and Maintenance of National Ambient Air
Quality Standards
■ Title II: Provisions Relating to Mobile Sources
■ Title III: Hazardous Air Pollutants
■ Title IV: Acid Deposition Control
■ Title V: Permits
■ Title VI: Stratospheric Ozone Protection
■ Title VII: Provisions Relating to Enforcement
■ Title VIII: Miscellaneous Provisions
■ Title IX: Clean Air Research
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■ Title X: Disadvantaged Business Concerns
■ Title XI: Clean Air Employment Transition Assistance
The eleven titles of the CAA dealt with diverse air pollutants, ranging from the local
pollutants such as the HAPs to the regional and global pollutants such as ozone, with very
different policies. The aggregate BCA does not show the effectiveness and efficiency of
the individual titles and has limited implications for the future air pollution control
policy. The USEPA is currently planning its third BCA on the CAA. It is expected that
the third study will evaluate the costs and benefits of the CAA as a whole as well as
separately for individual titles. This study empirically evaluated Title III of the 1990
CAAA at a community level and filled two gaps identified in the USEPA's national level
BCAs. First, it developed a methodology to evaluate Title III, which deals with the
HAPs. Second, it addressed the costs and benefits of Title III at a much more detailed
level than a national study would do.
In order to accomplish this, a methodology was devised to perform a community
level human health risk assessment. The risk assessment looked at real source facilities
using the emission information reported to the state environmental agency. The
experiences and the information gained from this study can be used to supplement and
refine the prior two USEPA BCA studies as well as future studies. The results of the
benefit and cost section of this study will also aid policymakers in developing future
policies that integrate technology-based standards with probability- or risk-based
standards. The results of this study can be used to guide future decisions on residual risk
and to configure future regulations that target pollution abatement to those pollutants that
pose the greatest human health risk and subsequently maximize net benefits.
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In order to consider the impact of only Title III, a facility-specific and
community-specific human health risk assessment had to be performed. Community
level risk assessment is an emerging science that requires detailed assessments of
pollutant fate and human exposure. The USEPA recently released the Air Toxics Risk
Assessment Reference Library Volume 3, Community Scale Assessment that is intended to
serve as a technical resource these community scale, multi-source, air toxics risk
assessments (USEPA, 2006c). However, the methodology presented in the USEPA guide
still needs to be expanded on and improved. The methodology used in this study will be
valuable for carrying out future community level risk assessments. Several of the lessons
learned during this study were provided to the USEPA in the form of written comments
during the public comment period on the peer review drafts of the above guide.
1.3 Hypothesis
Technology-based standards have been found to be effective in reducing air pollution.
The hypothesis of this research is that the uniform application of air pollution controls to
major sources of HAPs based primarily on industrial classification, while effective, may
not provide a significantly positive net benefit. A more effective approach may be to use
a risk-based framework that considers the impact of air pollutants on a community scale.
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1.4 Objectives
This study addressed two of the gaps identified in the USEPA's reports to Congress on
the benefits and costs of the CAA. The first gap addressed was that neither report
presented any quantitative cost or benefit data on the HAPs. The USEPA cited the fact
that essential data was lacking for the HAPs as the primary reason why the HAPs were
not fully incorporated into either of the studies. This study made use of publicly
available data on emissions and air dispersion modeling to quantitatively estimate the
human health risk posed by several source facilities before the application of the MACT
controls. The second gap addressed was that the USEPA's prospective study did not
quantitatively take into account the impact of the MACT standards. This study
quantitatively considered both the benefits and costs of the MACT standards on the
communities and the source facilities in the study area.
Future reforms of the CAA may allow for the consideration of risks, benefits, and
costs prior to the implementation of a reformed Act. Therefore, the third goal of this
study was to aid future policymaking decisions on air pollution regulation by
demonstrating how the public health effects posed by source facilities in a community
can be used to study the benefits and costs associated with air pollution control
regulation. In order to accomplish the goals of this study the following specific
objectives were defined prior to undertaking the study.
Objective 1. Identify the community to be studied by identifying emitting industries (i.e.,
source facilities), of defined industrial classes, located in a defined geographical region,
and which emitted greater than a threshold quantity of HAPS in 1990.
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Objective 2. Perform a community level public health risk assessment using reported
emissions data compiled from public records for the source facilities chosen in Objective
1. Carry out the risk assessment using the latest advances in air dispersion modeling and
accepted risk assessment methodologies. Generate a spatial representation of the baseline
public health risk in 1990 posed by the source facilities.
Objective 3. Estimate the air pollution controls the source facilities would need to apply
to be compliant with the MACT standards. Confirm if any air pollution measures were
undertaken through available public records.
Objective 4. Estimate the public health benefits that were attained or would be attained
through the addition of the air pollution controls required by the MACT standards.
Estimate the dollar value of any benefits from reductions in mortality and morbidity.
Objective 5. Estimate the cost to the source facilities of installing and operating the air
pollution controls required under the MACT standards.
Objective 6. Perform a benefit and cost assessment of the MACT standards. Estimate the
potential impact the residual risk standards may have on the source facilities and the
community.
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1.5 Procedure
The procedure used is this study is outlined below.
Study Design
■ Identify the community or geographic area of interest.
■ Identify the timeframe of interest.
■ Identify source facilities.
Hazard Assessment
■ Obtain and examine emissions reports for the source facilities.
■ Build the study area and source facilities in the Geographic Information System
(GIS).
Dose-Response Assessment
■ Research the dose-response and toxicity data for the emitted chemicals.
Exposure Assessment
■ Model all emission sources, from all source facilities, in the air dispersion model.
Risk Characterization
■ Calculate the spatial and temporal distributions of human exposure.
■ Estimate the baseline human health risk in 1990.
■ Estimate any cumulative risk from source facilities located in proximity to one
another.
Benefit and Cost Analysis
■ Estimate the air pollution controls that would be required under Title III of the
CAAA.
■ Estimate the cost of the air pollution controls.
■ Estimate the benefits in terms of reduced mortality and morbidity.
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1.6 Assumptions
Two simplifying assumptions have been made in this study:
1. Health effects (morbidity) are the direct result of chronic inhalation of HAPs.
2. Cancer (mortality) is the direct result of chronic inhalation of HAPs.
Furthermore, all cases of cancer are fatal and result in an individual dying.
CHAPTER 2
LITERATURE SURVEY
2.1 Introduction
Title III of the 1990 CAAA included the provisions for (1) the establishment of
technology-based emission standards for source categories and (2) the assessment of the
residual risk to public health that remains after the application of the technology-based
standards (USEPA, 1990b). Section 812 of Title VIII included provisions for analyzing
the benefits and costs of the CAA. Section 812 amended Section 312 of the original
CAA, which addressed economic impact analyses of the CAA. As part of the
requirements of Section 812, the USEPA is required to periodically assess the effect of
the CAA on the public health, economy, and environment of the United States. These
analyses are commonly referred to as Section 812 reports. In performing such analyses,
the USEPA was directed to consider the costs, benefits and other effects associated with
compliance for each standard issued for a HAP, including any technology-based standard
and/or risk-based standards (USEPA, 1990a).
In terms of the benefits, Section 812 directs the USEPA to consider all of the
economic, public health, and environmental benefits (USEPA, 1990a). In terms of the
costs, Section 812 directs the USEPA to consider the effects on employment,
productivity, cost of living, economic growth, and the overall economy of the United
States (USEPA, 1990a). The findings of the Section 812 analyses of costs and benefits
must be reported to Congress. Section 812 required the USEPA to issue the first analyses
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to Congress "not later than twelve months after the date of enactment of the Clean Air
Act Amendments of 1990" (USEPA, 1990a). Subsequent reports to update the original
report must be issued to Congress "not later than 24 months after the date of enactment of
the Clean Air Act Amendments of 1990, and every 24 months thereafter" (USEPA,
1990a).
The USEPA has conducted and published two separate Section 812 reports to date
(USEPA, 1997a, 1999b). The Section 812 reports have been responsible for much of the
progress in the field of valuation of morbidity and mortality benefits and many of the
methodologies for carrying out benefit and cost analyses of air pollution regulation. The
idea to study the benefits and costs of Title III separately from the other Titles of the Act
originated from critical reviews of the two existing Section 812 reports. The Section 812
reports and reviews were used as the starting point for the research done in this study,
especially for the benefit and cost assessment part.
2.2 Uniform Emission Standards
The concepts of considering risk, benefits, and costs when setting environmental policy
and regulations has been discussed for decades. The historical approach to air pollution
control was based primarily on emissions standards, such as those required for the HAPs
in both the 1970 CAA and the 1990 CAAA. These emission standards were commonly
referred to as the command-and-control approach because they set a legally enforceable
and uniform standard on the allowable concentration of a pollutant in ambient air over a
specified measurement time (Tietenberg, 2000a). Some economists argue that the
command-and-control approach is not cost effective because it assumes all emission
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sources pose the same risk to human health. In addition, uniformly applied controls fail
to consider variations in emission rates between sources, variations in pollutant fate
between sources, and variations in costs to control emissions between sources
(Marakovits & Considine, 1996; Nichols, 1982; Tietenberg, 2000a).
Nichols (1982) demonstrated the importance of considering exposure rather than
simply reductions in emissions when evaluating the cost effectiveness of proposed
regulations. The paper presented a case study of benzene emissions from maleic
anhydride plants that were the focus of a proposed USEPA standard in April 1980. The
proposed standard focused on maleic anhydride plants since estimates indicated that over
half of the benzene emitted from chemical manufacturing came from a handful of maleic
anhydride plants. In addition, these emissions emanated from a single process vent that
could easily be controlled using any of several different air pollution control
technologies. According to the CAA, any emission standard would need to ensure public
health with an AMOS. The costs were estimated using industry supplied cost estimates,
which have the potential to be over inflated. The benefits were estimated by performing
air dispersion modeling and estimating the exposure pre- and post-air pollution control.
The expected benefits, measured as a decrease in lifetime excess cancer risk, were
assumed to be proportional to the decrease in exposure. The benefits were converted into
dollars based on the assumption that a case of cancer was fatal and using a range of dollar
values for what a life saved was worth. The concept of placing a dollar value on a life
saved will be discussed later in this section. The case study found that the proposed
emission standard did not yield positive net benefits even when relatively high estimates
of the benefits were used in the analysis (Nichols, 1982).
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A case study by Marakovits and Considine (1996) looked at the benefits and costs
of emission-based standards compared to exposure-based standards for coke oven
emissions. The hypothesis was that environmental health standards should be based on
population exposure rather than on ambient air quality. The case study concluded that an
environmental policy based on exposure can achieve the same level of protection of
public health as do emission standards while at the same time reducing compliance costs
by up to sixty percent (Marakovits & Considine, 1996).
Policy makers can use the information from these case studies to guide future
regulations so that pollution abatement is targeted at those pollution sources that pose the
greatest risk to human health and subsequently maximize net benefits. The case study
presented by Nichols (1982) was used as a model for this study. However, Nichols
(1982) only considered a single process vent from eight malefic anhydride plants located
in the United States. The work in this study focused on 17 source facilities located in
three counties in New Jersey. Furthermore, this study considered the emissions of all
carcinogenic and all non-carcinogenic chemicals (regardless of whether or not they are
classified as a HAP) emanating from all process vents on the source facility for which
data was available in the public record. Using this methodology, this study predicted the
complete exposure profile from each of the source facilities.
2.3 Ample Margin of Safety (AMOS)
Prior to the 1990 Amendments, the 1970 and 1977 versions of the CAA required the
USEPA to list chemicals as HAPs and then set national emission standards for HAPs
(NESHAPs) based on their specific health risks. Congress directed the USEPA to set the
20
health-based limits at a level that provided an AMOS to protect public health [42 U.S.C.
§7412(b)(1)(B) (1970)] (Martineau, 2004; USEPA, 1999c). The major difficulty the
USEPA encountered in listing chemicals as HAPs was the risk analysis and ambient air
quality analysis necessary to determine the emission standard that would provide for an
AMOS to protect the public health (Martineau, 2004). This was especially true for
carcinogens. Carcinogenic and non-carcinogenic chemicals are evaluated separately in a
human health risk assessment because the mechanisms by which carcinogens cause
cancer are assumed to be fundamentally different from the mechanisms by which non-
carcinogens cause illnesses (Martineau, 2004; National Research Council, 1994;
Tietenberg, 2000a). The principal difference reflects the assumption that non-
carcinogenic chemicals exhibit a threshold dose below which no adverse effects occur,
whereas the general assumption held by most environmental agencies is that no such
threshold exists for carcinogenic effects (National Research Council, 1994). Therefore,
some environmentalists have argued that protecting public health with an AMOS requires
eliminating all exposures to carcinogens and an emission standard of zero. Completely
eliminating emissions is not always technically feasible nor necessarily a viable
economic option (Martineau, 2004; Tietenberg, 2000a). The USEPA cites an acceptable
range of 1 in ten thousand (1 x 10 -4) to 1 in one million (1 x 10 -6) for potential cancer
risk. Cancer risks less than 1 in one million are referred to as de minimis risk (USEPA,
1989).
The acceptable range for carcinogens was determined prior to the 1990 CAAA,
when the USEPA was tasked with setting NESHAPs for HAPs to protect public health
with an AMOS. In 1987, the NRDC took the USEPA to court (National Resources
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Defense Council v. EPA, 1987) to challenge the USEPA's decision to consider cost and
technical feasibility in setting the vinyl chloride NESHAP. First, the court ruled that the
USEPA must first determine a safe emissions level (i.e., one that represents an acceptable
level of risk) and then add a margin of safety to account for uncertainties (Martineau,
2004). Second, the court ruled that the USEPA could not consider cost when establishing
a safe level of exposure to a HAP but the USEPA could consider cost and technical
feasibility when setting a level of exposure that provides for an AMOS to protect public
health (Martineau, 2004). In response to the court's decision, the USEPA decided to base
its regulatory decision primarily on a quantitative risk assessment and adopted an
estimated lifetime cancer risk, from exposure to vinyl chloride, of less than 1 in ten
thousand (1 x 10 -4) as an acceptable risk. The USEPA went forward with the view that
the margin of safety should reduce the risk to no higher than 1 in one million
(1 x 10 -6) (National Research Council, 1994).
The USEPA used this two step regulatory framework when they designed the
benzene NESHAP. In the first step, the USEPA decided what an acceptable level of risk
was. This was considered the safe level. It is important to realize that safe does not
necessarily mean without risk. In the second step, the USEPA decided to make the
regulation more stringent by applying an AMOS. The framework used to develop the
benzene NESHAP is one potential framework for setting risk-based emission standards
(Martineau, 2004). Even though the benzene NESHAP considers risk when determining
what an AMOS is, it is still considered a uniformly applied emission standard because it
sets a legally enforceable concentration of benzene in air.
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2.4 Section 812 Analysis
The USEPA has conducted and published two Section 812 reports. The first report
entitled, The Benefits and Costs of the Clean Air Act, 1970 to 1990, was published by the
USEPA in 1997 (USEPA, 1997a). The second report entitled, The Benefits and Costs of
the Clean Air Act, 1990 to 2010, was published by the USEPA in 1999 (USEPA, 1999b).
Currently, the USEPA is in the planning stages for the third 812 analysis (USEPA,
2003d).
A USEPA Science Advisory Board (SAB) special council and others have
reviewed and commented on both Section 812 reports (Krupnick & Morgenstern, 2002;
USEPA, 1996, 1999a). A special council panel has also been convened to review the
revised analytical plan for the USEPA's third Section 812 report, The Benefits and Costs
of the Clean Air Act, 1990 - 2020. The panel expected to have the final analytical plan
ready for March 2005 but as of the writing of this study the plan had not been finalized.
Further information on the USEPA's third Section 812 report can be found on the SAB
webpage on the USEPA's website.
The first USEPA report was a retrospective BCA that attempted to compare a
baseline, based on a no emissions control scenario, to an emissions control scenario based
on the provisions of both the 1970 CAA and the 1977 Amendments to the CAA. The
findings of the study indicated that implementation of the provisions of the CAA from
1970 to 1990 significantly reduced air pollutant emissions. The report concluded that the
direct benefits of the CAA from 1970 to 1990 included reduced incidence of a number of
adverse human health effects, improvements in visibility, and avoided damage to
agricultural crops. A key assumption made in the report was that increased air pollution
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exposures have a causal relationship in terms of adverse health effects. The estimated
economic value of the estimated benefits ranged from $5.6 to $49.4 trillion (in 1990
dollars) with a mean estimate of $22.2 trillion. The direct costs of implementing the
CAA from 1970 to 1990, including annual compliance expenditures in the private sector
and program implementation costs in the public sector, totaled $523 billion (in 1990
dollars). Thus, the retrospective analysis of the benefits and costs of implementing the
CAA from 1970 to 1990 indicated that the mean estimate of total benefits over the period
exceeded total costs by more than a factor of 42. Taking into account the aggregate
uncertainty in the estimates, the ratio of benefits to costs ranged from approximately 10
to 100 times (USEPA, 1997a).
The Advisory Council on Clean Air Compliance Analysis (ACCACA) (hereafter,
the Council), a special committee of the USEPA's SAB, reviewed the first USEPA
report. The Council had several findings that stressed the importance of providing sound
estimates of costs and benefits (USEPA, 1996). The most significant finding the Council
had was with regard to uncertainty. The Council felt the use of a single point estimate for
cost and benefit was not the most scientifically sound practice given the state of
knowledge and could at worst be seriously misleading. The Council suggested that
ranges or probabilities would be more helpful. The Council also commented on the
controversies surrounding the use of contingent valuation (CV) within the economics
profession and the impact this had on the estimation of critical benefit inputs such as
morbidity and mortality (USEPA, 1996). In addition, the Council also recommended that
the costs and benefits of the specific Titles of the CAA be studied in contrast to just
looking at the aggregate benefits and costs. Other significant findings centered on
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discount rates, cost estimates, the relation between peak and average emissions, and
spatial estimates of air concentrations (USEPA, 1996).
The second USEPA Section 812 report was a prospective BCA aimed at
estimating the future social benefits and costs of the CAAA from 1990 to 2010.
According to the study, the economic value of the public health and environmental
benefits during this time period exceeded the costs by a margin of 4 to 1. The direct
benefits of implementing the provisions of the 1990 CAAA from 1990 to 2010 were
estimated to be $71 billion in 2000 (in 1990 dollars) and $110 billion in 2010 (in 1990
dollars). The direct cost was estimated to be $19 billion in 2000 (in 1990 dollars) and
$27 billion in 2010 (in 1990 dollars). Both estimates were the mean estimate. Thus, the
prospective analysis of the benefits and costs of implementing the 1990 CAAA (Titles I
through V) from 1990 to 2010 indicated that the mean estimate of total benefits over the
period exceeded total costs by a margin of approximately 4 to 1 for both 2000 and 2010
(USEPA, 1999b).
The benefit for Title VI (stratospheric ozone depleting compounds) was estimated
separately and found to be $530 billion (in 1990 dollars). This benefit estimate was not
considered in the overall results because the benefits were estimated over 175 years (i.e.,
the time period from 1990 through 2165) (USEPA, 1999b). The data in the prospective
study indicated that some titles delivered greater positive net benefits than others. A
1999 study by Smith and Ross (as cited in Krupnick and Morgenstern, 2002)
disaggregated the benefits of the 1990 CAAA by title. The total benefit estimates in 2010
(in 1990 dollars) was approximately $110 billion. The study attributed approximately
$26.6 billion (in 1990 dollars) of benefits to Title I (attainment and maintenance of
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NAAQS), $15 billion to Title II (mobile sources), $1.9 billion to Title III (hazardous air
pollutants), and $69.3 billion to Title IV (reducing acid rain precursors — SO2 and NO R)
(Krupnick & Morgenstern, 2002). Therefore, Title III accounted for approximately 2
percent of the total benefits of implementing Titles I through IV.
The estimated costs (in 1990 dollars) for compliance in 2010 with Title I was
predicted to be $14.5 billion, Title II was $9 billion, Title III was $840 million., Title IV
was $2 billion, and Title V (permitting) was 300 million (USEPA, 1999b). The data
indicate that the Title III provisions comprised only a small fraction of the total costs of
implementing the provisions of the 1990 CAAA (i.e., $840 million out of $27 billion).
Therefore, the cost of meeting the requirements of Title III was approximately 3 percent
of the total costs of implementing Titles I through IV.
The prospective study used an approach that compared two distinct scenarios, a
pre-CAAA scenario, and a post-CAAA scenario. The Pre-CAAA scenario takes the
emissions and air pollution control situation as it existed in 1990 and sets this as the
baseline. The Post-CAAA scenario considers the implementation of the 1990 CAAA.
The study uses economic activity projections to estimate the Pre-CAAA and Post-CAAA
emissions for the two target years, 2000 and 2010 (USEPA, 1999b).
With regards to Title III, the prospective study only considered the impacts of the
2- and 4- year MACT standards in the benefits and costs analyses (USEPA, 1999b). The
2-year MACT standards were the dry cleaning NESHAP and the hazardous organic
NESHAP (HON). The 4-year MACT standards were NESHAPs for the followings
source categories: aerospace; chromium electroplating; coke ovens; commercial
sterilizers; degreasing organic cleaners; gasoline distribution (stage 1); hazardous waste
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combustion; industrial cooling towers; magnetic tape surface coating; marine vessel
loading operations; off-site waste and recovery operations; petroleum refineries;
polymers and resins (I, II, & IV); printing and publishing surface coating; secondary lead
smelters; shipbuilding and ship repair surface coating; and wood furniture surface
coating. There are an additional twenty-one 7-year MACT standards and forty-seven 10-
year MACT standards whose benefits and costs were not considered in the prospective
study (USEPA, 1999b, 2006j). It is anticipated that the costs to implement Title III will
rise when the full costs of implementation of all the MACT standards are considered.
Furthermore, the benefits and costs of any residual risk standards were not considered in
the prospective study. If a residual risk assessment indicates that emissions exceed a
specified risk threshold after the technology-based controls have been instituted then
additional air pollution controls will need to be installed.
The USEPA was unable to quantify the health effects associated with reductions
in exposure to HAPs due to a lack of monitoring data, limited and inconsistent emission
inventories, lack of scientific literature on the effects of HAPs, and limited air modeling.
The USEPA identified this as a source of uncertainty with a likely major significance
since it could potentially lead to an underestimate of the net benefits. Since the data was
not available to do a quantitative risk assessment for the HAPs, the USEPA assumed an
80 percent rule effectiveness for all control measures under Title III (USEPA, 1999b).
This assumption simply reduced the Pre-CAAA and Post-CAAA estimated values in
2000 and 2010 by 80 percent.
The Council also reviewed the second USEPA report and again the Council
suggested that aggregate cost and benefits be broken down into individual titles. Other
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findings of the Council included recommending that the USEPA revise its estimates for
the value of a statistical life (VSL) and present cost effective results in terms of Net Cost
per Life Saved as well as Net Cost per Life-Year Saved (USEPA, 1999a). A critical gap
identified by the Council is that neither report presented any quantitative benefit and cost
analyses or other data on specific HAPs. Instead, the focus was primarily on the criteria
pollutants: sulfur dioxide (SO2), nitrogen oxides (N0x), carbon monoxide (CO),
particulate matter (PM), ozone (03), and lead (Pb). The USEPA and the Council cited
the fact that essential data were lacking for the HAPs and therefore, they were not fully
incorporated into either of the studies (USEPA, 1997a, 1999a).
An independent review of the USEPA's first two studies emphasized the need to
separate the costs and benefits of future analyses into specific titles and recommended
focusing future studies on specific policy issues that have the potential to increase the net
benefits of the CAA in the future (Krupnick & Morgenstern, 2002). For example,
decreased mortality accounted for approximately 81% and 90% of the benefits in the first
and second Section 812 reports, respectively. Since decreases in mortality are a major
benefit associated with implementation of the CAA, it would be important to study the
magnitude that the decreases in HAP emissions due to the provisions of Title III would
have on mortality.
2.5 Human Health Risk Assessment
In 1983, the National Research Council (NRC) published a report entitled Risk
Assessment in the Federal Government: Managing the Process which has become the
foundation of risk assessment theory and practice (National Research Council, 1983).
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The report is commonly referred to as the "Red Book" because of its bright red cover.
The Red Book addresses the practice of risk assessment, how to improve the practice of
risk assessment, and how to distinguish risk assessment from risk management. The Red
Book's recommendations have helped shape risk policy and practices in government,
academia, and industry (Johnson & Reisa, 2003). In 1984, the Administer of the USEPA,
William Ruckelshaus, officially endorsed the framework for risk assessment and risk
management presented in the Red Book as the primary framework to be used in USEPA
decision making (Andrews, 2000; Ruckelshaus, 1983). In 1994, the NRC published
Science and Judgement in Risk Assessment which expanded on the methodologies for
carrying out risk assessments (National Research Council, 1994).
The Red Book defines risk as "the probability of injury, disease, or death under
specific circumstances" and risk assessment as "the characterization of the potential
adverse health effects of human exposure to environmental hazards" (National Research
Council, 1983). The definitions combine two concepts: hazard and probability. This is
one area that causes confusion when people discuss risk assessment (Andrews, 2000).
People often simply assume that hazard equals risk. However, this is not a valid
assumption; a hazard does not always pose a risk. In order for a hazard to cause an effect
there must be some type of exposure to the hazard. In the risk assessment framework, the
probability or likelihood of suffering an effect is based on the severity of the hazard and
the magnitude of the exposure to the hazard.
The Red Book essentially codified the following four steps of a risk assessment
(Johnson & Reisa, 2003; National Research Council, 1983, 1994). In each step, the
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relevant and scientifically reliable information is evaluated and the related uncertainties
are described (USEPA, 2000c).
■ Hazard Identification: The determination of whether a particular chemical is or is
not casually linked to particular health effects.
■ Dose-Response Assessment: The determination of the relation between the
magnitude of exposure and the probability of occurrence of the health effects in
question.
■ Exposure Assessment: The determination of the extent of human exposure before
or after application of regulatory controls.
■ Risk Characterization: The description of the nature and often the magnitude of
human risk, including any uncertainty.
In this study, the hazard identification step involved identifying source facilities,
determining the timeframe of interest, and researching the air emissions from these
source facilities. The dose-response assessment step involved researching the toxicity
data available for all the emitted chemicals and describing the relationship between the
magnitude of exposure and the degree of the toxic effect. In the exposure assessment
step, data on the emission sources and the mass emission rates were used in an air
dispersion model to predict the spatial and temporal exposure distribution in the vicinity
of the source facilities. The selection of the air dispersion model is discussed in the next
section. The final step, the risk characterization step, combined the information from the
previous three steps to predict a numerical estimate of mortality and morbidity. Risk
characterization is the culminating step of the risk assessment process which
communicates the key findings and the strengths and weaknesses of the assessment
(USEPA, 2000c). In this study, the risk characterization was aided by the use of a
Geographical Information System (GIS), which allowed for better analyses of the
interactions between environmental exposure and public health.
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The results of this study can be used by policy makers and regulators in choosing
and justifying regulatory decisions (Andrews, 2000; National Research Council, 1994).
William Ruckelshaus suggested that our laws need to reflect scientifically sound risk
assessments. Ruckelshaus' belief was that "scientists assess the risk and find out what the
problems are. The process of deciding what to do about the problems is risk
management" (Ruckelshaus, 1983). The risk management process starts with the
predicted health risks and then determines what the possible control options are. Risk
management decisions may be influenced by factors such as the benefits and the costs of
the various control options (Ruckelshaus, 1983). The main goal of the risk assessment is
to prioritize the numerous environmental risks. This prioritization is then used during the
risk management step to inform regulatory decision making and aid in the allocation of
limited funds so that they go towards reducing the most serious risks (Russell & Gruber,
1987).
Travis et al. (1987) examined 132 federal regulatory decisions on environmental
carcinogens from 1976 through 1985. The results revealed that every chemical with an
individual lifetime excess cancer risk of 1 in ten thousand was regulated while only one
chemical with a risk less than 1 in one million was regulated. Risk alone was the primary
reason for regulating the chemicals that posed the highest risk. Regulatory decision
making on the chemicals that posed a risk less than 1 in ten thousand was based on risk
and cost effectiveness of the regulation (Travis et al. as cited in Andrews, 2000). The
results of the Travis study also relate to the discussion on AMOS since the results support
the earlier consideration that an excess cancer risk of 1 in ten thousand is a tolerable risk.
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2.6 Air Dispersion Modeling
Air dispersion models are designed to predict the fate and transport of air emissions of
pollutants in the atmosphere. Generally, emitted pollutants mix with the air where
physical processes, such as turbulence, and chemical reactions cause the pollutant to
disperse and the concentration to decrease. In some cases, chemical reactions involving
the primary pollutants produce secondary pollutants, such as ozone. Air dispersion
models predict the spatial and temporal ambient air concentrations of a chemical using
mathematical equations that describe the numerous and complex meteorological
processes that are responsible for dispersion. The calculations are based on user input
such that the greater the accuracy in the model inputs the greater the accuracy of the
modeling results. Data input includes actual meteorological data, source emission data in
the form of a mass emission rate, dimensions of nearby structures, and actual local terrain
information.
Most USEPA regulatory air dispersion modeling in the United States is conducted
in accordance with the procedures outlined by the USEPA in the Guideline on Air
Quality Models (hereafter, the Guideline) which provides federal guidance for all USEPA
regulatory modeling performed in the U.S. (USEPA, 2005d). Currently, there are two air
dispersion models commonly used in the United States to model gaseous pollutants over
a short range: AERMOD (American Meteorological Society/Environmental Protection
Agency Regulatory Model) and ISC (Industrial Source Complex). The November 2005
revision to the Guideline replaced the widely used ISC model with AERMOD, a state-of-
the-practice air dispersion model.
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The ISC model was originally released in the early 1980's and has undergone
several revisions of both the code and the algorithms used to model dispersion (Paine &
Lew, 1997). The current version of the ISC model was released in 1995 (USEPA,
1995a). The ISC model is based on a simplistic understanding of atmospheric processes,
while the newer AERMOD model incorporates what has been learned about air
dispersion modeling in recent years to more accurately represent the current
understanding of dispersion in the atmosphere (Trinity Consultants, 1999).
The ISC model is a Gaussian dispersion model that assumes any release from a
source disperses in a steady-state manner from the time of release until the time it reaches
the receptor. Gaussian dispersion models also assume that a normal distribution can
characterize the horizontal and vertical spread of a plume (Trinity Consultants, 1999).
The ISC model requires input data on source characteristics, receptor location,
meteorological parameters, and topography.
The Gaussian dispersion models are based on a simplistic understanding of
atmospheric processes. Therefore, in 1991, the American Meteorological Society (AMS)
and the USEPA co-sponsored a committee called the AMS/EPA Regulatory Model
Improvement Committee (AERMIC) that developed the AERMOD model. AERMOD
incorporates many of the same algorithms as ISC but contains advanced algorithms for
dispersion, plume rise, buoyancy and the handling of complex terrain. AERMOD, like
ISC, is a steady-state model and is most useful for analyzing short-range pollutant
transport within 20 kilometers of the source (Trinity Consultants, 1999; USEPA, 2002b).
As such, AERMOD is considered by the USEPA and the scientific community to be a
theoretically better model (USEPA, 2005d).
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A review of the available literature found several studies by the USEPA and
independent consultants that attempted to evaluate and validate AERMOD. The findings
of many of these studies were presented at the USEPA's 7 th Conference on Air Quality
Modeling held in June 2000 in Washington, D.C. (USEPA, 2000e). The main
justification for replacing ISC with AERMOD was that AERMOD incorporated many of
the scientific advances made in the 1970's and 1980's in understanding turbulence and
dispersion in the planetary boundary layer (PBL). The PBL is the turbulent region of the
atmosphere where pollutants are emitted, transported, mixed, and dispersed (Weil, 2000).
AERMOD's treatment of the PBL is therefore, considered more realistic. The AERMOD
meteorological pre-processor (AERMET) makes use of the surface characteristics of the
land surrounding the facility along with the hourly surface meteorological data to produce
more realistic values of parameters that affect dispersion such as albedo, bowen ratio, and
surface roughness. These parameters are discussed in further detail in Section 3.2.3.3
(Meteorological Data).
In this study, air dispersion modeling was carried out to determine the fate of the
vapor phase emissions in the atmosphere and to estimate air concentrations of pollutants
at specific ground level geographical receptor locations for defined averaging times. The
air dispersion model used in this study was AERMOD.
2.7 Geographical Information Systems (GIS)
GIS can be a very powerful tool in risk assessment. It can be used to better illuminate the
interaction between environmental pollution and public health (Jarup, 2004). GIS has
been used in environmental justice assessments to study the geographic distribution of
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industrial air emissions by income and race (Chakraborty, 2001; Dolinoy & Miranda,
2004; Maantay, 2002; Perlin et al., 1995). GIS allows analysis at several different
geographical units of analysis, such as a census tract, the block group, a municipality, zip
codes, or radius circles around a point of release (Chakraborty, 2001; Perlin et al., 1995).
GIS has been used to assess exposure to air pollution from traffic (Bellander et al.,
2001); from fine particulate matter (Goswami et al., 2002; Levy et al., 2001); from
products of combustion (Bellander et al., 2001; Levy et al., 2001); and from airborne
dioxin (Poulstrup & Hansen, 2004). Several studies have demonstrated the integration of
air dispersion modeling with GIS to assess geospatial trends in pollution and exposure
(Balagopalan, 1999; Dent et al., 2000; Folgert & Metcalfe, 1997; Kinman et al., 1999).
In several of the studies (Balagopalan, 1999; Dent et al., 2000; Dolinoy & Miranda, 2004;
Kinman et al., 1999; Perlin et al., 1995), the air emissions data was extracted from the
USEPA Toxic Release Inventory (TRI) database similar to what was done in this study.
Two papers provided a review of the literature where GIS was used to organize and map
health data, such as, disease rates and potential sources of environmental exposure
(Nuckols et al., 2004; Rushton, 2003). Both reviews concluded that a new discipline,
referred to as spatial epidemiology, will continue to enhance our understanding of the
association between environmental contaminants and disease and will alert public health
workers to disease clusters that require further attention.
Using GIS allows the risk assessor to leverage very high resolution geodata (e.g.,
digital orthophotos, digital terrain maps, and land-use land-cover data) during the hazard
identification, the exposure assessment, and the risk characterization phases. During the
risk characterization phase, GIS allows for realistic assessments of exposures and
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exceedances. Using a GIS, the risk assessor can determine if the point of maximum
concentration is located near a potential receptor of interest. If it is not, the risk assessor
can perform a realistic survey of the community to locate the most probable receptor and
the associated modeled concentration at that receptor.
2.8 Valuation of Benefits
There are several broad categories of benefits that can be evaluated when studying the
effectiveness of air pollution reduction programs. Categories such as decreased
destruction of buildings are indicators of economic activity because the repair of a
building has a cost associated with it. Other indicators of economic activity include
benefits to production or consumption (e.g., crops, forests, fisheries, or water supplies)
and benefits to economic assets (e.g., reduced corrosion or increased property values).
On the other hand, benefits such as increased visibility, decreased pollutant levels, and
overall cleaner skies are welfare enhancing benefits that are not sold in markets and
therefore, their value is not well defined (Davies & Mazurek, 1998). Other non-market
benefits include: benefits to individuals, such as, reductions in mortality, reductions in
morbidity or benefits to other environmental assets (e.g., recreation, visibility, or inherent
value). It has been estimated that more than 90 percent of the environmental benefits of
the CAA are due to non-market benefits and a majority of theses benefits are seen as
decreases in mortality (Davies & Mazurek, 1998; Krupnick & Morgenstern, 2002).
In order to estimate the benefits of an air quality regulation, the changes in air
quality must somehow be translated into improvements in human health. This is often
difficult because the effects of air pollutants can range from minor and reversible effects
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(e.g., eye irritation), to debilitating effects (e.g., aggravation of asthma or chronic
bronchitis) and in the worse case, fatal effects (e.g., cancer). In order to compare the
costs of implementing the CAA to the benefits gained as a result of the CAA's programs,
a monetary value must be assigned to the human health benefits of decreased morbidity
(i.e., chronic and debilitating health effects) and mortality (i.e., death) that are gained as a
result of the regulation.
In the USEPA's prospective Section 812 study, the agency explained the
assumptions used to derive the necessary monetary values of health effects (USEPA,
1999b). In that study a higher value was placed on mortality than on morbidity
(Krupnick & Morgenstern, 2002). In order to do that, the USEPA looked at the WTP
data gained from numerous studies in the literature and made valuation estimates on
several different health effects. The WTP data is an individual's WTP to avoid sickness
or death. In cases where the WTP data was lacking, the USEPA used data on the cost of
treatment or the cost of illness (COI). However, the COI estimates generally
underestimate the value of avoiding a health effect because they only consider direct
costs and ignore utility benefits such as happiness derived from better health (USEPA,
1999b). In the prospective study, the values (in 1990 dollars) for morbidity due to
respiratory illness from chronic bronchitis and chronic asthma were $260,000 per case
and $25,000 per case, respectively. These values represent the people's WTP to avoid a
case of chronic respiratory disease (USEPA, 1999b).
The USEPA retrospective and prospective Section 812 studies also estimated the
benefit of mortality effects. Here the benefit is the avoidance of small increases in the
risk of dying. By summing the individual WTP data to avoid small increases in the risk
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of mortality over enough individuals the USEPA estimated the value of a single statistical
death avoided (or life saved) as a result of regulatory action. This valuation was referred
to as the Value of a Statistical Life (VSL). Both studies used a VSL of $4.8 million (in
1990 dollars) (USEPA, 1999b).
In addition to the VSL, the USEPA carried out another valuation calculation
based on life-years lost and referred to this as the value of statistical life-year (VSLY)
approach. The VSLY approach looks at the number of life years saved as opposed to the
number of lives saved. Calculation of the VSLY takes into consideration the fact that
older individuals have a shorter life expectancy than younger people do and as such, the
VSLY prorates and discounts the VSL proportional to the life expectancy. Discounting
means that the present value of a life saved today is worth more than the present value of
a life saved in the future. In other words, a life saved today is worth more than a life
saved tomorrow. The USEPA employed the VSLY approach by first estimating the age
distribution of those lives projected to be saved by reducing air pollution. A life
expectancy table is then used to calculate the life years saved for each statistical life
within each age and gender cohort (USEPA, 1999b). If the discount rate increases, the
present value of the benefit would decrease and the VSLY would increase. The VSLY
can be multiplied by the number of years of remaining life expectancy for the affected
population to derive the total benefit (USEPA, 1999b).
The VSLY methodology has the potential to negatively impact the elderly, who
have fewer life years remaining and therefore, the estimated benefits would be less. The
question then becomes should we spend as much to prevent mortality in older people as
we do to prevent mortality in younger people? As expected, this was a highly
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contentious issue since it created equity issues across age cohorts. The VSLY only
considers age but if it were expanded to include other socio-economic parameters, it
could potentially create numerous equity and ethical issues. The USEPA has since
moved away from the use of the VSLY. The current practice is to apply the same VSL to
all ages and all risks (Maguire, 2006).
Most economists agree that WTP is an accepted benefits metric for government
and policymakers to use as a tool when evaluating policies that are meant to reduce risks
to human health (Jones-Lee et al., 1985; Pratt & Zeckhauser, 1996). The fundamental
principle of the WTP approach is that social decisions should reflect the individual
preferences of those affected (i.e., consumer preferences) and therefore, different people
will have different amounts they would be willing to pay for small reductions in their
probability of dying. The WTP approach tends to focus on individual marginal rates of
substitution of money in turn for a small decrease in the risk of death or injury (Jones-Lee
et al., 1985). Studies indicate that individuals are usually willing to pay more for a
specified reduction in risk, if the risk is concrete and concentrated. For example, people
are willing to pay more to save an identified life than a hypothetical statistical life, and
more willing to pay for remedies than for preventive measures (Pratt & Zeckhauser,
1996). Pratt and Zeckhauser also explored the rational choice theory that individuals go
through when they are faced with life threatening risks. One problem with the valuation
of health risks, that makes it different from consumer goods, is that any point estimate of
a market price may not accurately reflect the vast level of interpersonal variation
observed in the WTP approach (Rosen, 1981).
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Viscusi (1993, 1995, 1996) pointed out that even if society wanted to provide a
world free of risk, our economic resources are limited and do not allow for such an
option. If policymakers do not place bounds on risk reduction efforts, then society will
eventually end up with policies that cost more and more because of diminishing returns.
Such practice would also divert resources from more productive or beneficial uses
(Viscusi, 1995, 1996). If it is not practical to reduce risks to the lowest level, then what
levels of risk and cost are acceptable? The major consideration here would be the level
of risk reduction achievable for a given expenditure and the value that society places on
that level risk reduction (Viscusi, 1993). Since the answers to these questions are not
easily resolved, the common approach policymakers take is to regulate uniformly to an
established level (i.e., the command and control approach). Consideration of costs and
benefits may or may not enter into the decision making process. Consequently, a BCA
can be a useful tool for regulators to use in determining the economic feasibility of a
regulation.
2.9 National Scale Air Toxics Assessment
The National Scale Air Toxics Assessment (NATA) is the USEPA's ongoing
comprehensive evaluation of toxic air pollutants in the United States. In 2002, the
USEPA released the first NATA on 32 of the 188 listed HAPs using emissions data from
the 1996 National Toxics Inventory (NTI). The assessment concluded that of the four
main source types (i.e., area stationary, major stationary, on-road mobile, non-road
mobile), no one source type was a dominant contributor to the estimated concentrations
(USEPA, 2003g). In February 2006, the USEPA released the second NATA on 133 of
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the 188 listed HAPs using air toxics emissions from the 1999 NTI. The USEPA has
released a fact sheet which details the major findings (USEPA, 2006g). The following
bullets were excerpted directly from the USEPA's technical fact sheet. In general the
results showed:
■ From a national perspective, benzene is the most significant air toxic for which
cancer risk could be estimated, contributing twenty-five percent of the average
individual cancer risk. Based on the USEPA's national emissions inventory, the
key sources for benzene are on-road (49%) and non-road mobile sources (19%),
and open burning, prescribed fires and wildfires (14%).
■ For most of the noncancer health effects the USEPA assessed (e.g., liver, kidney,
developmental effects), the estimated exposures were below levels at which
adverse health effects are expected. The USEPA's assessment indicates the
potential for two types of noncancer effects: respiratory and neurological. Of
these, respiratory health effects show a higher potential for adverse effects to the
greatest number of people; considerably higher levels than neurological.
■ The assessment estimates that in most of the country people have a lifetime cancer
risk from air toxics between 1 and 25 in a million. This means that out of one
million people, between 1 and 25 people have increased likelihood of contracting
cancer as a result of breathing air toxics from outdoor sources, if they were
exposed to 1999 levels over the course of their lifetime. The assessment estimates
that most urban locations have air toxics lifetime cancer risk greater than 25 in a
million. Risk in transportation corridors and some other locations are greater
than 50 in a million. In contrast, one out of every three Americans (330,000 in a
million) will contract cancer during a lifetime, when all causes (including
exposure to air toxics) are taken into account. Based on these results, the risk of
contracting cancer is increased less than 1% due to inhalation of air toxics from
outdoor sources.
■ Over 92% of the U.S. population have "hazard index" values for respiratory
toxicity (a measure of the relative hazard for effects other than cancer) greater
than 1.0 and over 17% of the U.S. population have "hazard index" values greater
than 10. Because these exposures exceed the no-effect levels (1.0 or less) for
effects to the respiratory system, this result suggests that some people may
experience an increased risk of respiratory irritation or other adverse respiratory
effects from exposure to air toxics.
Based on the findings of the 2002 NATA, it appears that toxic air pollutants are a public
health concern that requires further continued attention. It is important to realize that
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both NATAs are meant to help regulatory agencies and communities understand the
emerging air toxics issues and trends. They are not intended to be used for estimating
risk at the local level, for quantifying benefits of reduced emissions, or for identifying
localized hotspots (USEPA, 2006g). One interesting conclusion the USEPA makes in the
2006 NATA is that "the risk of contracting cancer is increased less than 1% due to
inhalation of air toxics from outdoor sources". This finding suggests that reductions in
HAPs may not lead to significant changes in actual mortality.
This study looked at the baseline risk in 1990 posed by 17 source facilities in NJ.
Using the results of the risk assessment, this study estimated the magnitude change in
mortality and morbidity, due to anticipated reductions in HAPs, which would be achieved
through implementation of the provisions of Title III of the 1990 CAAA.
CHAPTER 3
DATA AND METHODS
3.1 Study Area and Source Facilities
New Jersey was the overall geographic area of interest for this study. Information on
HAPs in NJ was reviewed in order to identify a specific geographic area for the study.
The USEPA's Air Toxics website, which included information on the 2002 NATA was
examined first (USEPA, 2003g). As part of the 2002 NATA initiative, the USEPA
conducted a national-scale assessment of 32 air toxics based on 1996 emissions data. In
addition to the 2002 NATA results, information on HAPs in NJ was obtained from the
Environmental Defense Fund (EDF) Scorecard (EDF, 2003, 2005). Both the 2002
NATA and the EDF Scorecard defined stationary sources as stacks and vents located
within industrial source facilities (e.g., chemical plants, oil refineries, power plants, and
hazardous waste incinerators) that meet the classification of a major source as defined in
Section 112 of the CAA. A major source is any stationary source or group of stationary
sources located within a contiguous area under common business control (e.g., an
industrial facility) that emits or has the potential to emit (considering controls) in
aggregate, 10 tons per year (tpy) or more of any one HAP or 25 tpy or more of any
combination of HAP (Brownell, 2001; Martineau, 2004; USEPA, 1990a). Area sources
were defined as sources that generally have smaller emissions on an individual basis than
major sources and are often too small or ubiquitous in nature to be inventoried as
individual sources. Area sources include facilities that have air toxics emissions below
the major source threshold as defined in Section 112 of the CAA and thus emit less than
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10 tpy of a single HAP or less than 25 tpy of multiple HAPs (Brownell, 2001;
Martineau, 2004; USEPA, 1990a).
The EDF Scorecard rankings for HAPs indicated that NJ, when compared to other
states in the United States, ranked in the 90 th - 100th percentile, as one of the dirtiest/worst
states. The EDF Scorecard rankings were based on exposure estimates derived from the
1996 Toxic Release Inventory (TRI) data on emissions and accepted USEPA exposure
estimates. Section 313 of the Emergency Planning and Community Right to Know Act
(EPCRA) of 1986 (also known as Title III of the Superfund Amendments and
Reauthorization Act (SARA)) required source facilities to submit TRI reports to both the
USEPA and their state agency. In addition, many states, including NJ, created their own
TRI programs (USEPA, 2004c).
The EDF Scorecard results are meant to provide a perspective on the magnitude
and sources of HAP problems (EDF, 2003). The EDF Scorecard indicated that the
average individual's added cancer risk in NJ was 1,400 per million people for point
sources and 46 per million people for area sources. The EDF Scorecard also reported a
noncancer cumulative hazard quotient of 0.12 for point sources and 0.46 for area sources.
The hazard quotient was defined as the increased probability of developing adverse but
non-cancer health effects over a lifetime from exposure to the modeled ground level air
concentrations of HAPs. Hazard quotients greater than one indicate an increased
probability of suffering of a chronic disease (morbidity) as a result of exposure to a
pollutant. According to the EDF Scorecard, NJ ranked in the highest 20% of all states for
the number of people living in areas where the estimated cancer risk from HAPs was
greater than 1 in ten thousand (EDF, 2005).
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Building on the information learned from the review of the 2002 NATA and the
EDF Scorecard, the USEPA's TRI database was used to obtain preliminary data on the
emissions of HAPs in NJ. The USEPA compiles the TRI data each year into a database
and makes the data publicly available on-line through the USEPA's TRI Explorer and the
USEPA's Envirofacts. There are also non-governmental organizations (e.g., EDF) which
make the data available on-line through their own data access tools (e.g., EDF's
Scorecard). Detailed information on the TRI data and the potential uses for the data are
available on-line from the USEPA's TRI website (USEPA, 2004b).
For this study the USEPA's TRI Explorer was used to query the TRI database.
TRI Explorer is an on-line tool that allows the TRI database to be searched electronically
(USEPA, 2004d). The first year that the TRI data was compiled was 1988 (Martineau,
2004), however the TRI database only contains data starting with the year 1989. TRI
Explorer was originally designed to help communities identify source facilities and
chemical releases that warrant further study and analysis and as such provided a fast and
easy way to access the TRI data (USEPA, 2004b). In NJ, the Department of
Environmental Protection (NJDEP) is responsible for the state program. The NJ TRI data
is accessible on-line from the NJDEP (NJDEP, 2004b).
The first query of the TRI database was a report for all industries. An industry
report was generated for all HAPs, for all industries in NJ. This query produced a
downloadable data set that contained data on fugitive air emissions, stack air emissions,
and total air emissions of HAPs in pounds. The query was run once a year from 1988
through 2001. The results from the first query indicated that industries in the Standard
Industrial Classification (SIC) major group code of 28 were a significant source of air
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pollution (Table 3.1). SIC code 28 represents chemicals and allied products (OSHA,
2005). The SIC system is a series of number codes that attempts to classify all business
establishments by the types of products or services they provide. Establishments engaged
in the same activity, whatever their size or type of ownership, are assigned the same SIC
code. Within the manufacturing sector, chemicals and allied products are represented by
the major group code 28. This major group includes establishments producing basic
chemicals and establishments manufacturing products by predominantly chemical
processes. Establishments classified in this major group produce three general classes of
products: (1) basic chemicals, such as acids, alkalies, salts, and organic chemicals; (2)
chemical products to be used in further manufacture, such as synthetic fibers, plastics
materials, dry colors, and pigments; and (3) finished chemical products to be used for
ultimate consumption, such as drugs, cosmetics, and soaps; or to be used as materials or
supplies in other industries, such as paints, fertilizers, and explosives (OSHA, 2005). It
should be noted that the SIC code has now been replaced by the North American
Industrial Classification System (NAICS) (USCB, 2006a). Since the SIC code was in use
in 1990 (the baseline year for this study) use of the SIC code was considered appropriate
for this study.
As shown in Table 3.1, even though the annual quantity of HAPs emitted by all
industries of SIC code 28 has decreased dramatically, they still ranked either first or
second compared to all other SIC codes. From 1988 through 1997, the chemical industry
(SIC code 28) ranked first in terms of overall pounds of HAPs emitted. Beginning in the
1998 reporting year, source facilities in the electric utilities industry category
(SIC code 49) were required to report their emissions. Since 1998, the electric utilities
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industry has ranked above the chemical industry in terms of pounds released (USEPA,
2004b).
Table 3.1 HAPs Released by All Industries of SIC Code 28 in NJ
TRI Year Fugitive Air(pounds)
Stack Air
(pounds)
Total Air Emissions
(pounds)
NJ TRI Ranking by
Total Air Emissions
1988 3,755,598 5,148,992 8,904,590 1
1989 2,759,608 4,979,370 7,738,978 1
1990 2,051,782 4,095,593 6,147,375 1
1991 1,618,667 3,802,936 5,421,603 1
1992 1,676,766 3,145,934 4,822,700 1
1993 1,271,132 1,958,265 3,229,397 1
1994 820,312 2,282,367 3,102,679 1
1995 767,615 2,792,110 3,559,725 1
1996 672,790 2,548,211 3,221,001 1
1997 702,354 2,690,541 3,392,895 1
1998 728,898 1,325,765 2,054,663 2
1999 667,919 1,791,611 2,459,530 2
2000 632,931 1,379,613 2,012,545 2
2001 543,243 1,002,706 1,545,949 2
Source: TRI database (USEPA, 2004b).
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The second query of the Till database was a report by geography. The report was
generated for all HAPs, released by all industries of SIC code 28, in all counties,
throughout NJ. This query was run in order to identify a specific geographic region for
this study. The query was run annually per county in NJ to obtain data for 1988 to 2001,
inclusive. The queries each produced a downloadable data set that contained data about
on-site and off-site reported releases of HAPs in pounds. Table 3.2 shows that Essex
County, Middlesex County, and Union County consistently ranked high in terms of the
amount of HAPs emitted. Essex, Union, and Middlesex Counties are located in northern
NJ. As shown in Figure 3.1, these three counties lie within a heavily urban and
industrialized area of NJ and in close proximity to both New York City and the ports of
NJ and New York (NY).
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Table 3.2 HAPs Released by Industries of SIC Code 28 in NJ, by Coun
TRI
Year County
Fugitive
Air
(pounds)
Stack
Air
(pounds)
Total Air
Emissions
(pounds)
NJ TRI Ranking
by Total
Air Emissions
1988 Middlesex 1,049,050 1,071,428 2,120,478 1
1988 Essex 616,210 1,067,670 1,683,880 2
1988 Union 386,364 509,044 895,408 3
1989 Middlesex 872,055 1,008,091 1,880,146 1
1989 Essex 411,765 1,073,934 1,485,699 2
1989 Union 200,239 306,652 506,891 4
1990 Essex 239,696 695,534 935,230 2
1990 Middlesex 277,567 522,970 800,537 3
1990 Union 291,383 451,211 742,594 4
1991 Essex 195,965 795,450 991,415 1
1991 Middlesex 264,685 650,966 915,651 2
1991 Union 420,432 403,224 823,656 3
1992 Essex 150,243 1,036,524 1,186,767 1
1992 Union 343,185 324,447 667,632 3
1992 Middlesex 235,226 383,901 619,127 4
1993 Union 280,234 288,946 569,180 1
1993 Essex 149,495 397,245 546,740 2
1993 Middlesex 194,174 323,262 517,436 3
1994 Union 181,501 356,101 537,602 3
1994 Essex 116,933 412,620 529,553 4
1994 Middlesex 200,538 230,188 430,726 5
1995 Essex 114,009 444,903 558,912 4
1995 Union 214,790 329,094 543,884 5
1995 Middlesex 324,557 218,181 542,738 6
1996 Middlesex 212,740 353,240 565,980 3
1996 Union 224,469 296,989 521,458 5
1996 Essex 63,356 275,347 338,703 6
1997 Essex 60,109 431,324 491,433 4
1997 Middlesex 166,823 304,841 471,664 5
1997 Union 149,085 288,493 437,578 6
1998 Middlesex 179,090 286,049 465,139 2
1998 Union 202,411 232,234 434,645 3
1998 Essex 94,203 147,931 242,134 5
1999 Union 224,172 279,620 503,792 3
1999 Middlesex 123,281 202,684 325,965 4
1999 Essex 66,987 151,651 218,638 5
2000 Union 244,274 271,361 515,635 2
2000 Middlesex 142,570 195,872 338,442 4
2000 Essex 72,263 141,330 213,593 6
2001 Middlesex 199,369 199,860 399,229 3
2001 Union 172,684 209,175 381,859 4
2001 Essex 82,522 102,469 184,991 5
Source: TRI database (USEPA, 2004b).
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Figure 3.1 Geographic location of Essex, Union, and Middlesex Counties.
Source: County boundary shapefiles obtained from NJDEP (NJDEP, 2004a).
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The third query of the TRI database was carried out for all source facilities of SIC
code 28, for all HAPs, by specified county (i.e., Essex, Middlesex and Union), by year of
interest. This query was run to identify the source facilities from which the air pollution
emissions originated. This query was run 14 times per county, for each of the three
counties, to obtain data for 1988 to 2001, inclusive. The queries each produced a
downloadable data set that included on-site and off-site reported releases of HAPs in
pounds. The downloaded data also contained information on the TRIF ID (the TRI
facility identification number), the geographic coordinates of the facility (latitude and
longitude), and specific information on pollutant releases (i.e., fugitives, stack, and total
air releases).
As discussed previously, 1990 was selected as the baseline year for this study.
The 1990 data was filtered to identify the source facilities that emitted greater than 10 tpy
of a single HAP or 25 tpy of multiple HAPs. Facilities meeting the major source criteria
in 1990 were selected as candidates for the MACT standards and therefore, were selected
for inclusion in the study. Twenty (20) source facilities were initially selected for
inclusion in the study. Seven source facilities were located in Essex County, eight in
Middlesex County, and five in Union County.
In NJ, the Open Public Records Act (OPRA) mandates disclosure of
governmental records and allows the public to access these records. An OPRA request
was performed on all 20 source facilities to obtain the 1990 emission statements and air
permits on file at the NJDEP. Information on NJ's OPRA and the forms needed to carry
out the OPRA requests were accessed on-line from the NJDEP. The OPRA request was
processed by the NJDEP and emissions statements for 17 of the 20 source facilities were
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located. The three source facilities for which there was no information were ISP Van
Dyk Inc. (Essex County), Ferro Corporation (Middlesex County) and Nutro Labs Inc.
(Middlesex County). The initial OPRA request was followed up with a second OPRA
request in order to locate information on the three missing source facilities. The second
OPRA request was also unable to locate information on the three missing source
facilities. The NJDEP could not provide any additional information on why there were
no emissions statements for these source facilities for 1990. One possibility was that
1990 was the first reporting year and therefore, these source facilities may not have
reported (D. Wong, NJDEP, personal communication, October 8, 2004). The emissions
statements for 1991 and 1992 were also requested to check if they could be used to fill
gaps in the 1990 data. The research into the 1991 and 1992 data revealed that the NJDEP
did not collect data for 1991 and much of the data for 1992 was of low quality and with
many missing data points (D. Wong, NJDEP, personal communication, October 8, 2004).
In conclusion, the 1990 data represented the best available data from the early
years of reporting and therefore, was chosen for use in the study. Since no emissions
statements for 1990 could be located for ISP Van Dyk Inc., Ferro Corporation, and Nutro
Labs Inc. these three source facilities were dropped from the study. The 1990 emissions
statements for the remaining 17 source facilities were then examined to determine the
number of point sources and the HAPs emitted by each point source. Table 3.3 lists the
17 source facilities that were selected for inclusion in this study. Figure 3.2 shows the
geographic location of the 17 source facilities in NJ.
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Table 3.3 Source Facilities Identified in the Study Area
Facility City County TRIF ID
1. Firmenich Inc. Newark Essex 07114CHMFL92896
2. Hoechst Celanese Corporation Newark Essex 07105HCHST354D0
3. Hoffmann-La Roche Inc. Nutley Essex 07110HFFMN340KI
4. Penick Corporation Newark Essex 07114PNCKC158MT
5. Sun Chemical Corporation Newark Essex 07105SNCHM185F0
6. Troy Chemical Corporation Newark Essex 07105TRYCHONEAV
7. Amerchol Corporation Edison Middlesex 08818MRCHL136TA
8. Private Formulations Inc. Edison Middlesex 08818PRVTF460PL
9. RBH Dispersions, Inc. Bound Brook Middlesex 08805RBHDSL5FAC
10. Rhodia Inc. New Brunswick Middlesex 08901RHNPL298JE
11. Staflex Products, Inc. Carteret Middlesex 07008STFLXMIDDL
12. Union Carbide Corporation Piscataway Middlesex 08854NNCRB1RIVE
13. Ciba-Geigy Corp. Summit Union 07901CBGGY556M0
14. Exxon Corp. Linden Union 07036XXNCH1400P
15. Merck & Co. Inc. Rahway Union 07065MRCKC126EL
16. Schering Corporation Kenilworth Union 07033SCHRN2000G
17. Schering Corporation Union Union 07083SCHRN1011M
Source: TRI database (USEPA, 2004b).
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Figure 3.2 Geographic locations of the 17 selected source facilities.
Source: County boundary shapefiles obtained from NJDEP (NJDEP, 2004a).
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The SIC sub-codes (e.g., 28XX) for all 17 source facilities were compiled. The
MACT regulations corresponding to those SIC sub-codes were obtained on-line from the
USEPA's list of NESHAPs (USEPA, 2005e). The SIC sub-codes for the 17 source
facilities were covered under four separate MACT standards. A list of the SIC codes and
MACT standards are shown in Table 3.4. A detailed description of the applicable MACT
standards is presented in Table 3.5.
Table 3.4 SIC Codes and Principle Products of the Study Facilities
Facility Plant IDs SIC Code(s) Principle Products MACT*
Firmenich, Inc. 06242 2869 Fragrance Raw 3Materials
Hoechst Celanese Corp. 05131 2869 Formaldehyde Solutions 3
Hoffman LaRoche Inc. 30374, 05004 2834 Pharmaceuticals 4
Penick Corp. 06265 2833 Pharmaceuticals 4
Sun Chemical Corp. 06262 2819 Synthetic Organic 2Chemicals
Troy Chemical Corp. 05459 2851 Specialty Chemicals 1
Amerchol Corp. 15343 2843 Cosmetic Intermediates 1
Private Formulations, Inc. 15579 2834 Pharmaceuticals 4
RBH Dispersions, Inc. 15678 2899, 2851 Pigment Dispersions 1
Rhodia Inc. 15101 2869 Industrial Organic 3Chemicals
Staflex Products, Inc 15074 2869 Esters 1
Union Carbide Corp. 15031 2833 Polyethylene 4
Ciba-Geigy Corp. 40017 2834, 2833 Pharmaceuticals 4
Exxon Corp. 40064,40276
40003, 2869, 2911 Petrochemicals 3
Merck & Co., Inc. 40009 2833 Pharmaceuticals 4
Schering Corp.
(Kenilworth) 40384 2834 Pharmaceuticals 4
Schering Corp.
(Union) 40084 2834 Pharmaceuticals 4
* Refer to Table 3.5 for a description of the applicable MACT standards.
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Table 3.5 MACT Standards Relevant to this Stud
MACT Standard Description
1.
NESHAP: Miscellaneous Organic
Chemical Manufacturing
(Miscellaneous Organic NESHAP)
(MON)
■ 68 Fed. Reg. 63851, Nov. 11, 2003
■ Compliance date: Nov. 10, 2006
• Facilities described by the SIC Codes 282, 283, 284,
285, 286, 287, 289, and 386 that are not already covered
by a specific MACT rule.
■ Applies to producers of specialty organic chemicals,
explosives, certain polymers and resins, and certain
pesticide intermediates.
2.
NESHAP: Hazardous Organic Air
Pollutants From the Synthetic
Organic Chemical Manufacturing
Industry
(Hazardous Organic NESHAP)
(HON)
• 59 Fed. Reg. 19402, Apr. 22, 1994
• Compliance date: May 12, 1999
• NAICS Code 325 — Chemical Manufacturing (Includes
SIC code 2819 — Industrial Inorganic Chemicals, Not
Elsewhere Classified)
• To be subject to the HON, a chemical manufacturing
process must be used to produce one or more of the 396
SOCMI chemicals listed in subpart F of the rule.
3.
NESHAP: Organic Liquids
Distribution (Non-Gasoline)
(Organic Liquids Distribution
NESHAP)
(OLDN)
■ 69 Fed. Reg. 5038, Feb. 03, 2004
■ Compliance date: Feb. 03, 2007
■ Facilities described by the SIC Codes 2821, 2865, 2869,
2911, 4226, 4612, 5169, and 5171.
■ Applies to new and existing organic liquids distribution
(non-gasoline) operations, which are carried out at
storage terminals, refineries, crude oil pipeline stations,
and various manufacturing facilities.
4.
NESHAP: Pharmaceuticals
Production
(Pharm MACT)
■ 63 Fed. Reg. 50280, Sept. 21, 1998
■ Compliance date: Sept. 21, 2001
■ Facilities described by the SIC codes 2833 and 2834.
■ Producers of finished dosage forms of drugs, for
example, tablets, capsules, solutions, that contain an
active ingredient generally, but not necessarily, in
association with inactive ingredients.
• Applies to producers of components whose intended
primary use is to furnish pharmacological activity or
other direct effect in the diagnosis, cure, mitigation,
treatment, or prevention of disease, or to affect the
structure or any function of the body of humans or other
animals.
Source: (USEPA, 2005e)
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3.2 Estimation of the 1990 Baseline Health Risk
3.2.1 Hazard Identification
The emissions statements for all 17 source facilities were reviewed for content
completeness. The emissions statement data were supplied by the NJDEP as Microsoft ®
Office Excel spreadsheets. Separate spreadsheets were obtained for all 17 source
facilities. Within each spreadsheet there were seven individual worksheets labeled Al,
A2, B 1, Cl, D1, El, and Fl. The worksheets contained the following information:
■ Al — plant level data
■ A2 — process identification data for sources on record with the NJDEP
■ B1 — process and emission information for fuel combustion
■ Cl — process and emission information for VOC storage tanks
■ D1 — process emission information for batch operations
■ El — process and VOC emission information for surface coating operations
■ F 1 — process and emission information for other process types and pollutants
No supporting documentation, such as table descriptions or field descriptions, was
received from the NJDEP along with the electronic files. Therefore, another OPRA
request was filed with NJDEP, requesting a copy of the guidance document that was
issued with either the collection of or the release of the emissions statements. The
NJDEP was unable to locate a copy of the guidance document. The earliest guidance
document that the NJDEP could locate was the Guidance Document for the 1993
Emission Statement Report of Actual Emissions (NJDEPE, 1994). This guidance
document was used to determine the general information, table descriptions, and field
descriptions for the seven worksheets.
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A review of all the worksheets indicated that worksheets Al, A2, and D1
contained the most useful information. Worksheets B 1, Cl, El, and F 1 did not contain
any information that was pertinent to this study. In most cases, worksheets Bl, Cl, El,
and Fl did not contain any data at all. The actual field values were then checked for
consistency with the descriptions reported in the 1993 guidance document. The only
deviation found was for the stack diameter field. The stack diameter, reported in the
1990 emissions statements, was in inches as opposed to feet in the 1993 guidance
document. The field descriptions of the most relevant fields in worksheet A2 and D1 are
listed in Appendix B.
Worksheets Al and A2 contained the data the source facility had originally
entered into parts 1 and 2 of form A of the 1990 New Jersey Department of
Environmental Protection and Energy (NJDEPE) Emission Statement (NJDEPE, 1994).
Worksheet D contained the data entered on form D. Form A was a multi-part form that
was designed to tie together the whole emission statement. It included overview data
about the source facility in part 1 and a list of sources that emitted air pollutants in part 2
(NJDEPE, 1994). Form D allowed source facilities to avoid having to report emissions
on a source by source basis. Reporting on form D was done on a batch basis. The
emissions from the batch were not apportioned to any individual source. If source
facilities reported on form D for batch operations then the source facilities were required
to identify on part 2 of form A every piece of equipment or emission control device
associated with a batch operation (NJDEPE, 1994).
The emissions and point sources for each source facility were determined from
worksheets Al, A2, and D1 as follows. First Table Dl (form D) was queried, using the
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CHEM NAME (chemical name) field, to create a list of all the chemicals emitted. The
chemicals were checked against the list of 188 HAPs to determine which of the emitted
chemicals were HAPs (USEPA, 1990a) (the list of HAPs can be found in Appendix A).
If a chemical was determined to be a HAP it was automatically added to a list of COCs
for the study. The review of the emissions data indicated that the source facilities emitted
numerous chemicals that were not included on the USEPA's original HAP list. These
non-HAP chemicals were temporarily added to the list of COCs. In order to evaluate
whether the non-HAP COCs should be included in the study, the toxicity of the non-HAP
COCs was assessed.
The toxicity information on the non-HAP COCs was researched. Section 3.2.2
(Toxicity Assessment) of this study describes the methodology used to research the
available toxicity information. If no chronic toxicity values were available for a
chemical, that chemical was dropped from the study. For many of the chemicals, chronic
toxicity criteria were not available because the appropriate toxicity testing has not been
conducted. This is due to the fact that testing is not usually done on chemicals whose
exposure experience suggests a limited potential for long term risk (National Research
Council, 1994). The toxicity assessment produced a final list of 102 COCs for which
adequate toxicity information existed. The final list of COCs selected for evaluation in
this study is listed in Table 3.6. The list of the 35 chemicals dropped from this study due
to inadequate toxicity information is shown in Table 3.7. A review of the emissions
reports indicated that the annual mass of these 35 chemicals was minimal and therefore,
removing them from the study would not have a significant impact. Detailed information
on the COCs is presented in Section 3.2.2 (Toxicity Assessment). It is important to note
60
that the CAA only regulates emissions of HAPs. In this study, the public health risk was
assessed for both the HAPs and the non-HAP air pollutants. Including the non-HAP
chemicals, as well as the HAPS, allowed for a complete assessment of public health risk
imposed by the emitted chemicals.
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Table 3.6 List of Chemicals of Concern
Acetic acid
Acetic anhydride
Acetone
Acetonitrile *
Acrylic acid *
Acrylic momoner
Ammonia
Benzaldehyde
Benzene *
Benzonitrile
Bis (2-ethylhexyl) adipate
Butane
Butanol
Butyl acetate
Carbon disulfide *
Chlorine *
Chlorobenzene *
Chloroform *
Cyclohexane
Cyclohexanone
Di(2-ethylhexyl)phthalate *
Diacetone alcohol
Dibutyl phthalate *
Dichlorobenzene *
Diethylene glycol
Diethylene triamine
Dimethyl carbamoyl chloride
Dimethyl sulfate *
Dimethylamine
Dimethylformamide *
Dioxane *
Epichlorohydrin *
Ethanol
Ethyl acetate
Ethyl acrylate *
Ethyl chloroformate
Ethyl ether
Ethylene dichloride *
Ethylene glycol *
Ethylene oxide *
Formaldehyde *
Formic acid
Glycerine
Heptane
Hexane *
Hydrazine *
Hydrochloric acid *
Hydroquinone *
Isobutane
Isobutyl alcohol
Isopentane
Isopentyl alcohol
Isopropanol
Isopropylamine
Maleic anhydride *
Methanol *
Methyl acetate
Methyl acrylate
Methyl amyl alcohol
Methyl bromide *
Methyl cyclohexane
Methyl ethyl ketone *
Methyl formate
Methyl hydrazine *
Methyl isobutyl ketone
Methyl methacrylate
Methylene chloride *
Naphthalene *
N-butyl acrylate
Nonanal
N-propyl acetate
Oil
Pelargonic acid
Pentanal
Phenol *
Phosphoric acid
Phthalic anhydride *
Propane
Propanol
Propargyl alcohol
Propionic acid
Propylene glycol, methyl ester
Propylene oxide *
Pyridine
Styrene *
Styrene oxide *
tert-butanol
tert-butyl chloride
Tetrachloroethane *
Tetrahydrofuran
Toluene *
Trichloroacetic acid
Trichloroethane *
Tridecyl alcohol
Triethylamine *
Triethylene glycol
Trimethyl benzene
Trimethyl borate
Vinyl acetate
Vinyl chloride *
Vinyl methyl ether
Xylene *
Note: Compounds marked with an asterisk (*) are HAPs
Table 3.7 List of Chemicals Dropped from the Study
1,3-butylene glycol
1-Chloro-3-bromopropane
1-Chloro-3-methoxypropane
2-(1-hydroxypenty1)-cyclopentanone
2-ethylhexanol
2-ethylhexyl acrylate
2-pentylidene-cyclopentanone
3-amino-5-methy1-1H-pyrazole
5-methyl isoxazole
Amyl cinnamic aldehyde
Bromoacetyl bromide
Butoxymethanol
Butyl isocyanate
Butyl methyl ether
Caprolactone
Cyclopentanone
Dimethoxy propane
D-lactone
Ethyl trifluoroacetate
Gamma-butyrolactone
Heptanoic acid
Isobutylene
Isobutyraldehyde
Isophytol
Methoxymethanol
Methyl malonate
N-(1,1-dimethylethyl)-benzenemethanamine
N-ethyl pyrrolidone
Pentyl malonate
Peracetic acid
Phenylacetaldehyde
Phytadiene
Tocopherol
Trimethyl hydroquinone
Vitamin A acetate
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Worksheet D1 (form D) also provided information on the stack identifier and the
batch identifier the emissions were assigned to. The stack identifier and batch identifier
were cross-referenced to worksheet A2 (part 2 of form A) which contained parameters on
the equipment used in and the emission sources of each batch process. In all cases, the
equipment and emission points listed in worksheet A2 were assigned to a batch process.
The emission source parameters and the corresponding emission rates were necessary
information required for the air dispersion modeling analysis to determine the ground-
level concentration of COCs.
In several cases, there was no information on the physical parameters of the
emission sources in worksheet A2. When no information was available, the emissions
were transferred to a surrogate emission source located at the same facility. The emission
source with the highest emission rate, and for which physical parameter information was
available, was chosen as the surrogate. In other cases, information on an entire batch
process was missing in worksheet A2. When the batch information was missing, the
emissions were transferred to a surrogate emission source as described above. By doing
so, all the emissions were captured in the modeling and health risk assessment.
The NJDEP emissions statements contained information on air pollution control
devices and the efficiencies of these control devices. In some cases, the source facilities
provided information on existing controls. Unfortunately, information on the codes used
for the control devices could not determined because the 1990 guidance document could
not be located and because the codes used in the 1993 guidance document did not
correspond to the 1990 codes. Verbal guidance provided by the NJDEP indicated that the
1990 emissions, listed in the emissions statements, were the total tons per year of the
grams = ■. tons . 2000 pounds
x
( 454 grams 	 1
x
year
x
second , year, x ton 	 , pound 8760 hours )
.	 hour
3600 seconds (3.1)
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chemical, emitted from the batch process, after the use of any and all control devices.
Appendix B lists the COCs, their emission rates, and the emission source parameters for
the point sources for all 17 source facilities.
In this study, the batch operations were assumed to occur continuously throughout
the year (i.e., 8,760 hours per year). This assumption was necessary in order to calculate
the emission rate for the modeling, since information on the actual batch run time and the
actual number of batches per year was not contained in the emissions statements. The
emission rates reported in the emissions statements were converted from tons per year to
grams per second (g/s) using Equation 3.1.
The emissions statements from the NJDEP did not contain any data on fugitive
emissions from the source facilities. As mentioned earlier, the TRI database contained
information on both point sources and fugitive emissions. Therefore, the TRI data was
the only available source of information to obtain fugitive emissions for this study. The
TRI data reflect any reductions in emissions due to the presence of air pollution control
devices (N. Lopez, USEPA, personal communication, December 12, 2005). However, a
review of the TRI data on fugitive emissions for 1990 did not specifically indicate if any
pollution control devices were applied. Therefore, the TRI data for fugitive emissions
was assumed to be the amount of fugitive emissions coming from a source facility. It is
important to note that source facilities usually estimated fugitive emissions based on
simple mass balance calculations and not on true measured values.
Like the point emissions, the fugitive emissions were assumed to occur
continuously throughout the year (i.e., 8,760 hours per year). This assumption was
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necessary since information on the actual number of tanks fills, tank empties, batch run
times, and the actual number of batches per year was not contained in the TRI database
for 1990. The emission rates reported in the TRI were converted from pounds per year to
grams per second (g/s) using Equation 3.2.
rgrams 	 pounds \ 	 ( 454 grams"
	 = 	  x 	
second 	 year , 	 pound ,
	( 	 \year 	 hour
	
x 	
, 8760 hours , 
x
(3600 seconds (3.2)
Appendix B also lists the COCs, their emission rates, and the emission source parameters
for the fugitive sources for all 17 source facilities.
3.2.2 Toxicity Assessment
Toxicity (dose-response) is defined as the ability of a chemical to cause adverse effects at
a defined dosage in biological systems. The purpose of the toxicity assessment was two-
fold: (1) to identify the carcinogenic and non-carcinogenic effects that may arise from
chronic direct inhalation exposure of humans to the COCs and (2) to provide an estimate
of the quantitative relationship between the magnitude and duration of exposure and the
probability or severity of adverse effects. These estimates of toxicity, commonly known
as unit risk (UR) factors and reference concentrations (RfC), can be used to evaluate
public exposure to the COCs. In this study only chronic, direct toxicity (both
carcinogenic and non-carcinogenic) to humans from the inhalation exposure pathway was
evaluated. The term carcinogenic refers to any chemical for which there is sufficient
evidence that exposure may result in continuing cell division (i.e., cancer) in humans or
animals. Conversely, the term non-carcinogenic refers to any chemical for which the
carcinogenic evidence is negative or insufficient (National Research Council, 1994).
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Exposure to some chemicals may result in both carcinogenic and non-carcinogenic
effects.
Carcinogenic and non-carcinogenic endpoints were evaluated separately because
the mechanisms by which chemicals cause cancer are assumed to be fundamentally
different from the processes that cause non-carcinogenic effects. The principal difference
is the assumption that non-carcinogenic chemicals exhibit a threshold dose below which
no adverse effects occur, whereas the general assumption held by most environmental
agencies is that no such threshold exists for carcinogenic effects (National Research
Council, 1994).
The estimates of toxicity for chronic inhalation exposure are expressed differently
for carcinogens and non-carcinogens. For carcinogenic effects, the toxicity estimate was
expressed as the inhalation Unit Risk (UR) factor with units of 1 over microgram per
cubic meter [(iag/m 3) -1 ]. The UR is defined as the upper-bound excess lifetime cancer
risk resulting from continuous exposure over a lifetime to an agent at a concentration of 1
3 •µg/m3
 in air. UR can be interpreted as follows: if UR equals 2 x 10 -6 then two excess
cancer cases (upper-bound estimate) are expected to develop per million people if
exposed daily for a lifetime to 1 microgram (ig) of the chemical in 1 cubic meter (m 3) of
air (USEPA, 2005a). For non-carcinogenic health effects, the toxicity estimate was
expressed as the reference dose concentration (RfC) with units of milligrams per cubic
meter (mg/m3). The RfC is an estimated concentration level (with uncertainty spanning
perhaps an order of magnitude) under which a continuous inhalation exposure to the
human population (including sensitive subgroups) is likely to cause an appreciable risk of
deleterious effects during a lifetime. Therefore, exposure to a chemical below the RfC,
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even over a long period of time, is not expected to have any negative effects on health.
RfCs can be derived from a No Observed Adverse Effect Level (NOAEL), a Lowest
Observed Adverse Effect Level (LOAEL), or a benchmark concentration. Uncertainty
factors (UFs) are generally applied to the RfC to reflect limitations of the data (USEPA,
2005a). The UR and RfC were used as health benchmarks, to evaluate the potential
health effects of the COCs in Section 3.2.3 (Exposure Assessment).
The exposure estimates used standard assumptions of body weight of 70
kilograms (kg) and inhalation rates of air of 20 cubic meters per day (m 3/day) for an
adult. When exposures to children were assessed, the exposure estimates were corrected
to account for differences in exposure between adults and children. This will be
discussed in detail in Section 3.2.3 (Exposure Assessment).
Appendix C lists the chronic toxicity values selected for use in this study to
evaluate the potential chronic risks associated with direct exposure to air emissions of the
COCs. The chronic toxicity criteria used in this study were obtained from the sources
listed below and in priority order.
■ USEPA Office of Air Quality Planning and Standards (OAQPS) Dose-Response
Assessment Tables, February 28, 2005 Version (USEPA, 2005b).
■ USEPA Integrated Risk Information System (IRIS) computer database (July
2005). The IRIS database is maintained by the Office of Research and
Development, National Center for Exposure Assessment (NCEA), Cincinnati, OH
(USEPA, 2005a).
■ USEPA Health Effects Assessment Summary Table (HEAST) (July 31, 1997
Edition). The HEAST table was originally produced by the USEPA Office of
Emergency and Remedial Response, Washington, DC and is maintained by the
Office of Research and Development, National Center for Exposure Assessment
(NCEA), Cincinnati, OH (USEPA, 1997b).
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■ USEPA Region III Risk Based Concentration (RBC) Table (October 2005
Edition). The table is published by the USEPA Region III, Technical Support
Section, Philadelphia, PA (USEPA, 2005c).
■ New Jersey Department of Environmental Protection (NJDEP) Air Quality
Permitting Program Table of Reference Concentrations for Inhalation and the
Table of Unit Risk Factors for Inhalation (September 2005 Versions) (NJDEP,
2005).
■ California EPA (Cal EPA) Toxicity Criteria Database (July 2005). The Cal EPA
database is maintained by the Office of Environmental Health Hazard Assessment
(OEHHA), Sacramento, CA (Cal EPA, 2005c). In addition to the database, the
Cal EPA Air Resources Board (ARB) publishes a Consolidated Table of
OEHHA/ARB Approved Risk Assessment Health Values (April 25, 2005
Edition) (Cal EPA, 2005a).
■ Texas Commission on Environmental Quality (TCEQ) Effects Screening Levels
(ESLs) Table, October 01, 2003 Version. The table is produced by TCEQ
toxicologists (TCEQ, 2003).
The USEPA OAQPS has prepared toxicity tables for risk assessments of HAPs.
The OAQPS has two separate tables available. One table provides values for long-term
(chronic) inhalation and oral exposures, and the second table values for short-term (acute)
inhalation exposures. The OAQPS table for chronic inhalation was used as the primary
source of toxicity data in this study. The advantage to using the OAQPS table is that they
draw from numerous sources of toxicity data for many of the 188 HAPs. In creating the
table, the OAQPS toxicologists considered the available chronic dose-response toxicity
assessments; evaluated their conceptual consistency with USEPA risk assessment
guidelines; evaluated their level of peer review; evaluated any available chemical-specific
information; and used professional judgment to derive a list of chronic inhalation toxicity
values suitable for use in risk assessments. For the oral exposure pathway, the OAQPS
table also lists chronic oral toxicity values for persistent and bioaccumulative substances
likely to pose important non-inhalation risks when emitted from air sources. The OAQPS
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states that the values in the table support hazard identification and dose-response
assessment, as defined in the National Academy of Sciences (NAS) risk assessment
paradigm, for estimating the risk of contracting cancer and the level of hazard associated
with adverse health effects other than cancer (National Research Council, 1983, 1994).
It is important to note that values in these tables are single point estimates within
a range of possible values. As such, these values incorporate a certain amount of
uncertainty and variability. The OAQPS states the tables are generally appropriate for
screening-level risk assessments, including assessments to select contaminants, exposure
routes, or emission sources of potential concern, or to help set priorities for further
research (USEPA, 2005b).
As mentioned earlier, the OAQPS table contained information on many of the
HAPs. Since the OAQPS table only contained HAPs, the IRIS database was used as the
primary source of toxicity information for the COCs that were either HAPs but not listed
in the OAQPS table or COCs that are not classified as HAPs. IRIS is a database of
human health effects that may result from exposure to various substances found in the
environment. IRIS was initially developed for the USEPA staff in response to a growing
demand for consistent information on chemical substances for use in risk assessments,
decision-making, and regulatory activities. The toxicity values in the IRIS database have
been subjected to extensive peer-review (USEPA, 2005a, 2005b). Many of the values in
the OAQPS table are taken from the IRIS database.
The HEAST tables were used as an additional source of toxicity information for
the COCs that were HAPs but not listed in the OAQPS table and the COCs that are not
classified as HAPs. The HEAST tables are for use at both Superfund and Resource
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Conservation and Recovery Act (RCRA) sites and provide a comprehensive listing of
provisional risk assessment information relative to oral and inhalation routes of exposure
for chemicals. Some of the values in the OAQPS table are taken from the HEAST tables.
The RBC table was used as an additional source of toxicity information for the
COCs that were HAPs but not listed in the OAQPS table and the COCs that are not
classified as HAPs. The RBC table lists toxicity values from several sources, including
IRIS, HEAST, and provisional USEPA peer reviewed values and is therefore, an
excellent source of toxicity information. The RBC table incorporates values from the
following sources: (1) IRIS database; (2) HEAST and HEAST Alternate tables; (3)
Agency for Toxic Substances and Disease Registry (ATSDR) chronic Minimum Risk
Levels (MRLs); (4) USEPA NCEA provisional values; and (5) USEPA provisional peer-
reviewed values.
The NJDEP table of Reference Concentrations for Inhalation and table of Unit
Risk Factors for Inhalation were used as an additional source of toxicity information for
the COCs that were HAPs but not listed in the OAQPS table and the COCs that are not
classified as HAPs. The NJDEP Air Quality Permitting Program uses the UR factors and
RfCs in these tables in the current risk screening process to evaluate potential health
effects from source facilities seeking permits to emit air toxics in New Jersey (NJDEP,
2005).
If none of the above tables or databases produced toxicity values for the COCs,
the next source of information consulted was the Cal EPA OEHHA, Toxicity Criteria
Database and the Consolidated Table of OEHHA/ARB Approved Risk Assessment
Health Values. The table is a quick look-up table of all cancer potency values and
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noncancer acute and chronic Reference Exposure Levels (RELs) that are available for use
in the California Air Toxics "Hot Spots" Program. The table includes cancer potency
values and chronic noncancer RELs that have been approved by the OEHHA and the
ARB, or are listed in the California Air Pollution Control Officers Association's
(CAPCOA) Risk Assessment Guidelines (1993). Cancer potency factors are used to
assess the cancer risk from carcinogens in the air and RELs are used to assess noncancer
health impacts. A chronic REL is an airborne level of a chemical at or below which no
adverse health effects are anticipated in individuals indefinitely exposed to that level. Cal
EPA develops RELs using the best available published scientific data and based solely on
health considerations (Cal EPA, 2005b).
For several COCs the above sources did not provide the required toxicity values.
The last source used to locate toxicity information was the TCEQ ESLs. The ESLs are
based on data concerning health effects, the potential for odors to be a nuisance, effects
on vegetation, and corrosive effects. It is important to note that they are not ambient air
standards. However, if predicted or measured airborne levels of a constituent do not
exceed the screening level, adverse health or welfare effects are not expected. If ambient
levels of constituents in the air exceed the screening levels, it does not necessarily
indicate a problem but rather, it triggers a review in more depth. There are two types of
ESLs: short-term and long-term. Short-term ESLs are typically measurements for a one-
hour averaging period and long-term ESLs are typically measurements for an annual
averaging period. The long-term ESLs were used as sources of toxicity data in this study
(TCEQ, 2003).
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It should be noted that there has been some controversy centered on using the
ESLs to determine adverse health levels (TCEQ, 2003). In response to this, the TCEQ
has contracted an independent reviewer to do a scientific peer review of the ESL
methodology. As of the writing of this study, the findings of their review of the ESL
methodology had not been released. The decision to use the ESLs in this assessment was
based on the fact that without a toxicity value a COC can not be quantitatively evaluated
in the risk assessment. The decision was therefore, made to use the ESL data so that the
greatest number of COCs could be included in this study.
3.2.3 Exposure Assessment
3.2.3.1 Geographic Information System (GIS). The GIS software used for this
project was ArcGIS (ESRI, Redlands, CA, Version 9.1 for Windows). The base
shapefiles for New Jersey were obtained from the NJDEP Bureau of Geographic
Information Services website (NJDEP, 2004a). The shapefiles downloaded from the
NJDEP and used in this study were:
■ Aerial photographs (1995) (supplied as Digital Ortho-QuarterQuads (DOQQs))
■ Land Use and Land Cover (LULL) (1986) (filenames: esslulc; unilulc; midlulc)
■ State Boundary of New Jersey (filename: state)
■ Counties of New Jersey (filename: stco)
■ Municipalities of New Jersey (filename: muncoast)
The maps in this study were developed using NJDEP GIS digital data. However, this
study and the maps in this study have not been verified by NJDEP and are not state-
authorized.
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The geographic (latitude and longitude) coordinates of the 17 source facilities in
the study were converted to New Jersey State Plane projected coordinates and mapped in
GIS. The publicly available software package, Corpscon (U.S. Army Corps of
Engineers, Version 5.11.08 for Windows) was used to convert from geographic
coordinates (latitude and longitude), NAD 83 into projected coordinates with the State
Plane, NAD 83, New Jersey-2900 (U.S. Survey Feet) projection.
In order to verify the accuracy of the geographic coordinates supplied with the
TRI data, a field survey was completed. During the field survey, the location and
coordinates of all 17 source facilities were verified using a Magellan Meridian GPS unit
with an accuracy of three meters or better. The field visit also found that one source
facility (Hoechst Celanese Corp.) no longer physically existed. In addition, one of the
source facilities (Rhodia Inc.) was no longer operating but the physical facility still
existed. Street locations were confirmed using the ArcView extension StreetMAP (ESRI,
Redlands, CA). The boundaries of the 17 source facilities were determined based on the
results of the field survey and a review of the street level data and aerial photographs in
the GIS. The accuracy of the source facility boundaries and property lines was not
confirmed with the source facilities themselves. However, the resolution of the street
level data and the NJDEP aerial photographs proved extremely helpful in determining the
most probable boundaries of the source facilities.
In this study, the human health effects of the emitted COCs were derived from the
exposure estimates based on the predicted ground-level air concentrations of the COCs.
The air dispersion model was used to predict the ambient air concentrations of the COCs
at specific spatial locations around each source facility. The exposure estimates were put
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into the GIS for ease of analysis. Using the GIS allowed the results to be interpreted
spatially. It also allowed the results for the individual source facilities to be overlaid on
each other to estimate the overall cumulative exposure over the geographic area of study.
3.2.3.2 Air Dispersion Model. Air dispersion modeling was carried out to
determine the fate of the vapor phase emissions in the atmosphere. The model estimated
the average ground-level air concentration at defined geographical receptors during
defined timeframes. The air dispersion model used in this study was AERMOD. The
AERMOD model has three components:
■ AERMET — the meteorological preprocessor
■ AERMAP — the terrain data preprocessor
■ AERMOD — the air dispersion model
The commercial software package, BREEZE ® AERMOD GIS Pro (Trinity Consultants
Inc., Dallas, TX, Version 5.1.0) was used for all modeling runs. The BREEZE ® software
incorporates USEPA Version 04300 of AERMOD. The basic model calculations
performed by the BREEZE® software are identical to the calculations performed by the
USEPA version of AERMOD that is available on the USEPA Support Center for
Regulatory Air Models (SCRAM) web site for public distribution (USEPA, 2002d). The
commercial package was chosen simply because the graphical user interface is user-
friendly and makes application of the USEPA model easier.
The air dispersion model required input data on source characteristics, emission
rates, receptor locations, meteorological parameters, and surrounding terrain elevations.
The air dispersion modeling in this study was carried out in accordance with the
procedures outlined by the USEPA in the Guideline on Air Quality Models which
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provides guidance for all regulatory modeling performed in the United States (USEPA,
2005d). In practice, emissions emanating from stacks, vent boxes, and tank vents are
modeled as point sources. Fugitive emissions from a tank or a group of tanks are
modeled as area sources in which the emission rate is divided by the source area to obtain
an area-weighted emission rate. Fugitive emissions from process pads and buildings are
modeled as volume sources and assigned dimensions based on the building size in
accordance with USEPA guidance (USEPA, 1995a). In this study, the emissions from
point sources were modeled as point sources. The emissions statements from the NJDEP
did not contain any data on the origin of the fugitive emissions. Therefore, all the
fugitive emissions were assumed to emanate from the production buildings and as such,
were modeled as volume sources.
Once emitted, pollutants mix with the existing air where turbulence causes the
concentration of the pollutants to decrease. Buildings and structures in the vicinity of a
stack can affect wind flow which sometimes causes turbulence to develop on the lee side
of a building. The turbulence can effect the ground-level concentrations of the emitted
pollutant on the lee side of a building and downwind from a building. This phenomenon
is known as building downwash (Venkatram & The, 2003). Downwash can have
important ramifications in the field of air dispersion modeling (USEPA, 1995b). For
example, the plume can get caught in the turbulence on the lee side of a building causing
concentrations next to a building to be relatively high. The plume may also be carried
downwind and dispersed more rapidly by the turbulence (Venkatram & The, 2003).
The building downwash algorithms in AERMOD are designed to determine the
extent of building downwash occurring. A separate building profile program should be
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run for all point emission sources prior to execution of the air dispersion model to
determine whether a stack is potentially subject to wake effects from the surrounding
structures. The information is then used as an input by the air dispersion model. Since
no information about the buildings and structures located on the 17 source facilities was
available through the public records, no buildings or structures were included in this
study. Therefore, the building profile program was not run prior to the air dispersion
modeling runs. Since industrial facilities contain numerous buildings and supporting
structures (e.g., sheds and pipe racks) it was assumed that these buildings would cause
turbulence. It was further assumed that this turbulence would lead to increased ground-
level concentrations within the facility and decreased concentrations downwind of the
facility.
The emissions statements from the NJDEP did not contain any data on the
geographical locations of the point source and fugitive emissions. Information on the
geographical locations of the emissions sources is a required parameter in the air
dispersion model. Therefore, assumptions had to be made on where the emissions
probably emanated from the source facility. Information gained from the field visits to
the source facility and the aerial photographs in the GIS were used to determine possible
locations of production buildings or tank farms at the source facility. For example, if the
roof of a building contained numerous vents it was assumed to be a production building.
The locations selected as the most probable areas for point source emissions and fugitive
emissions at all 17 source facilities were digitized and converted into shapefiles using the
GIS. Figure 3.3 depicts an example of one of the source facilities in the study. In the
example, several buildings were identified to be potential production buildings. The
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emissions from the source facility were assumed to emanate from the identified area.
Next, a shapefile of the area was digitized in the GIS. The shapefiles were then imported
into the air dispersion modeling software and the point sources and volume sources were
arbitrarily assigned to geographical locations within the shapefile boundary.
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Figure 3.3 Probable location of a facility's emission sources.
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
79
The air dispersion model required the Universal Transverse Mercator (UTM)
coordinates, the release height above ground, and the base elevation above mean sea level
for all emission sources. For point sources, the model also required data on mass
emission rate, stack gas temperature, stack gas vertical velocity, and stack diameter. The
additional inputs required for volume sources were mass emission rate, initial lateral
dimension, and initial vertical dimension.
The volume sources were assigned dimensions based on building size in
accordance with USEPA guidance (USEPA, 1995a). The initial lateral dimension of the
volume source was entered as the length of the digitized volume source divided by 4.3.
The length of the building was determined using the aerial photographs in the GIS. Since
no information on the height of the buildings was available, some assumptions had to be
made. It was assumed that a default building was 6 meters (19.7 feet) high and therefore,
the release height (i.e., the center of the building) was assumed to be 3 meters (9.8 feet)
above ground level. The initial vertical dimension was calculated using the regulatory
standard equation of initial vertical dimension (6 meters) divided by 2.15, which equaled
2.79 meters (9.2 feet). A release height of 3 meters and an initial vertical dimension of
2.79 meters were used for all volume sources modeled.
Reported emission rates were used for all point and volume sources in all
modeling runs. Point sources and volume sources at each source facility were grouped
into a single "source group" in the air dispersion modeling software. The Breeze ®
software has a "source groups" option that allows the user to model aggregate
contributions from individual emission sources. Each source facility was modeled as an
individual source group. The software also allowed several source groups to be modeled
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in a single modeling run. This allowed the source groups to be modeled individually and
collectively (Trinity Consultants, 2004). Refer to Appendix B for a detailed description
of all sources, source parameters, and mass emission rates used in the model. All source
facilities except for the Ciba-Geigy Corp. and the Schering Corp. (Union) source
facilities contained both point and volume sources. Since there were no fugitive
emissions listed in the TRI for the Ciba-Geigy Corp. and the Schering Corp. (Union)
source facilities, no volume sources were modeled for those facilities.
All modeling runs used the annual averaging time option. USEPA regulatory
default options were chosen for all other model options. The USEPA version of
AERMOD only allows one pollutant to be modeled at a time. However, the BREEZE®
version of AERMOD has a special add-in, AERMOD-MSP, that allows multiple
pollutants to be modeled in a single run (Trinity Consultants, 2004).
All air dispersion modeling output was collected in standard text format files that
contained geographical locations ('X' and 'Y' coordinates) for each receptor as well as a
modeled air concentration at that receptor. The height for all modeled receptors was
ground level (i.e., 'Z' = 0). The modeled air concentrations were expressed as
micrograms per cubic meter (.1g/m3). The maximum annual concentrations from the
modeling runs were used in the exposure assessment step.
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3.2.3.3 Meteorological Data. Five years of AERMOD formatted metrological
data for Newark International Airport, covering the time period 1991 through 1995, was
purchased from Trinity Consultants, Inc. The data was comprised of hourly surface air
data recorded at Newark International Airport (Call sign EWR, WBAN Station ID
14734). The WBAN Station ID number is a five digit station identifier assigned by the
National Climatic Data Center (NCDC) for digital data storage and general station
identification purposes (NOAA, 2005). The Newark International Airport weather
station is located in Newark, NJ, Essex County. The elevation of the station at ground
level is 2.1 meters (7 feet) above mean sea level. The anemometer height is 9.1 meters
(30 feet) above ground level. The latitude and longitude of the station is 40° 43' N and
74° 10' W (NOAA, 2005). The hourly surface data contained information on pressure,
temperature, cloud cover, ceiling height, wind speed, wind direction, humidity, and
precipitation.
The upper air data required for the air dispersion modeling was obtained from the
Atlantic City Airport upper air station (Call sign ACY, WBAN Station ID 93755) for all
years except 1995. In late 1994, the upper air station was moved from Atlantic City
Airport in Atlantic County, NJ to Brookhaven National Laboratory in Suffolk County,
NY (Call Sign OCX, WBAN Station ID 94703). The upper air data for 1995 was
obtained from the Atlantic City Airport upper air station. This change in location was not
anticipated to have any effect on the analysis since the upper air data contains
information on pressure, temperature, wind direction, and wind speed at higher altitudes.
Upper air data is taken every twelve hours from weather balloons which measure
upper air conditions over a particular location. The upper air data contained vertical
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measurements of various upper air parameters collected at various pressures. The upper
air measurements are in units of pressure instead of height. Pressure decreases
exponentially in the atmosphere as height increases, reaching zero pressure in space. The
standard unit for pressure is millibars (mb). The atmospheric pressure at sea level is
approximately 1015 mb (UNISYS, 2005).
The raw meteorological data was processed for use in AERMOD using the
AERMOD Meteorological preprocessor (AERMET) (Breeze ®
 AERMET, Trinity
Consultants Inc., Dallas, TX, Version 4.1.0). AERMET is a three stage meteorological
preprocessor. The first two stages involve merging the surface air data and the upper air
data into a single file called a merge file (Trinity Consultants, 2004). Since this study
involved multiple sites, the best option was to obtain a single merge file (preprocessed
through stage two) from a commercial vendor. The benefit of purchasing the merge files
from a commercial source was the professional preparation and quality analysis of the
data by a professional meteorologist. The quality analysis process identified such issues
as missing data, out of range values, and data inconsistencies, and then repaired the data
with accepted default values. The Newark International Airport data was supplied in
merge format. The merge file was later combined with the various site-specific land use
parameters in stage three of AERMET.
The Auer land use method was used to determine the site-specific land use
parameters for each of the 17 source facilities. According to the Auer method, a circle
with a radius of three kilometers was drawn around the center of each facility in the GIS
and the circular area was divided into twelve sectors of thirty degrees each, starting with
sector one which was centered on zero degrees (i.e., due north). The land use within each
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sector was then classified as either water, urban, deciduous forest, coniferous forest, or
grassland, consistent with USEPA guidance (Auer, 1978; USEPA, 1998). The aerial
extent of each land use classification, in square meters and as a percentage of the total
sector area, was determined using the LULC shapefiles for NJ (obtained from the
NJDEP) in the GIS.
GIS analyses indicated that urban was the primary land use in the three kilometer
circles for all the 17 facilities. Since all 17 source facilities had the same land use
classification, there was no need to create site-specific land use characteristics for each
source facility. The land use classifications for the entire study area are shown in Figure
3.4. A single meteorological file was created in AERMET using the Newark
International Airport merge file and the land use parameters characteristic of urban areas
(USEPA, 2004e). The parameters were taken from Tables 4-1 to 4-3 in Paine (1987), as
specified in the Revised Draft User's Guide for the AERMOD Meteorological
Preprocessor (AERMET) (USEPA, 1998). These tables list typical values of the albedo,
Bowen ratio, and surface roughness length as a function of season and land use type. The
parameters were incorporated into AERMET using a single sector, as shown in Table 3.8.
The input file and summary file from the AERMET run was included in Appendix D.
The AERMET processed data was then imported into the air dispersion modeling
software.
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Figure 3.4 Land use characteristics surrounding the source facilities.
Source: County boundary and land use and land cover shapefiles obtained from NJDEP (NJDEP, 2004a).
Table 3.8 Site-Specific Land Use Parameters Used in AERMET
Frequency' Albedo 2 Bowen Ratio 3 Roughness 4(meters)
Winter 0.35 1.75 1.00
Spring 0.14 1.00 1.00
Summer 0.16 2.00 1.00
Autumn 0.18 2.00 1.00
Notes:
1) The four seasons are based on the emergence and growth of vegetation.
2) The albedo is the fraction of total incident solar radiation reflected by the
surface back to space without absorption. Typical values range from 0.1 for thick
deciduous forests to 0.90 for fresh snow.
3) The Bowen ratio is the ratio of the sensible heat flux to the latent heat flux and
is used for determining planetary boundary layer parameters for convective
conditions. The daytime Bowen ratio, an indicator of surface moisture, stays fairly
constant during the day. Midday values of the Bowen ratio range from 0.1 over
water to 10.0 over desert.
4) The surface roughness length is related to the height of obstacles to the wind
flow and is, in principle, the height at which the mean horizontal wind speed is
zero. Typical values range from less than 0.001 m over a calm water surface to 1 m
or more over a forest or urban area.
Source: (USEPA, 1998)
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3.2.3.4 Digital Elevation Models (DEMs). A digital elevation model (DEM) is a
digital file consisting of an array of terrain elevations for defined ground positions at
regularly spaced horizontal intervals and referenced horizontally either to a projected
coordinate system (UTM) or to a geographic (latitude and longitude) coordinate system.
The DEM data files used in this study were 7.5-minute DEM files. Each 7.5-minute
DEM data file corresponded to a single 1:24,000 scale United States Geological Survey
(USGS) topographic map quadrangle of the United States. The 7.5-minute DEM data file
consisted of an array of elevations referenced horizontally in the UTM coordinate system,
with a uniform horizontal spacing of 10 or 30 meters (USEPA, 2003c). The geographic
area for which DEMs were required was determined in the GIS by selecting all USGS
quadrangles that were within five miles of any of the 17 source facilities. DEM data was
obtained for the following USGS quadrangles: Paterson-NJ, Hackensack-NJ,
Morristown-NJ, Caldwell-NJ, Orange-NJ, Weehawkin-NJ-NY, Bernardsville-NJ,
Chatham-NJ, Roselle-NJ, Elizabeth-NJ-NY, Jersey City-NJ-NY, Bound Brook-NJ,
Plainfield-NJ, Perth Amboy-NJ-NY, Arthur Kill-NJ-NY, Monmouth Junction-NJ, New
Brunswick-NJ, South Amboy-NJ-NY, and Keyport-NJ-NY.
The 7.5-minute DEM data files, with uniform spacing intervals of 10 meters (i.e.,
10 meter resolution), were downloaded from an on-line spatial data warehouse (Internet:
www.geocomm.com) in Spatial Data Standard Transfer (SDTS) format. The DEM data
files were converted from SDTS format into native format, the format required by the air
dispersion modeling software. The SDTS files were downloaded in UNIX compression
format (file type: *.TAR.GZ) and were un-compressed using the shareware version of
WIN-ZIP® . Once the files were un-compressed, the public domain program "sdts2dem"
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was used to translate the USGS DEM data files from SDTS format to native format
(Internet: http://www.cs.arizona.edu/topovista/sdts2dem/) . The processed DEM data files
were imported into the air dispersion modeling software. As shown in Figure 3.5, the
terrain in the study area was relatively consistent with elevations ranging from 0 to 60
meters (0 to 200 feet) above mean sea level.
Figure 3.5 Topography of the study area.
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Source: County boundary shapefiles obtained from NJDEP (NJDEP, 2004a). Elevation data from the
USGS and downloaded from www.geocomm.com .
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3.2.3.5 Receptor Grids. In order to spatially model the ambient air concentrations
of the emitted COCs, the air dispersion modeling software required a receptor grid layer
be created. The GIS was used to create receptor grids that adequately captured the
emissions from all 17 source facilities in the study. As presented in Figure 3.4, the three
kilometer buffers drawn around each facility boundary suggested four spatial clusters of
source facilities. As shown in Figure 3.6, four unique receptor grids were created in the
GIS. The boundary of these receptor grids encompassed all the geographical area
covered by the three kilometer buffers in each of the four clusters of source facilities.
The four receptor grids were named North Essex, East Union, West Union, and South
Middlesex.
The North Essex and West Union receptor grids each contained a single source
facility. The East Union receptor grid contained ten source facilities and the South
Middlesex receptor grid contained five source facilities. The North Essex and West
Union receptor grids were both created with 70 points in the X direction (east — west), 70
points in the Y direction (north — south), and with 100 meter (328 feet) spacing between
the points. The East Union receptor grid was created with 79 points in the X direction ,
98 points in the Y direction, and with 250 meter (820 feet) spacing between the points.
The South Middlesex receptor grid was created with 69 points in the X direction, 60
points in the Y direction, and with 250 meter (820 feet) spacing between the points. The
use of 100 meter spacing was not practical with the East Union and South Middlesex
receptor grids due to the large geographic area that needed to be covered. The North
Essex and West Union grids contained 4,900 receptors, the East Union grid contained
7,742 receptors, and the Lower Middlesex grid contained 4,140 receptors.
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Once the receptor grids were finalized in the GIS, they were digitized in the air
dispersion modeling software as a uniform Cartesian grid. A uniform Cartesian grid is
comprised of an array of points identified by their X (east — west) and Y (north — south)
coordinates. The receptor grid had a series of parameters associated with it that were
used to define it, such as receptor elevation and receptor height (Trinity Consultants,
2004). The height of all receptors in this study was set at ground level. The uniform
Cartesian receptor grid was converted into individual discrete receptors in the air
dispersion model.
In addition to the discrete receptors, the air dispersion modeling software allows
for the creation of discrete boundary receptors. Boundary receptors were placed along
the entire boundary of a source facility and allowed for modeling impacts at the property
boundary (Trinity Consultants, 2004). The boundaries of all 17 source facilities were
digitized in the GIS and imported into the air dispersion modeling software. Discrete
boundary receptors were placed along the source facility boundary at 30 meter (98 feet)
intervals.
Use of uniform receptor grids resulted in receptors that were located within the
property boundaries of several source facilities. The air dispersion model calculates the
impacts at all receptors. However, for most regulatory uses, the impacts at on-site
receptors are usually excluded because the regulations focus on the ambient environment
beyond the facility fenceline (Trinity Consultants, 2004). Therefore, all on-site receptors
were automatically removed by selecting the "remove on-site receptors" option in the air
dispersion modeling software.
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Figure 3.6 Boundaries of the receptor grids used in the air dispersion model.
Source: County boundary shapefiles obtained from NJDEP (NJDEP, 2004a).
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3.2.4 Risk Characterization
The risk assessment evaluated the direct risk from inhalation of vapors using standard
risk equations and assumptions (USEPA, 1989) and the maximum ground-level air
concentrations predicted by the air dispersion model. The USEPA exposure assumptions
result in different risk characterizations for adults and children because of varying body
weights, exposure times, and inhalation rates. Specifically a Hazard Index (HI) and a
Lifetime Incremental Cancer Risk (LICR) were calculated at all receptors for the COCs
emitted by the 17 source facilities.
The HI is a measure of the potential for non-carcinogenic adverse effects
following exposure to a chemical (USEPA, 1989, 1999c). The HI was calculated using
the equation shown below.
(3.3)
where:
Parameter
yr
Description Value Units
HI Hazard Index chemical specific
C a„ Air concentration at receptor chemical specific mg/m3
Iltair Inhalation rate of air (adult/child) 20 / 7.2 m3/day
EF Exposure frequency 365 days/year
ED Exposure duration (adult/child) 25 / 6 year
13W Body weight (adult/child) 70 / 15 kg
RfDi Inhalation reference dose chemical specific mg/kg-day
AT Averaging Time - non-carcinogens (adult/child) 25 / 6 year
Equation 3.3 is the relationship between the Average Daily Dose (ADD) and the
Reference Dose (RfD) for a particular chemical. The RfD is a measure of the lowest
daily dose of a chemical to a human that results in no adverse health effects. Therefore,
as long as the ADD is less than the RfD than no adverse health effects are expected. The
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RfC described in Section 3.2.2 (Toxicity Assessment) is simply the RfD adjusted for
eynnciire ac
5 	 b 	
Therefore, Equation 3.3 can be simplified and expressed as:
(3.5)
where Carr is the ambient air concentration of the chemical predicted by the air dispersion
modeling software. A HI of 1 or less for the inhalation pathway typically indicates that
exposure to that chemical will not result in any potential adverse health effects from that
particular pathway of exposure (USEPA, 1989).
In order to account for exposures to multiple pollutants, regulatory agencies often
set the HI goal below 1 for individual chemicals. The HIs for individual chemicals are
then summed to calculate the Hazard Quotient (HQ). The cumulative HQ represents the
health risk from exposure to multiple pollutants. If the HQ is less than the threshold
value of 1 then the individual would not suffer negative health impacts from exposure to
all the emitted chemicals (National Research Council, 1994). In this study, a HI was
calculated for each COC and a cumulative HQ was calculated for all COCs emitted by all
source facilities.
The LICR is defined as the upper-bound probability of developing cancer as a
result of continuous exposure to a chemical at the estimated concentration over a 70 year
period. This 70 year period is assumed to be the average human lifespan. The predicted
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LICR focuses on the additional risk of cancer predicted from the exposure to a chemical
(USEPA, 1999c). The LICR was calculated using the equation shown below.
(3.6)
where:
Parameter Description Value Units
LICR Lifetime Incremental Cancer Risk chemical specific --
Ca Air concentration at receptor chemical specific mg/m3
EF Exposure frequency 365 days/year
ED Exposure duration (adult / child) 70 / 6 yea
SFi Inhalation slope factor chemical specific (mg/kg-day) -1
IRair Inhalation rate of air (adult / child) 20 / 7.2 m3/day
BW Body weight (adult / child) 70 / 15 kg
ATc Averaging time — carcinogens (adult / child) 70 / 6 year
Equation 3.6 is the relationship between the Lifetime Average Daily Dose (LADD) and
the cancer Slope Factor (SF) for a chemical (USEPA, 1989). The Unit Risk (UR) factor
described in Section 3.2.2 (Toxicity Assessment) is simply the cancer SF adjusted for
exposure, as such:
The UR factor is the upper-bound estimate of the lifetime incremental cancer risk as the
result of continuous exposure over a lifetime to an ambient air concentration of one
microgram per cubic meter (µg/m 3) of a chemical. Therefore, for carcinogens, the LICR
evaluates the degree to which a receptor may have an increased likelihood of developing
cancer over a lifetime due to exposure to a chemical. The LADD differs from the ADD
in that it assumes a person is exposed continuously to the exposure concentration
throughout their lifetime. The inherent assumption for carcinogens is that there is no
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threshold dose for carcinogenic effects. Therefore, any exposure to a carcinogen has the
potential to cause an effect and as such, all exposures are averaged over the entire
lifetime of an individual. The LADD may be adjusted to account for varying exposure
durations but the averaging time stays constant at a lifetime. With the ADD, the
exposure duration and the averaging times are equal. Equation 3.6 in can be simplified
and expressed as:
(3.8)
where Carr
 is the ambient air concentration of the chemical predicted by the air dispersion
modeling software. LICRs are expressed as a unitless probability and are represented in
scientific notation as a negative exponent of 10. For example, the probability of
developing cancer of one chance in 10,000 is written as 1 x 10 -4. For the great majority
of HAPs, the LICR provides an upper-bound prediction of cancer risk as a result of a
lifetime of exposure to a level of chemical. In reality, the actual risk may be lower than
the predicted risk (USEPA, 1999c). The USEPA cites an acceptable range of 1 in ten
thousand (1 x 10 -4) to 1 in one million (1 x 10 -6) for potential cancer risk. Cancer risks
less than 1 in one million are considered de minimis risk (Martineau, 2004; USEPA,
1989, 1999c).
The risk characterization in this study was a deterministic and simplistic estimate
of risk and hazard. In reality, there is variability in the effects seen as a result of
exposure. Therefore, a distribution of risk or hazard would be a more realistic
representation. This is why the USEPA SAB recommended, in their comments on the
prospective Section 812 study, that a probabilistic assessment be used to account for
uncertainty and variability, (USEPA, 1999a, 1999c).
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In this study, the HI and LICR were estimated for all receptors using the
maximum modeled annual average air concentration of the COC, from a source group, at
that receptor. The LICR and HI were calculated for each receptor using the exposure
calculations for adults and children described in Section 3.2.3 (Exposure Assessment).
The LICRs for the individual COCs were summed to derive a cumulative LICR from all
COCs. The HI for the individual COC was summed to derive a cumulative HQ for all
COCs. The receptors that represented the maximum cumulative LICR and HQ for each
source facility were selected. These points of maximum cumulative LICR and HI
represented the maximum exposed individual (MEI). The MEI is the receptor where the
maximum value occurs, regardless of whether there is a person there or not (USEPA,
2004a). The maximum cumulative LICR values less than the de minimus cancer risk of 1
in one million and the maximum cumulative HQ values less than the hazard no-effect
level of 1 were considered to be acceptable and were not investigated further in the study.
The source facilities that had a maximum cumulative LICR value greater than 1 in one
million or a maximum cumulative HQ value greater than 1 were chosen for further
investigation in the study.
The data was the imported into the GIS so that the receptor that represented the
maximum individual risk (MIR) could be selected. The MIR was a concept included in
the benzene NESHAP (USEPA, 1999c). The MIR. represents the point of highest
estimated LICR or HI to a receptor in areas where people are believed to occupy
(USEPA, 2004a). For example, a MIR would not be located in the middle of a stream or
in a parking lot. The MIR can be considered equivalent to the term "individual most
exposed" which is used in Section 112(f) of the CAA on residual risk (USEPA, 1999c).
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To identify the MIR precisely, it is necessary to know detailed information about the
locations of actual people in the study area. The GIS is an extremely useful tool in
identifying the MIR.
Population assessments were used to estimate the populations exposed to various
risk levels in the study area (USEPA, 1999c, 2004a, 2006c, 2006e). This was done by
summing up the populations that have predicted LICRs or HQs above a given risk
threshold. The LICR multiplied by the population was used to predict the excess cancer
cases in the exposed population (ECR, 2005) This 70 year population risk estimate is
sometimes divided by 70 to obtain an upper-bound prediction of the number of cancer
cases per year (ECR, 2005; USEPA, 1999c).
3.3 Estimation of Human Health Benefits
3.3.1 Air Pollution Controls Required by the MACT Standard
This part of the study assesses the air pollution controls the source facilities would apply
to be compliant with the MACT standards. As mentioned previously, the USEPA has
specific MACT standards that apply to specific source categories. The MACT standards
relevant to this study are described in Table 3.5. An OPRA request was filed with the
NJDEP requesting information to help determine if the 17 source facilities in this study
had notified the NJDEP of their intent to be covered under the MACT standards. Under
the CAA, source facilities are required to notify the NJDEP of their status under MACT.
An additional OPRA request was submitted to the NJDEP requesting information and
records on the source facilities that had notified the NJDEP of their status under MACT.
The information obtained during the record reviews was used to determine what (if any)
MACT controls the source facilities may have installed since the baseline year of 1990.
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Using actual information on the reported MACT source category and/or the MACT
controls installed at each facility, the magnitude decrease in toxic emissions was
estimated. If no data could be located then assumptions about the most probable MACT
controls applied at each facility had to be made. Since data may not always be available
on the effectiveness of the installed controls, it may need to be estimated (USEPA,
1999b). The USEPA has several implementation tools available from the Technology
Transfer Network (TTN) website to aid in estimating what MACT controls would be
required for a facility. This study evaluated all the emitted COCs not just the HAPs. It is
important to note that if the risk happens to be driven by a non-HAP COC, installing
MACT controls does not necessarily mean that the non-HAP emissions will be
controlled.
As discussed earlier, the USEPA uses a risk range of 1 in ten thousand to 1 in one
million as a level of acceptable risk (i.e., 1 x 104 to 1 x 10 -6). Since the USEPA is still in
the process of promulgating the final residual risk standards, there is no risk threshold
against which residual risk can be definitively evaluated. In this study, the lower bound
of the acceptable risk range (1 x 10 -6) was chosen so that the goal of protecting public
health with an AMOS would be met. If a source facility's predicted post-MACT risk
level was less than 1 in one million then there was no need for additional air pollution
controls or reductions in risk. If a facility's predicted post-MACT risk exceeded 1 in one
million, then the emission reductions the facility would need to take to meet 1 in one
million was assessed and the cost for any additional air pollution controls was also
estimated.
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3.3.2 Economic Valuation of Human Health Benefits
Translation of health benefits into dollar value is the most contentious aspect of a benefit
and cost analysis (Davies & Mazurek, 1998). The difficulty arises in attempting to place
a dollar value on a good, such as health, that is not sold in markets. The contention arises
due to the large interpersonal variability people exhibit when asked to place a value on a
reduction in risk, an improvement in health, or a human life. Health benefits can be
expressed in terms of the lessening of effects of a chronic disease (morbidity) or
preventing a premature death (mortality). When estimating morbidity benefits,
economists consider empirical criteria such as loss of income while a person is sick
and/or the medical costs incurred to treat the illness. In addition, psychological aspects
such as the unpleasantness of being sick should also factor into the overall estimate of the
benefits (Portney, 2000). Mortality benefits are usually measured by a person's WTP for
an air quality improvement that reduces the probability of dying (Portney, 2000).
Obviously, the WTP is affected by how the probability is defined and the magnitude of
the reduction in probability. The WTP to prevent mortality is the VSL and it represents
the value of preventing one case of premature mortality.
There are two broad classifications of economic methods used to estimate
environmental values and health benefits: direct and indirect methods. Both the direct
and indirect methods can be based on observable behavior (i.e., revealed preference
studies) or behavior that takes place when a person is presented with a survey about a
hypothetical situation (i.e., stated preference studies) (Tietenberg, 2000b).
The direct observable method infers the value from actual observable choices in a
real market. For example, the economic loss of crop injury from a drought can be
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directly calculated using market prices. The direct observable method is not useful in
estimating a value for incremental changes in human health since health is not sold in
markets. The direct hypothetical method, also known as contingent valuation or stated
preference studies, makes use of the personal choices a consumer makes in a hypothetical
situation. The choices a person makes are used to estimate the person's WTP for an
environmental or health benefit that does not have a market value. Several indirect
observable methods can also be used in the valuation of health benefits. These methods,
commonly referred to as revealed preference methods, are the revealed choice method,
the hedonic property value method, the hedonic wage method, and the averting behavior
method. All these methods infer a value estimate by studying related real markets (Smith
& Huang, 1995; Tietenberg, 2000b; Tsuge et al., 2002; Viscusi, 1993). A common
indirect and hypothetical method used to estimate the value of health benefits is the
contingent valuation method. This method uses a sample survey designed around a
hypothetical model to estimate people's WTP for the health benefit (Viscusi, 1993).
In this study, the post-MACT health benefits were estimated by the reduction in
emissions the MACT controls would produce. The post-MACT health benefits were then
compared to the baseline 1990 pre-MACT results. The benefit of the regulation was
estimated by analyzing reductions in mortality and morbidity. In this study, mortality
was measured by the LICR due to exposure to the COCs. Morbidity was represented by
the increased possibility of developing chronic health effects and was measured by the HI
and HQ. The HI assessed the possibility of increased incidence of a chronic disease for a
particular COC and the HQ assessed the probability of increased incidence of a chronic
disease cumulatively from all COCs. In this study, the de minimus risk threshold is 1 in
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one million for the LICR. There was no need to quantify the health benefits gained by
lowering the LICR below the de minimus levels. Similarly, if the predicted HQ was
below 1 there was no need to quantify the health benefits gained by lowering the HQ
below the acceptable threshold.
Benefit transfer is the valuation method used by the USEPA in its prospective
Section 812 study to derive monetary values of health effects. Benefit transfer is the
application of existing information available from research, to new contexts for which
information is not available (Rosenberger & Loomis, 2001). The existing information
can be on a place, an observed behavior, or a hypothetical scenario. The new context can
be another related place, a related benefit, or a policy for which there is little or no data
available on the economic value. Benefit transfer provides a means by which a value can
be estimated in the new context using existing information about the value for similar
context (Rosenberger & Loomis, 2001). In this study, the monetary value of the health
benefit was based on the WTP data in the literature. This WTP data was estimated
through stated preference and revealed preference methods.
In the prospective Section 812 study, the USEPA used WTP data to estimate the
value of avoiding several morbidity effects. For example, the mean value of avoiding
incidence (in 1990 dollars) of morbidity due to respiratory illness from chronic bronchitis
and chronic asthma was estimated at $260,000 per case and $25,000 per case,
respectively (USEPA, 1999b). In the same prospective study, the USEPA used $4.8
million (in 1990 dollars) as the VSL (USEPA, 1999b). This VSL was based on twenty-
six relevant studies available at that time in the literature. Five of the twenty-six studies
were contingent valuation studies and the remainder were hedonic wage studies (USEPA,
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1999b). Therefore, the VSL was estimated using primarily hedonic wage studies
(USEPA, 1999b).
The mortality benefits were calculated by multiplying the VSL by the estimated
number of deaths prevented. Morbidity effects were calculated in a similar fashion by
combining the estimates of the reduction in the number of cases of a disease prevented,
the reduction in lost work days, and the value of each effect. The USEPA has also
developed economic guidelines for its regulatory impact analyses. The guideline
recommends a VSL of $6.2 million (in 2000 dollars) (USEPA, 2000a).
Recently, Viscusi and Aldy (2003) critically reviewed thirty years of scientific
work on the VSL. The review is a meta-analysis of sixty mortality studies and forty
morbidity studies using several valuation methodologies, namely contingent valuation
studies, hedonic wage studies, hedonic housing price studies, and averting behavior
studies. The review discussed the advantages and limitations of the various valuation
methodologies and considered VSL estimates from both the United States and abroad.
They found the estimates of the VSL, using the hedonic wage model, ranged from $4 to
$9 million in 2000 dollars in the United States. Canadian estimates ranged from $2 to $6
million in 2000 U.S. dollars and were in line with U.S. estimates. However, in England
the VSL estimates ranged from $18 million to as high as $68 million in 2000 U.S.
dollars. The English numbers were primarily based on CV studies, which might account
for the wide disparity between England and the United States. The review suggested
using a median estimate VSL of $7 million in 2000 dollars (Viscusi & Aldy, 2003).
In order to estimate the benefits, it was also necessary to determine the number of
individuals exposed to levels of COCs that exceeded the safe threshold levels. The
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affected population was estimated using 1990 Census information available electronically
at the block group level. The block group level was the highest resolution data available
for the 1990 Census. Digital boundary files for the 1990 Census block groups were
available on-line as shapefiles from the United States Census Bureau (USCB) (USCB,
2005).
The 1990 Census block groups that had receptors with a LICR greater than 1 in
one million or a HQ greater than 1 were selected in the GIS. The populations of the
selected block groups were found in the Summary Tape File (STF-1) for the 1990 Census
which was available on-line from the USCB (USCB, 2006b). The numbers of
individuals in each block group were summed to derive the total number of people
residing in the affected area. The total population impacted was an overestimate since
the population of the entire block group was included in the assessment regardless of the
percentage of the block group that actually exceeded the thresholds. The total population
impacted (at a LICR greater than 1 in one million or HQ greater than 1) was assumed to
be the number of incidences of mortality or morbidity that could be reduced. The
benefits were calculated by multiplying the number of reduced incidences of morbidity or
mortality by the estimated WTP values of avoiding the health effects.
This study only looked at the benefits and costs of Title III of the 1990 CAAA.
As in the prospective Section 812 study by the USEPA, minor and reversible effects and
acute duration exposures were not addressed as benefits in this study. In addition,
environmental benefits such as improvements in ecosystem health, improvements in
visibility, or benefits to agriculture were not considered in the calculation of benefits.
Environmental benefits are more accurately reflected in Titles I, II, IV, and VI of the
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1990 CAA Amendments. In addition, acute health effects possibly attributable to short
term upsets or meteorological disturbances were not considered within the scope of this
study.
Several USEPA guidance documents were consulted during the process of benefit
estimation. They are the Guidelines for Preparing Economic Analysis (USEPA, 2000a),
the Handbook for Non-Cancer Health Effects Valuation (USEPA, 2000b), the Children's
Health Valuation Handbook (USEPA, 2003a), and the Cost of Illness Handbook which is
an on-going project that is provided on-line by the USEPA (USEPA, 2006d). In addition,
a USEPA National Center for Environmental Research project on valuation for
environmental policy included numerous helpful references pertaining to valuation of
mortality and morbidity (USEPA, 2003b).
3.3.3 Normalization of Costs and Benefits
The benefit and cost estimates presented throughout this study were normalized to the
base year 2003 and are expressed in 2003 U.S. dollars. Normalization of costs and
benefits were necessary to ensure all costs and benefits were comparable. For example,
the USEPA used a VSL of $4.8 million (in 1990 dollars) in its retrospective study and a
VSL of $6 million (in 1998 dollars) in its prospective study. The VSLs were actually
equivalent in both studies after the adjustment for inflation. One method of normalizing
is to adjust the dollar values to a base year using a price index (USEPA, 2000a).
The benefit and cost estimates presented throughout this study were all
normalized to 2003 dollars based on the latest price indices by U.S. Department of Labor
(USDOL), Bureau of Labor Statistics. The USDOL publishes a variety of price indices
tailored to specific sectors and/or industries. The most recognizable indices are the
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Consumer Price Index (CPI) and the Producer Price Index (PPI). The CPI is the most
widely used measure of inflation and is called the cost of living index. The CPI is a
measure of the average change over time in the prices paid by urban consumers for a
market basket of consumer goods and services. The CPI can be used as a deflator of the
value of the dollar to aid in determining a consumer's purchasing power at different time
periods. As prices increase, the purchasing power of the consumer could decline if the
total income of the consumer stays the same. CPIs are available for major groups of
consumer expenditures (e.g., food and beverages, housing, apparel, transportation,
medical care, recreation, education and communications, and other goods and services),
for items within each major group, and for special categories such as services (USDOL,
2003a). CPIs are available on-line from the USDOL (USDOL, 2003a).
The PPI is a family of indices that measures the average change over time in
selling prices received by domestic producers for their goods and services (USDOL,
1997). The USDOL PPI data contains over 500 industry price indices in combination
with over 10,000 specific product line and product category sub-indices. PPIs are
available on-line from the USDOL (USDOL, 2003c). In 1994, the USEPA created a
series of custom indices, referred to as the Vatavuk Air Pollution Control Cost Indexes
(VAPCCI), that specifically focused on eleven environmental pollution control devices
(USEPA, 2000a). In 2005, the USEPA stopped supporting the VAPCCI due to changes
in the data collected by the USDOL, Bureau of Labor Statistics (USEPA, 2006h).
In this study, the MACT control costs in a given year were adjusted for inflation,
to the cost in 2003 dollars, by multiplying the control cost by a ratio of the PPIs in both
years as reported by the USDOL, as shown in Equation 3.9.
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Control Cost year Control Cost base year (3.9)
This methodology is described in the USDOL guidance document, Escalation and
Producer Price Indexes (USDOL, 1991) and the USEPA guidance document, Guidelines
for Preparing Economic Analyses (USEPA, 2000a).
A review of the available industry specific PPIs did not locate a PPI specific to
the pollution abatement industry (USDOL, 2003c). Therefore, the PPI database was
queried using the following selections: the industry was set to special industry machinery
(code #3559) with the product set to chemical manufacturing machinery, equipment and
parts (code #1) (query code PDU3559#1). This query produced a table of annual PPI
data from 1990 to 2003, which is shown in Table 3.9. The industry classifications used
in the PPI were based on the SIC system. SIC code 3559 describes Special Industry
Machinery, Not Elsewhere Classified. The product code designated specific products
manufactured within the specified industry. A second query was carried out using a
generic, aggregate index for total manufacturing industries (query code PCUOMFG#)
(USDOL, 2003c). The overall change in the aggregate index was less than the change in
the specific index because it included the effects of all industries, some of which are
volatile and may have decreased the overall index. For this study, the cost of the
pollution abatement equipment was adjusted using the data for the chemical
manufacturing machinery, equipment, and parts index, since this index was considered
more relevant.
Price Index year 	Price Index base year
Table 3.9 Selected Annual Producer Price Indices
Chemical	 Total
Year	 Manufacturing	 Manufacturing
PPI 1
	PPI 2
1990 130.4 114.5
1991 133.9 115.9
1992 137.9 117.4
1993 142.0 119.1
1994 144.9 120.7
1995 150.4 124.2
1996 152.5 127.1
1997 158.7 127.5
1998 161.8 126.2
1999 165.8 128.3
2000 168.5 133.5
2001 168.5 134.6
2002 165.7 133.7
2003 163.3 137.1
Notes:
1) Series Id: PDU3559#1
Industry: Special industry machinery, n.e.c.
Product: Chemical manufacturing machinery, equipment and parts.
2) Series ID: PDUOMFG#
Industry : Total manufacturing industries
Product : Total manufacturing industries
Source: (USDOL, 2003c).
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Benefits year Benefits base year
=
Price Index year Price Index base year
(3.10)
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The benefits in a given year were adjusted for inflation to 2003 dollars, using the
CPIs as reported by the USDOL, in a similar manner, as shown in Equation 3.10.
This methodology was described in the U.S. Department of Labor (USDOL) guidance,
How to Use the CPI Index for Escalation (USDOL, 2003b).
CPI data were obtained for the aggregate index for U.S. Medical Care and U.S.
All Items over the time frame 1990 to 2003. The CPI data are shown in Table 3.10. The
benefits in this study were normalized using the CPI relating to the aggregate index for
U.S. Medical Care. The CPI relating to the aggregate index for U.S. Medical Care was
considered more relevant since the goal was to standardize the value of health effects.
Table 3.10 Selected Annual Consumer Price Indices
Year Annual CPI 1U.S. Medical Care
Annual CPI 2
U.S. All Items
1990 162.8 130.7
1991 177.0 136.2
1992 190.1 140.3
1993 201.4 1445
1994 211.0 148.2
1995 220.5 152.4
1996 228.2 156.9
1997 234.6 160.5
1998 242.1 163.0
1999 250.6 166.6
2000 260.8 172.2
2001 272.8 177.1
2002 285.6 179.9
2003 297.1 184.0
Notes:
1) Series Id: CUUROOOOSAM
Area: 	 U.S. city average
Item: 	 Medical care
2) Series ID: CUUR0000SA0
Area: 	 U.S. city average
Item: 	 All items
Source: (USDOL, 2003a).
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3.4 Estimation of Cost Data for Air Pollution Controls
In this part of the study, the cost of the air pollution control equipment that the source
facility would incur or had incurred due to the MACT standards was estimated. First, the
Pharmaceutical MACT Rule Assistant, a USEPA on-line tool, was run to determine the
compliance options available under the Pharmaceuticals MACT standard for the source
facilities (USEPA, 20060. The following information on compliance options was
obtained from the Pharmaceutical MACT Rule Assistant. The Pharmaceuticals MACT
has specific standards, test methods, and initial compliance requirements for each of the
four source categories: process vents, storage tanks, equipment leaks, and wastewater. In
addition, there are specific monitoring, reporting, and recordkeeping requirements
associated with the individual compliance options. The pharmaceutical MACT specifies
air emissions standards (1) across all process vents within a process and (2) for large
individual process vents that meet a certain flowrate threshold.
There are several compliance options existing source facilities can undertake to
demonstrate compliance across all process vents within a process.
■ Set annual mass limits for all vents within a process. In order for a source facility
to choose this option, the emission rate must be less than 900 kilograms per year
(< 2000 pounds per year) for each vent and less than 1,800 kilograms per year for
the entire facility (< 4000 pounds per year).
■ Reduce emissions from all vents within a process, which exceed a minimum flow
rate, by 93 percent.
■ Add a combustion control device (e.g., a thermal incinerator) at each outlet.
Compliance with the second air emission standard (the individual vent standard) requires
that each individual vent, which exceeds a minimum flow rate, must reduce uncontrolled
emissions by 98 percent.
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The USEPA regulations also provide for an alternative option (the pollution
prevention option) to meet the emission standards. The pollution prevention option
allows the source facilities to incorporate pollution prevention initiatives instead of
traditional end-of-pipe controls. After initial compliance with the emission standards is
demonstrated, the source facility must conduct periodic monitoring and reporting to
confirm on-going compliance. Similar information on air emission standards was
obtained for the HON, MON, and the OLDN (Table 3.5).
Based on the review of the MACT standards, the traditional end-of-pipe controls
that would be applied to the source facilities in this study were thermal incineration with
a post-incineration wet scrubber. Detailed information on these two air pollution control
technologies was obtained from the USEPA's Technology Transfer Network (TTN),
Clean Air Technology Center (USEPA, 2006a, 2006b, 2006h). According to the
USEPA, the thermal incinerator unit is also referred to as a thermal oxidizer unit (TOU)
and the control of volatile organic chemicals (VOCs) is based on destruction by thermal
oxidation (USEPA, 2006b). VOC destruction efficiency depends upon design criteria
(e.g., chamber temperature, residence time, inlet VOC concentration, compound type,
and degree of mixing). Typical thermal incinerator design efficiencies range from 98 to
99.99 percent and above depending on system design and characteristics of the waste
stream. If the waste stream contains halogen- or sulfur-containing compounds then
hydrogen chloride, hydrogen fluoride, sulfur dioxide, and other highly corrosive acid
gases may form. In that case, installation of a post-oxidation acid gas treatment system
(i.e., a wet scrubber) is required for control of the acid gases (USEPA, 2006b). Wet
scrubbers are used to control inorganic gases and are commonly referred to as acid gas
112
scrubbers. They remove air pollutants by inertial or diffusional impaction, reaction with
a sorbent or reagent slurry, or absorption into a liquid solvent. Control efficiencies range
from 95 to 99 percent depending on the type of reagent used and the scrubber design
(USEPA, 2006a).
The former Innovative Strategies and Economics Group of the USEPA (now
known as the OAQPS — Air Benefit and Cost Group) have developed methodologies for
estimating the costs of air pollution regulations. Their findings are available on-line at
the USEPA TTN webpage and include cost methodology manuals as well as spreadsheets
for estimating capital and annual costs (USEPA, 2006i). The USEPA fact sheets
contained the costs of both the thermal incinerator (USEPA, 2006b) and the wet scrubber
(USEPA, 2006a). The costs were adapted from USEPA cost estimating spreadsheets and
the USEPA Air Pollution Control Cost Manual, 5 th Edition (EPA 453/B-96-011). The
costs in the fact sheets are referenced to the volumetric flow rate of the treated waste
stream. According to the fact sheets, thermal incineration has an annualized cost of $400
to $3,300 per short ton (i.e., 2,000 pounds) of VOCs ($440 to $3,600 per metric ton).
The wet scrubber has an annualized cost of $45 to $860 per short ton of VOCs ($50 to
$950 per metric ton).
The USEPA Air Pollution Control Cost Manual details the engineering
information and cost information and is an accepted standard in the field of
environmental pollution control sizing and costing. The estimating procedures used in
the Manual are nominally accurate to within plus or minus 30 percent and are referred to
as "study" estimates. The Manual is useful for estimating costs intended for use in
regulatory development because the estimating procedures do not require detailed site-
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specific information. The detailed information necessary for site-specific level analyses
are usually proprietary and not readily available to the regulator. In addition, detailed
analyses are usually very costly to carry out. Therefore, the cost estimates in the Manual
offer sufficient detail for regulatory analysis purposes (USEPA, 2002a).
The annualized cost reflected the total capital investment and the total annual
operation and maintenance cost for the air pollution control device. The total capital
investment captures the total direct and total indirect costs of the air pollution control
equipment plus any additional costs for land or off-site facilities. The total direct and
total indirect costs comprise the majority of the costs for air pollution control equipment.
The total direct costs include the costs required to purchase the equipment needed for the
control system (purchased equipment costs); the costs of labor and materials for installing
that equipment (direct installation costs); the costs for site preparation and buildings; and
certain other costs (indirect installation costs). Indirect installation costs include
engineering costs, construction and field expenses, contractor fees, start-up and
performance test costs, and contingencies (USEPA, 2002a).
Once routine operations begin, the total annual cost occurs. Routine operation of
the control device does not begin until the system is working within its design
parameters. The total annual cost is comprised of the direct costs, indirect costs, and any
recovery credits for materials or energy. The direct costs are the costs for raw materials,
energy, utilities, and waste treatment and disposal. The indirect costs are for labor,
maintenance materials, and repair parts. The indirect costs are comprised of costs for
administration, overhead, property taxes, insurance, and capital recovery (USEPA,
2002a).
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As mentioned earlier, the risk was calculated using actual emissions from the
source facilities expressed in pounds per year of COCs emitted. The costs of the air
pollution control were converted to an abatement cost per pound of COC emitted. The
cost, of the MACT air pollution controls for a source facility, was calculated by
multiplying the abatement cost for the COCs (in terms of pounds emitted) by the actual
amount of all COCs emitted in pounds per year.
3.5 Benefit and Cost Assessment
The final part of the study compared the public health benefits gained through the
additional MACT air pollution controls to the implementation cost of installing and
operating and maintaining the additional controls. The benefits and costs of the air
pollution control devices occur over an extended period of time. Consequently, the
benefit and cost assessment must capture the future effects of current decisions.
The USEPA's prospective Section 812 study indicated that the Title III provisions
of the 1990 CAAA comprised only a small fraction ($840 million out of $27 billion, in
1990 dollars) of the total costs of implementing the provisions of the CAA. However, the
implementation costs of meeting the requirements of Title III only reflected the public
costs incurred to the federal and state regulatory agencies. These public costs did not
take into account the private costs of implementing the MACT standards incurred by the
source facilities. Therefore, it is anticipated that the total costs of implementing Title III
will be substantially higher when the private costs of MACT implementation are
considered.
The results of the quantitative risk assessment were used as the basis for a benefit
and cost comparison of the MACT standards. Title III of CAA would be efficient if
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MACT standards were maximizing the net social benefits to society (i.e., maximizing
social welfare). The net social benefit to society is equal to the sum of the gains
(benefits) minus the losses (costs) to society from policies that change prices and
quantities (Figure 3.7). In this study, the primary recipient of the benefits was the
community and the primary bearer of the costs was the source facilities. The costs were
the private costs to the source facilities for implementing the MACT controls. The public
costs to society to administer and enforce Title III were not considered. Therefore, the
net benefit in this study was calculated as the benefits to society minus the private costs
to the source facilities from implementing the MACT standards as outlined in Title III of
the 1990 CAAA.
Figure 3.7 Components of the net social benefit.
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CHAPTER 4
RESULTS, ANALYSIS, AND UNCERTAINITIES
4.1 Air Dispersion Modeling
The air dispersion model (AERMOD) was run four times, one time for each of the four
receptor grids in the study (North Essex, East Union, West Union, and South Middlesex).
Each of the four model runs simultaneously modeled all of the emission sources at all the
source facilities located within the boundaries of each receptor grid. The AERMOD-
MSP option in the BREEZE® software automatically created a batch file that ran each of
the four modeling runs 102 times, one time for each of the COCs. The final number of
modeling runs done for this study was 408 runs (i.e., 4 receptor grids x 102 COCs). The
total number of receptors modeled were 4,900 in both the North Essex and West Union
grids; 7,742 in the East Union grid; and 4,140 in the Lower Middlesex grid.
All air dispersion modeling output was collected in standard text format files that
contained geographical coordinates ('X' and 'Y') for every receptor as well as a modeled
air concentration for every COC at that receptor. The height for all modeled receptors
was ground level (i.e., 'Z' = 0). The modeled air concentrations were expressed as
micrograms per cubic meter (1.1s/m 3). Appendix E contains the model input for the
modeling runs. The modeling generated 408 output files, which is one file for each COC
for each of the four receptor grids.
The output files included a summary table of the ten highest, maximum annual
average air concentrations of a COC, for all source groups modeled. A source group was
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comprised of all the emissions sources located at a source facility. Appendix F contains
several example output files. The LICR and the HI were calculated for every receptor
using the maximum annual average air concentration for that receptor. The maximum
annual average air concentrations for each COC considered the impact from all the
emission sources located at a facility. The LICR and HI were calculated for each
receptor using the exposure calculations for adults and children described in Section 3.2.3
(Exposure Assessment). The LICRs for the individual COCs were summed to derive a
cumulative LICR from all COCs, emitted from all emission sources located at a source
facility. The HIs for the individual COCs were summed to derive a cumulative HQ from
all COCs, emitted from all emission sources located at a source facility. An analysis of
all the individual LICRs and HIs and the cumulative LICRs and HQs was conducted in
the GIS. The following quality assurance checks were performed on the data and the
results.
■ Confirmed that all the COCs listed in Appendix B were modeled and that the
correct emission rates were used. This was accomplished by checking all
emission rates for all the emission sources against the output files from the air
dispersion modeling.
■ Confirmed the toxicity values used in the exposure assessment were up to date
and correct.
■ Confirmed the correct annual average air concentrations were imported into the
GIS.
■ Confirmed the exposure assessment calculations were correct.
■ Confirmed the dispersion coefficients, derived from the air dispersion modeling,
were within the expected range for the source parameters and the emission rates
modeled. This check was completed for one source facility and verified by
comparing the modeled values against values reported in an air permit on file at
the NJDEP.
■ Confirmed that the COCs modeled all appeared in the final GIS analysis.
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4. 2 Risk Characterization
The risk assessment evaluated the risk from direct inhalation of vapors using standard
risk equations and assumptions (USEPA, 1989), site-specific COCs and their emission
rates, and the maximum, ground level, annual average air concentration predicted by the
air dispersion model. Specifically, a HI and a LICR were calculated for all the COCs
emitted by the 17 source facilities in this study.
4.2.1 Individual Facility Risk
The receptors that represented the maximum cumulative LICR and HQ for each source
facility were selected and are presented in Table 4.1. These receptors represent the MEI.
The maximum cumulative LICR values less than the de minimus cancer risk of 1 in one
million (1 x 10 -6) and the maximum cumulative HQ values less than the HQ no-effect
level of 1 were considered to be acceptable and were not investigated further in the study.
The source facilities that had a maximum cumulative LICR value greater than 1 in one
million or a maximum cumulative HQ value greater than 1 were chosen for further
investigation in the study.
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Table 4.1 Maximum Cumulative LICRs and HOs for the 17 Source Facilities
Facility ReceptorGrid
HQ
Adult Child Adult
LICR
Child
Hoffman LaRoche Inc. NE 0.9 1.6 * 2.9E-05 * 4.9E-05 *
Ciba-Geigy Corp. WU 0.8 1.4 * 2.6E-07 4.3E-07
Exxon Corp. EU 0.2 0.3 0.0E+00 0.0E+00
Firmenich, Inc. EU 0.0 0.1 3.0E-11 5.0E-11
Hoechst Celanese Corp. EU 0.5 0.8 1.6E-05 * 2.7E-05 *
Merck & Co., Inc. EU 0.1 0.2 9.2E-06 * 1.5E-05 *
Penick Corp. EU 0.5 0.8 0.0E+00 0.0E+00
Schering Corp.
(Kenilworth) EU 0.0 0.0 0.0E+00 0.0E+00
Schering Corp.
(Union) EU 0.0 0.0 0.0E+00 0.0E+00
Staflex Products, Inc EU 0.0 0.0 1.6E-07 2.6E-07
Sun Chemical Corp. EU 0.1 0.1 0.0E+00 0.0E+00
Troy Chemical Corp. EU 0.1 0.1 0.0E+00 0.0E+00
Amerchol Corp. SM 5.8 * 9.8 * 3.6E-05 * 6.1E-05 *
Private Formulations,
Inc. SM 0.0 0.0 0.0E+00 0.0E+00
RBH Dispersions, Inc. SM 0.1 0.2 0.0E+00 0.0E+00
Rhodia Inc. SM 0.1 0.1 1.5E-10 2.6E-10
Union Carbide Corp. SM 0.4 0.6 3.2E-06 * 5.4E-06 *
Notes:
1) Receptor Grids: NE = North Essex, EU = East Union, WU = West Union, SM = South Middlesex
2) Source facilities that had receptors with a LICR value greater than 1 in one million (1 x 10 -6) or a HQ
value greater than 1 are shown with an asterisk (*).
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The source facilities chosen for further investigation were Hoechst Celanese
Corp., Hoffman LaRoche Inc., Amerchol Corp., Union Carbide Corp., Merck & Co., Inc.,
and Ciba-Geigy Corp. In all cases the calculated health risks were worst for children.
Children are often considered a sensitive population within the general population.
Therefore, the general population risk, for both adults and children in this study, was
estimated using the LICRs estimated for children. The assumption was that other less
sensitive groups would be protected since the population risk was estimated using the
most sensitive group.
The next step in the analysis was to determine if the LICR exceeded 1 in one
million or the HQ exceeded 1 at the MIR. This analysis involved locating the MIR for
each source facility in the GIS. For this analysis, the MIR was considered a residential
receptor. The Amerchol Corp., the Ciba-Geigy Corp., and the Hoechst Celanese source
facilities were examined using the aerial photographs obtained from the NJDEP. The
examination found that all of the HQs were less than 1 and all of the cumulative LICRs
were less than 1 in one million at all residential receptors. Therefore, the health risk
posed by the emissions in 1990, from these three source facilities, was considered
acceptable to the surrounding community.
The Hoffman LaRoche Inc. facility was further examined using the aerial
photographs obtained from the NJDEP. The examination determined that the HQ did not
exceed 1 for any residential receptors and therefore, the hazard posed by the non-
carcinogenic COCs from this source facility was considered to be acceptable. The
maximum cumulative LICR value did not exceed 1 in ten thousand (1 x 10 4) at any
receptor. Spatial examination of the LICR distribution showed that the cumulative LICR
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did not exceed 1 in one hundred thousand (1 x 10 -5) for any residential receptors. The
LICR for the receptors, near the source facility, fell between 1 in one hundred thousand
(1 x 10 -5) and 1 in one million (1 x 10 -6). The distribution of the carcinogenic risk posed
to children is presented in Figure 4.1.
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Figure 4.1 Carcinogenic risk to children in 1990 (Hoffman LaRoche Inc.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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A population analysis was therefore, carried out on the source facility using 1990
Census information available electronically at the block group level. Digital boundary
files for the 1990 Census block groups were available as shapefiles on-line from the
USCB (USCB, 2005). The 1990 Census block groups that fell within the 1 x 10 -5 to
1 x 10-6 isopleths were selected in the GIS and are presented in Figure 4.2. Each block
group is associated with a unique identifier, called the GEOID. Information on the
selected GEOIDs was queried in the 1990 detailed Summary Tape File (STF-1) for the
1990 Census. The STF-1 file was available on-line from the USCB (USCB, 2006b). The
STF-1 file contained information on the number of individuals in each of the impacted
block groups (Figure 4.2) as well as additional information such as age, sex, and race.
The number of individuals in each block group was then summed to derive the
number of people residing in the area of impact. This assessment of the number of
people potentially impacted was conservative since a block group was included in the
assessment as long as the block group was impacted to any extent. Since some groups
were impacted more than others, the total potentially impacted population was
overestimated. The total number of potentially impacted people was 9,008.
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Figure 4.2 1990 Census block tracts of interest (Hoffman LaRoche Inc.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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The Merck & Co., Inc. facility was further examined using the aerial photographs
obtained from the NJDEP. The examination determined that the HQ did not exceed 1
near any residential receptors and therefore, the hazard posed by the non-carcinogenic
COCs from this source facility was considered to be acceptable. The maximum
cumulative LICR value did not exceed 1 in ten thousand (1 x 10 4) at any receptor.
Spatial examination of the LICR distribution showed that the cumulative LICR did not
exceed 1 in one hundred thousand (1 x 10 -5) for any residential receptors. The LICR for
the receptors, in the vicinity of the source facility, fell between 1 in one hundred thousand
(1 x 10-5) and 1 in one million (1 x 10 -6). The distribution of the carcinogenic risk posed
to children is presented in Figure 4.3.
A similar population analysis was performed on the source facility using 1990
Census information at the block group level. The 1990 Census block groups that fell
within the 1 x 10 -5 to 1 x 10 -6 range were selected and are presented in Figure 4.4. The
number of individuals in each block group was then summed to derive the number of
people residing in the area of impact. The total number of potentially impacted people
was 14,949.
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Figure 4.3 Carcinogenic risk to children in 1990 (Merck & Co., Inc.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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Figure 4.4 1990 Census block tracts of interest (Merck & Co., Inc.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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The Union Carbide Corp. facility was further examined using the aerial
photographs obtained from the NJDEP. The examination determined that the HQ did not
exceed 1 near any residential receptors and therefore, the hazard posed by the non-
carcinogenic COCs from this source facility was considered to be acceptable. The
maximum cumulative LICR value did not exceed 1 in one hundred thousand (1 x 10 -5) at
any receptor. The LICR for the receptors, near the source facility, fell between 1 in one
hundred thousand (1 x 10 -5) and 1 in one million (1 x 10 -6). The distribution of the
carcinogenic risk posed to children is presented in Figure 4.5.
A similar population analysis was performed on the facility using 1990 Census
information at the block group level. The 1990 Census block groups that fell within the
1 x 10-5 to 1 x 10 -6 range were selected and are presented in Figure 4.6. The number of
individuals in each block group was then summed to derive the number of people
residing in the area of impact. The total number of people that potentially were impacted
was 7,676 people.
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Figure 4.5 Carcinogenic risk to children in 1990 (Union Carbide Corp.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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Figure 4.6 1990 Census block tracts of interest (Union Carbide Corp.).
Source: Aerial photograph obtained from NJDEP (NJDEP, 2004a).
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The cumulative LICR values were analyzed for the Hoffman LaRoche, Merck,
and Union Carbide source facilities to determine what COCs were responsible for the
LICR. The individual COCs responsible for the LICRs are shown in Table 4.2. The risk
drivers for the Hoffman LaRoche source facility were methyl hydrazine, tetrahydrofuran,
and methylene chloride. The risk drivers for the Merck source facility were
tetrahydrofuran, benzene, and methylene chloride. The risk drivers for the Union
Carbide source facility were vinyl chloride and methylene chloride. All the risk drivers
were HAPs except for tetrahydrofuran (THF).
In this assessment, it was assumed that the provisional USEPA cancer slope factor
for THF is valid and therefore, it was assessed as a carcinogen. However, it should be
noted that THF is not yet considered a carcinogen by the USEPA. Including THF, a non-
HAP, and treating it as a carcinogen (using the provisional cancer slope factor) make this
assessment a conservative one.
Table 4.2 COCs Driving Carcinogenic Risk in Children
Carcinogenic Risk for Children
COC Hoffman LaRoche Inc. Merck & Co., Inc. Union Carbide Corp.
Benzene 1.8E-08 4.3E-06 ---
Epichlorohydrin --- --- 1.2E-07
Ethyl acrylate --- --- 1.2E-07
Formaldehyde 8.8E-10 2.3E-11 1.4E-09
Methyl hydrazine 3.1E-05 --- ---
Methylene chloride 1.6E-06 6.6E-07 1.4E-06
Tetrachloroethane --- 9.8E-08 ---
Tetrahydrofuran 1.8E-05 1.3E-05 1.7E-08
Vinyl chloride --- --- 4.3E-06
Total LICR 5.1E-05 1.8E-05 5.9E-06
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4.2.2 Cumulative Risk
The cumulative or additive risk posed by the emissions from multiple source facilities
was also studied in the GIS. As shown in Figure 3.2, several source facilities were
located in close proximity to each other. Analysis of the maximum cumulative LICRs
and HQs in the GIS showed that no source facility had a significant spatial impact
beyond their immediate boundary. In no case did a LICR greater than 1 in one million or
a HQ greater than 1 from one source facility spatially intersect a LICR greater than 1 in
one million or a HQ greater than 1 from another source facility. Therefore, there was no
cumulative risk to calculate in this study.
4.2.3 Benefit and Cost Assessment
The Hoffman LaRoche, Merck, and Union Carbide source facilities were chosen for the
benefits and costs comparison. In each case the lifetime excess probability of cancer (as
measured by the cumulative LICR for children) at the MIR exceeded the de minimus
threshold of 1 in one million (1 x 10-6). However, in no case did the MIR exceed the
acceptable risk threshold of 1 in one hundred thousand (1 x 10 -5). In order to predict the
excess cancers, the population estimated to be exposed to risk levels above 1 in one
million was multiplied by the maximum potential risk level of 1 x 10 -5 . In reality, the
risk distribution in the impacted population ranges from a maximum of 1 x 10 -5 to less
than 1 x 10 -6 . The 1 x 10-5
 risk level was used in order to be practical and conservative.
As presented in Table 4.3, the predicted excess cancer cases were less than one for all the
source facilities. It is important to note that the specific person whose probability of
developing cancer due to the additional controls cannot be identified or predicted. The
Estimated Size of
Population Exposed to
a Risk Greater than
1 x 10-6
Estimated
Excess
Cancers 2
Estimated
Cancers per
Year 3
Facility MaximumLICR 1
Hoffman LaRoche
	 1.0 x 10 -5 	14,949
	 0.15 	 0.002
Merck 	 1.0 x 10 -5
	9,008	 0.09 	 0.001
Union Carbide
	 1.0 x 10 -5 	7,676
	 0.08 	 0.001
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results indicated that implementation of the MACT standards at these three source
facilities would result in relatively small changes in mortality risks, even from the HAPs.
Table 4.3 Risk Estimates Due to COC Exposure 
Notes:
1) The Maximum LICR is the highest lifetime excess risk of developing cancer for the exposed
population.
2) Estimated Excess Cancers = Maximum LICR x Number of people in the exposed population.
3) Estimated Cancers per Year = Estimated Excess Cancers ± 70 years
Reference: (ECR, 2005; USEPA, 1999c)
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The VSL used in this study was based on the VSL value the USEPA cites in its
Guidelines for Preparing Economic Analyses (USEPA, 2000a) and the VSL estimate
provided by Viscusi & Aldy (2003). The USEPA guideline recommends a VSL of $6.2
million in 2000 dollars. Viscusi & Aldy (2003) suggests a median estimated VSL of $7
million in 2000 dollars. A VSL value of $7 million (in 2000 dollars) was chosen for use
in this study. The VSL was normalized to 2003 dollars using the CPI data from Section
3.3.3 (Normalization of Costs and Benefits). Since the CPI was 260.8 in 2000 and 297.1
in 2003, the VSL was normalized to $7,980,000 in 2003 dollars. Therefore, the benefit to
society was $7.98 million dollars for this study.
The next step in the benefit and cost comparison was to estimate the costs the
three source facilities might have incurred to install the air pollution controls in
compliance with the MACT standards. An important assumption was that all three
source facilities would continue to operate under the MACT standards. An OPRA
request was submitted to the NJDEP to find out if the three source facilities had notified
the NJDEP that their facility would be subject to the provisions of one or more of the
MACT standards listed in Table 3.5. A file review of the MACT notification records
indicated that Hoffman LaRoche Inc. and Merck & Co., Inc. had both notified the NJDEP
their facilities were subject to both the Pharmaceuticals NESHAP and the Hazardous
Organic Air Pollutants from the Synthetic Organic Chemical Manufacturing Industry
NESHAP (HON). No information was located on the Union Carbide source facility.
Since no information could be located on the Union Carbide source facility, it was
dropped from the benefit and cost comparison.
137
The file review also revealed that five source facilities, that did not show
unacceptable risk in 1990, had also registered with the NJDEP that they were subject to a
MACT standard(s). The source facilities and the MACT standard(s) they are subject to
are as follows: Sun Chemical Corp. (MON); Ferro Corp. (HON); Rhodia (MON);
Conoco Phillips (formerly Exxon Bayway) (HON and OLDN); and Schering (Union)
(Pharm MACT and HON). The data are summarized in Table 4.4.
Table 4.4 MACT Facilities on Record with NJDEP
Facility 	 MACT Standard
Hoffman LaRoche Inc. 	 Pharm MACT and HON
Merck & Co., Inc.
	 Pharm MACT and HON
Exxon Corp.
	 HON and OLDN
Ferro Corp. 	 HON
Rhodia Inc.
	 MON
Schering Corp. (Union)
	 Pharm MACT and HON
Sun Chemical Corp.
	 MON
Note: Refer to Table 3.5 for a description of the MACT standards.
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The file review revealed that Merck & Co., Inc. had installed a thermal
incineration unit and a post-incineration scrubber. Several file reviews were also made of
the actual air permits for the Merck source facility. These file reviews involved extensive
volumes of information and were difficult to process without an intimate knowledge of
the source facility. The option of reviewing the air permits for the Hoffman LaRoche
source facility was dropped since the above review did not produce useable information.
A thorough review of the emissions statements used in Section 3.2.1 (Hazard
Identification) and information in the MACT notifications on file at the NJDEP indicated
that the Hoffman LaRoche source facility had installed air pollution controls similar to
the Merck source facility.
The compliance date of the HON was May 12, 1999 and the Pharmaceuticals
MACT was Sept. 21, 2001. For this study, the assumption was made that the earliest
year a source facility would have been compliant was 1998. Cost data was taken from
the USEPA air pollution control technology fact sheets on the thermal incinerator
(USEPA, 2006b) and the wet scrubber (USEPA, 2006a). According to the fact sheets,
thermal incineration has an annualized cost of $400 to $3,300 per short ton (i.e., 2,000
pounds) of VOCs ($440 to $3,600 per metric ton). The wet scrubber has an annualized
cost of $45 to $860 per short ton of VOCs ($50 to $950 per metric ton). The annual cost
data for the TOU and the wet scrubber were adjusted for each year of operation using the
PPI data in Section 3.3.3 (Normalization of Costs and Benefits).
The annual tons per year of point source emissions for the Hoffman LaRoche and
Merck source facilities were calculated based on the emissions information provided in
the emissions statements from the NJDEP. The annual tons per year of emissions were
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then used to calculate the annual cost of the TOU and the TOU scrubber. The
assumption was made that all HAP and non-HAP emissions, from all the point sources at
the source facility, vent through the TOU and TOU scrubber. Since the MACT standards
only address the HAPs, there is no requirement for a source facility to vent all its non-
HAP VOC emissions through the TOU and TOU scrubber.
The total annual emissions, from point sources at the Hoffman LaRoche source
facility, were 453.1 tons. The total annual emissions, from point sources at the Merck
source facility, were 652.2 tons. The normalized data, for the range of control costs, were
used to calculate the annual operating cost for the TOU and the TOU scrubber from 1998
through 2003. Since emissions statements were not available from the early 1990's (refer
to Section 3.2.1 (Hazard Identification) and the TRI database only tracks emissions post
air pollution control devices, there was no data available to estimate the emissions going
to the air pollution control devices post 1990. Therefore, the assumption was made that
the tons per year produced by the two source facilities remained constant throughout the
years. The cost data is presented in Table 4.5.
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Table 4.5 Cost Estimate for MACT Controls at Two Facilities
Year
Hoffman LaRoche Inc.
Emissions 	 Cost
	 Cost
(tpy)
	
(low range) 	 (high range)
Emissions
(tpy)
Merck & Co., Inc.
Cost 	 Cost
(low range) 	 (high range)
1998 453.1 $196,893 $1,840,613 652.2 $283,392 $2,649,235
1999 453.1 $201,760 $1,886,117 652.2 $290,398 $2,714,729
2000 453.1 $205,046 $1,916,832 652.2 $295,127 $2,758,938
2001 453.1 $205,046 $1,916,832 652.2 $295,127 $2,758,938
2002 453.1 $201,638 $1,884,979 652.2 $290,223 $2,713,092
2003 453.1 $198,718 $1,857,677 652.2 $286,019 $2,673,795
Total $1,209,100 $11,303,050 $1,740,284 $16,268,726
Note: All costs are expressed in 2003 dollars.
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The total benefits obtained were calculated as the number of excess cancers (or
the number of reduced deaths) x $7,980,000 (the VSL). Therefore, the total benefits
derived from the addition of the MACT air pollution controls was $1,192,930 for the
Hoffman LaRoche source facility and $718,838 for the Merck source facility. The total
cost for the Hoffman LaRoche source facility for the first six years of operation ranged
from a $1,209,100 to $11,303,050. The calculated net benefits for the Hoffman LaRoche
source facility ranged from a negative net benefit of $16,170 to a negative net benefit of
$10,110,119. This equaled a benefit to cost ratio that ranged from 1 to 0.1. The total cost
for the Merck source facility for the first six years of operation ranged from $1,740,284
to $16,268,726. The calculated net benefits for the Merck source facility range from a
negative net benefit of $1,021,446 to a negative net benefit of $15,549,888. This equaled
a benefit to cost ratio that ranged from and 0.4 to 0.04. The benefit and cost comparisons
suggest that the incremental cost to install, operate, and maintain the MACT controls
exceeds the benefits of the controls.
4.3 Variability and Uncertainty
A key component of the risk characterization step is a discussion on variability and
uncertainty (USEPA, 2000c). Variability arises from true heterogeneity in characteristics
such as dose-response differences within a population and spatial and temporal
differences in exposure levels throughout the exposed population. Emission sources
differ from each other in terms of their physical characteristics and their mass emission
rates. This variability means individual exposure, dose, and risk can vary widely in a
large population (USEPA, 2000c). This study attempted to minimize variability by using
the high-end or upper-bound estimates when estimating the public health risk to the
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The toxicity assessment and exposure assessment steps made use of the most
current knowledge about the toxicity of the emitted COCs and the latest advances in air
dispersion modeling. Still, the estimation of human risk is always subject to much
uncertainty. The emissions in this study were modeled using a constant emission rate
throughout the year. In reality, emissions vary temporally in terms of rate and release
characteristics such as temperature. The predictions of concentration by the air
dispersion model are dependent on numerous meteorological factors and data on the
terrain surrounding the modeled source facilities. In order to address this variability and
uncertainty, five years of meteorological data were used to capture the true
meteorological patterns. Standard risk assessment equations and default assumptions,
such as body weight, inhalation rate, exposure duration, and exposure frequency, were
used to assess exposure in the study. In reality, distributions of these parameters would
more accurately reflect the variability seen in a heterogeneous population.
In estimating the health effects, a causal relationship must be assumed between
direct exposure to an atmospheric pollutant and adverse health effects. In reality, a
human being is exposed to many different environmental stressors and to different
combinations and levels of environmental stressors. Predictions of health effects become
even more complicated when one considers the many components of variability that are
observed after exposure, such as biological variability. Biological variability can be
subdivided into inter-individual and intra-individual variability. Intra-individual
variability reflects the physiological differences and responses that occur within an
individual over time and inter-individual variability reflects the differences between
individuals. These inter-individual and intra-individual variabilities may cause some
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individuals or groups to be more susceptible to the effects of chemicals (Grassman et al.,
1998; National Research Council, 1994). To address this, safety factors are incorporated
into the toxicity estimates for non-carcinogens to account for inter-individual and intra-
individual variability. For carcinogenic effects, the toxicity estimate was defined as an
upper bound, approximating a 95 percent confidence limit, on the increased cancer risk
from a lifetime of exposure. This study used the most current knowledge about the
toxicity of the emitted COCs. For example, the chemical THF is currently considered a
non-HAP and a non-carcinogen by the USEPA. However, the USEPA NCEA has
released a provisional cancer slope factor for THF. In this assessment, it was assumed
that the provisional USEPA cancer slope factor for THF was valid and therefore, it was
assessed as a carcinogen. Including THF was done to be protective of public health.
Lastly, the health status of exposed individuals has been shown to play a role in disease
initiation and progression.
The risk characterization step was performed using point estimates for the toxicity
values and point estimates for all the exposure assessment parameters. In reality,
distributions of these parameters would more accurately reflect the variability seen in a
heterogeneous population. Use of a probabilistic approach would move away from the
worst case assumptions used in deterministic estimations and offer a more realistic
distribution of risk or hazard. Regardless, the use of point estimates in this study was
appropriate for assessing risk since policymakers have essentially adopted a bright line
approach when dealing with toxicity, hazard, and risk. The use of point estimates is
easily understood by policymakers, risk managers, and the public because the risk
assessment results in bright lines between acceptable and unacceptable. In addition, there
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is currently no framework to design regulations based on probabilistic assessments. The
NRC and the SAB have both recommended the use of probabilistic assessments to
account for uncertainty and variability (National Research Council, 1994; USEPA,
1999a).
The benefit and cost comparison also used point estimates of the benefits and
costs. The benefits were estimated using a central tendency estimate for the VSL that
was based on numerous VSL studies. Valuation decisions regarding the VSL are
contentious, even among economists and many assumptions went into the hedonic wage
and contingent valuation studies used to derive the VSL. The cost assessment used high
and low end estimates of cost derived from USEPA cost estimating guidance. These
estimates have a reported accuracy of plus or minus thirty percent.
Lastly, this study did not attempt to include the impact of benefits and costs that
could not be monetized or were extremely difficult to monetize. For example, omission
of public environmental effects and public sentiment could potentially lead to an
underestimation of social benefits, although the impact that HAPs have on these social
benefits was not anticipated to be large in this study. In general, the primary concern
with the HAPs is their effects on human health. The ecological effects of the emissions
were also not considered in this study. The valuation of ecological benefits is an on-
going and emerging science and the SAB is currently debating methodologies to address
ecological valuation. The ecological effects of the HAPs were not anticipated to be large
in this study. Since none of the emitted COCs were classified as persistent or
bioaccumulative chemicals, the indirect risk that HAPs may pose through the food chain
was deemed not relevant to this study.
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Considering the numerous sources of variability and uncertainty, this study used the
best available data to provide a comprehensive and detailed analysis of the public health
risk posed by the 17 source facilities in 1990.
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exposed population. The benefit and cost assessment used a central tendency estimate for
the VSL and a high- and low-end range of cost estimates.
Uncertainty arises from lack of knowledge about factors such as adverse effects,
emission rates, and pollutant levels in the environment. Generally, risk assessments are
affected by several categories of uncertainty. One type of uncertainty is measurement
uncertainty which refers to the error that accompanies scientific measurements. This type
of uncertainty was associated with the economic models used to estimate the VSL and the
estimation of the costs of air pollution control. There are also uncertainties associated
with the use of scientific models, such as the dose-response models used to estimate
toxicity factors and the air dispersion model used to predict the ambient air
concentrations of the emitted COCs (USEPA, 2000c). Many of the uncertainties
identified with this study are the same ones that surrounded the two prior USEPA Section
812 studies.
The hazard identification step of the risk assessment made use of source facility
reported emissions data in 1990 that were available in the public records. A detailed
emissions reporting procedure was relatively new to the source facilities and the NJDEP
in the early 1990s and as such, the statements were often returned to the NJDEP lacking
data. The emissions data supplied by the source facilities were usually based on
engineering assumptions and other scientific modeling tools rather than actual monitoring
of emissions. In cases where the data was incomplete or missing, assumptions had to be
made or default assumptions needed to be used. Considering all this, the data reported by
the source facilities were still the most comprehensive and detailed data available and
therefore, were the most appropriate to use in the study.
CHAPTER 5
SUMMARY AND CONCLUSIONS
The CAA Amendments of 1990 required the USEPA to regulate the emissions of all
HAPs through technology-based standards. The mandate led to the creation of the
technology-based MACT standards. This study examined the risks, benefits, and costs of
using technology-based standards in a highly industrialized area in New Jersey. In the
first part of this study, a quantitative human health risk assessment was carried out to
evaluate the public health risk posed by 17 source facilities in 1990, the year the CAA
was last amended. The risk evaluated all emissions of HAP and non-HAP pollutants
from the source facility. Therefore, the assessment provided a picture of the risk from the
VOCs emitted from the source facility. If a source facility posed a cancer risk to the
community greater than 1 in one million, than the source facility was carried forward into
the second part of the study, a comparison of benefits and costs.
Three source facilities out of 17 were carried forward into the benefit and cost
comparison. These facilities were examined to determine the level and type of air
pollution controls that would need to be installed to meet the requirements of the MACT
standards. In all three case studies, it was predicted that the source facility would be
required to install a thermal oxidizing unit and a scrubber. The thermal oxidizing unit
would be for control of combustible VOCs. The scrubber would be for control of any
acid gases generated during the combustion process in the thermal oxidizing unit. In
order to estimate the benefits, two simplifying assumptions had to be made in this study:
First, health effects (i.e., morbidity) are the direct result of chronic
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inhalation of VOCs. Secondly, cancer (i.e., mortality) is the direct result of chronic
inhalation of VOCs and in addition, all cases of cancer are assumed fatal.
The benefits of the air pollution controls were estimated by calculating the annual
reduction in human health risk and subsequently deaths, which would be predicted from
the reductions in emissions of VOCs due to the controls. A VSL of $7.98 million in 2003
dollars was used in this study to assign a value to the reduction in predicted deaths. The
annualized cost to control the emissions of VOCs from the source facilities was estimated
using USEPA cost estimation fact sheets. The costs were presented as a range of dollars
spent per ton of VOC reduced.
The 1 in one million risk threshold was chosen because Congress directed the
USEPA, in the 1970 CAA, to set health-based limits at a level that provided an ample
margin of safety (AMOS) to protect public health [42 U.S.C. §7412(b)(1)(B) (1970)].
The USEPA cites an acceptable range of 1 in ten thousand to 1 in one million for
potential cancer risk to the MEI. Cancer risks less than 1 in one million are referred to as
de minimis risk (USEPA, 1989) and do not require any additional risk reduction
measures. The acceptable range for carcinogen risk was determined when the USEPA set
the NESHAP for vinyl chloride (National Research Council, 1994).
To date, the USEPA has carried out two benefit and cost analyses (i.e., Section
812 analyses) of the CAA. This study addressed some of the gaps identified in the
previous studies and presented a flexible methodology for evaluating the risks, benefits,
and costs of air pollution regulations at a community level. This study demonstrated that
a quantitative public health risk assessment and a quantitative benefit and cost
comparison of Title III (i.e., the HAPs) of the 1990 CAAA could be designed and carried
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out on a community level. The fact that this was not done in the prior two USEPA
Section 812 analyses was identified as a gap in those studies. However, it was
discovered that a large level of effort was required to design and carry out a study of this
magnitude. This finding suggests that it might not be practical to perform a similar study
on a national level. The approach demonstrated in this study suggests it is suitable for
modeling exposures from single source facilities as well as cumulative exposure from
multiple source facilities in a community. The community level, public health risk
assessment carried out in this study parallels and supports the methodology recently
developed by the USEPA in its Air Toxics Risk Assessment Reference Library — Volume 3
for conducting air toxics analyses at the facility and community levels.
The emission source parameters and the mass emission rates contained in the
1990 emission reports were limited and not very detailed. Regardless, this study used
publicly available data as inputs for air dispersion modeling. The USEPA had cited the
fact that essential data was lacking for the HAPs as the primary reason the HAPs were
not fully incorporated into either of the prior USEPA Section 812 analyses. In the future,
researchers will have an easier time performing similar risk assessments due to the
improved quality of the information submitted being submitted currently and the ease of
which the information can be accessed electronically.
The publicly available emissions statements contained information on the HAPs
as well as non-HAPs. This study considered the human health effect of both HAPs and
non-HAPs and therefore, provided a more complete representation of the health risks
posed by the source facilities. Interestingly, the study concluded that the risk drivers for
the community were predominantly HAPs. In fact, the only non-HAP pollutant that was
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identified as a risk driver in this study was tetrahydrofuran (THF). This suggests that a
human health risk assessment that only considers HAP emissions would be a good
predictor of risk to the community yet simpler to carry out. If the risk assessment
indicated the potential for hot spots than a more detailed and comprehensive risk
assessment could be performed on the source facility. Decreasing the number of
chemicals included in the risk assessment would decrease its size and allow for the
incorporation of a greater number of industrial source categories and/or a greater number
of source facilities into the assessment. This approach would help address the earlier
observation that the magnitude of this study suggests that it may not be practical to
perform a similar study on a national level. If a risk assessment considering just the
HAPs indicates hot spots in the community than a more complete assessment of the
aggregate risk faced by a community could be undertaken.
This study suggests that the spatial impact of HAP emissions from the 17 source
facilities was limited to the receptors in close proximity to the source facilities. In
addition, no cumulative or additive impacts were predicted even when source facilities
were located in close proximity to each other. The latter supports the finding that
receptors in close proximity to a source facility are the most affected. This suggests that
receptors in close proximity to multiple industrial facilities may be a priority for future
studies.
The MIR represents the point of highest estimated LICR or HI to a receptor in a
community. The health risk in 1990, from non-carcinogenic air pollutants, emanating
from all 17 source facilities, was within acceptable levels at the MIR. The baseline
health risk in 1990, from carcinogenic air pollutants, emanating from all 17 source
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facilities, was within the USEPA acceptable risk range of 1 in ten thousand to 1 in one
million excess risk at the MIR. No source facility presented a risk to the community
greater than 1 in one hundred thousand at the MIR and only three source facilities posed a
risk greater than 1 in one million at the MIR. In all cases, the MIR was located in close
proximity to the source facility. These findings suggest that the technology-based air
pollution control standards (i.e., MACT) required under Title III of the 1990 CAAA
result in relatively small changes in an individuals' morbidity and mortality risks for the
source facility types and the geographic region evaluated in this study.
The predicted net benefits for two of the source facilities, that posed a risk
between 1 in one hundred thousand and 1 in one million to the community, were both
negative. The net benefits for the third source facility could not be predicted due to a
lack of information. The calculated net benefits for the one source facility ranged from
negative $16,000 to negative $10.1 million and the second source facility ranged from
negative $1 million to negative $15.5 million. The benefit and cost comparison
suggested that the incremental cost to install and operate and maintain the MACT
controls exceeded the benefits of the controls for the source facility types and the
geographic region evaluated in this study.
The only health benefits considered in this study were benefits derived from
reductions in direct inhalation of air pollutants. However, VOCs in the atmosphere can
react with nitrogen oxides, oxygen, and sunlight to produce photochemical smog. Ozone,
along with nitric acid and partially oxidized VOCs, are the major constituents of
photochemical smog and are referred to as secondary pollutants (Baird, 1999). No
attempt was made to estimate any health benefits derived from a reduction in the
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formation of secondary pollutants, such as ozone. The assessment of ozone formation
would require a detailed analysis of the VOCs emitted to determine their relative
reactivity factor, additional modeling specifically designed to treat the formation, fate,
and transport of ozone in the atmosphere, and a dose-response assessment of the health
effects of ozone. Exposure to ozone has been shown to produce transient irritation of the
respiratory system (Baird, 1999). The results of this study suggested that the spatial
impact of the VOC emissions occurred in close proximity to the source facilities
therefore, any impact to the community from the formation of secondary pollutants was
assumed not to be significant. Nonetheless, a quantitative assessment of how reductions
in VOC emissions affect secondary pollutants could be the subject of future work in this
area. If an improvement in health effects were predicted, because of the decrease in
ozone formation, the benefits would need to be included in the calculation of the overall
health benefits and the benefit-cost comparison would need to be reevaluated.
This study focused on the human health benefits, in terms of reduced morbidity
and mortality, due to direct inhalation of air pollutants. The study did not attempt to
include the impact of benefits and costs that could not be monetized or were extremely
difficult to monetize. However, one could envision several potential non-market benefits.
For example, the study did not consider any welfare effects attributable to a reduction in
VOCs. As mentioned earlier, one of the components of photochemical smog is nitric
acid. Sulfuric acid and nitric acid are the two predominant acids in acid rain (Baird,
1999). Therefore, one could envision that a reduction in VOC emissions could
potentially lead to benefits for biological organisms, the environment, and inanimate
objects such as buildings. In addition, no benefits were assigned to the positive public
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sentiment that usually accompanies policies that reduce pollution. The omission of
benefits derived from reductions in secondary pollutants was not anticipated to be large
in this study since in general, the primary concern with the HAPs is their effects on
human health.
Another potential benefit, not assessed in this study, is the reduction in emissions
seen as an indirect result of the pending implementation of the 1990 CAAA. As shown
in Table 3.1, the annual quantity of HAPs emitted by all industries of SIC code 28 in
New Jersey decreased from 8.9 million pounds in 1988 to 1.6 million pounds in 2001.
One potential reason for the reductions was the increased levels of air pollution control
installed since 1988. One could envision that a potential source facility may have
undertaken several initiatives to decrease emissions in order to remain below the
emissions threshold for a major source and therefore, avoid having to install additional air
pollution controls. For example, source facilities may have reduced HAPs by applying
cleaner chemistry, substituting for HAPs in the manufacturing process, applying better
operation and maintenance procedures, and/or reducing output all in an effort to decrease
emissions.
All of the un-captured benefits discussed above have the potential to influence the
benefit and cost comparison. However, the goal of this study was not to consider all of
the benefits and costs of the MACT regulations but rather to focus on the major risks and
benefits to the community and the major costs to industry of the regulation. It was
interesting to discover that none of the baseline risks in 1990 were unacceptable (i.e.,
greater than 1 in ten thousand) and that only three of the source facilities posed a risk
greater than the de minimus risk level of 1 in one million. The results indicate that in this
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study, application of the MACT standards at the source facilities is not expected to show
a large reduction in risk for the community. Caution should be used in extrapolating the
results of this study to other source facilities, in other industrial source classifications,
located in other communities throughout the nation. A better option would be to use the
methodology presented in this study to assess how well a regulation is working in other
communities throughout the nation.
The results of this study indicate that, the provisions set forth in Title III of the
1990 CAAA, may not produce positive net benefits in a community. However, several
benefits were not captured in this study and capturing these benefits, in future studies
may change the outcome of the benefit and cost comparison. There are scientific,
economic, social, and regulatory reasons for desiring health effective and cost effective
air pollution regulations. Therefore, future policymaking decisions on air pollution
regulations should consider the approach used in this study, or a similar approach, to
assess the public health benefits to the community gained because of the regulation as
well as the costs associated with implementing the regulation. Developing a regulatory
framework that accounts for risks, benefits and costs at a community level would allow
for increased economic efficiency. For example, a regulation may call for universal and
uniform controls in all cases, except where an assessment of risk could demonstrate an
alternate control strategy. This framework could potentially allow resources to be
conserved. These saved resources could then be reallocated to other uses more beneficial
to public health.
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Future Work
In order to address all the gaps identified in the prior two Section 812 analyses of the
CAA the following work is recommended:
■ The risk characterization in this study was a deterministic and simplistic estimate
of risk and hazard. In reality, a probabilistic assessment that accounts for
uncertainty and variability would produce a distribution of risk or hazard that
would be a more realistic representation.
■ Expand the methodology used in this study to include a greater number of
facilities, of a particular source type, and over a wider geographic area.
■ Expand the methodology used in this study to capture a greater number of
benefits in the benefit and cost assessment.
These studies will facilitate the development of a regulatory framework that will allow
for designing regulations that consider risks, benefits, and costs at a community level.
APPENDIX A
THE LIST OF HAZARDOUS AIR POLLUTANTS
The U.S. Congress included a list of 189 HAPs in the 1990 Amendments to the Clean Air
Act. The complete list of the HAPs can be found at 42 U.S.C. §7401 et seg. (1990).
Table A.1 lists the HAPs.
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Table A.1 List of Hazardous Air Pollutants
CAS No. Chemical Name CAS No. Chemical Name
75070 Acetaldehyde 111422 Diethanolamine
60355 Acetamide 121697 N,N-Diethyl aniline & N,N-Dimethyl aniline
75058 Acetonitrile 64675 Diethyl sulfate
98862 Acetophenone 119904 3,3-Dimethoxybenzidine
53963 2-Acetylaminofluorene 60117 Dimethyl aminoazobenzene
107028 Acrolein 119937 3,3'-Dimethyl benzidine
79061 Acrylamide 79447 Dimethyl carbamoyl chloride
79107 Acrylic acid 68122 Dimethyl formamide
107131 Acrylonitrile 57147 1,1-Dimethyl hydrazine
107051 Allyl chloride 131113 Dimethyl phthalate
92671 4-Aminobiphenyl 77781 Dimethyl sulfate
62533 Aniline 534521 4,6-Dinitro-o-cresol, and salts
90040 o-Anisidine 51285 2,4-Dinitrophenol
1332214 Asbestos 121142 2,4-Dinitrotoluene
71432 Benzene 123911 1,4-Dioxane (1,4-Diethyleneoxide)
92875 Benzidine 122667 1,2-Diphenylhydrazine
98077 Benzotrichloride 106898 Epichlorohydrin (l-Chloro-2,3-epoxypropane)
100447 Benzyl chloride 106887 1,2-Epoxybutane
92524 Biphenyl 140885 Ethyl acrylate
117817 Bis(2-ethylhexyl)phthalate (DEHP) 100414 Ethyl benzene
542881 Bis(chloromethyl)ether 51796 Ethyl carbamate (Urethane)
75252 Bromoform 75003 Ethyl chloride (Chloroethane)
106990 1,3-Butadiene 106934 Ethylene dibromide (Dibromoethane)
156627 Calcium cyanamide 107062 Ethylene dichloride (1,2-Dichloroethane)
133062 Captan 107211 Ethylene glycol
63252 Carbaryl 151564 Ethylene imine (Aziridine)
75150 Carbon disulfide 75218 Ethylene oxide
56235 Carbon tetrachloride 96457 Ethylene thiourea
463581 Carbonyl sulfide 75343 Ethylidene dichloride (1,1-Dichloroethane)
120809 Catechol 50000 Formaldehyde
133904 Chloramben 76448 Heptachlor
57749 Chlordane 118741 Hexachlorobenzene
7782505 Chlorine 87683 Hexachlorobutadiene
79118 Chloroacetic acid 77474 Hexachlorocyclopentadiene
532274 2-Chloroacetophenone 67721 Hexachloroethane
108907 Chlorobenzene 822060 Hexamethylene-1,6-diisocyanate
510156 Chlorobenzilate 680319 Hexamethylphosphoramide
67663 Chloroform 110543 Hexane
107302 Chloromethyl methyl ether 302012 Hydrazine
126998 Chloroprene 7647010 Hydrochloric acid
1319773 Cresols/Cresylic acid (isomers and mixture) 7664393 Hydrogen fluoride (Hydrofluoric acid)
95487 o-Cresol 123319 Hydroquinone
108394 m-Cresol 78591 Isophorone
106445 p-Cresol 58899 Lindane (all isomers)
98828 Cumene 108316 Maleic anhydride
94757 2,4-D, salts and esters 67561 Methanol
3547044 DDE 72435 Methoxychlor
334883 Diazomethane 74839 Methyl bromide (Bromomethane)
132649 Dibenzofurans 74873 Methyl chloride (Chloromethane)
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Table A.1 List of Hazardous Air Pollutants (Continued)
CAS No. Chemical Name CAS No. Chemical Name
96128 1,2-Dibromo-3-chloropropane 71556 Methyl chloroform (1,1,1-Trichloroethane)
84742 Dibutylphthalate 78933 Methyl ethyl ketone (2-Butanone)
106467 1,4-Dichlorobenzene(p) 108883 Toluene
91941 3,3-Dichlorobenzidene 95807 2,4-Toluene diamine
111444 Dichloroethyl ether (Bis(2-chloroethyl)ether) 584849 2,4-Toluene diisocyanate
542756 1,3-Dichloropropene 95534 o-Toluidine
62737 Dichlorvos 8001352 Toxaphene (chlorinated camphene)
1634044 Methyl tert butyl ether 120821 1,2,4-Trichlorobenzene
101144 4,4-Methylene bis(2-chloroaniline) 79005 1,1,2-Trichloroethane
75092 Methylene chloride (Dichloromethane) 79016 Trichloroethylene
101688 Methylene diphenyl diisocyanate (MDI) 60344 Methyl hydrazine
101779 4,4--Methylenedianiline 74884 Methyl iodide (Iodomethane)
91203 Naphthalene 95954 2,4,5-Trichlorophenol
98953 Nitrobenzene 88062 2,4,6-Trichlorophenol
92933 4-Nitrobiphenyl 121448 Triethylamine
100027 4-Nitrophenol 1582098 Trifluralin
79469 2-Nitropropane 540841 2,2,4-Trimethylpentane
684935 N-Nitroso-N-methylurea 108054 Vinyl acetate
62759 N-Nitrosodimethylamine 593602 Vinyl bromide
59892 N-Nitrosomorpholine 108101 Methyl isobutyl ketone (Hexone)
56382 Parathion 624839 Methyl isocyanate
82688 Pentachloronitrobenzene (Quintobenzene) 80626 Methyl methacrylate
87865 Pentachlorophenol 75014 Vinyl chloride
108952 Phenol 75354 Vinylidene chloride (1,1-Dichloroethylene)
106503 p-Phenylenediamine 1330207 Xylenes (isomers and mixture)
75445 Phosgene 95476 o-Xylenes
7803512 Phosphine 108383 m-Xylenes
7723140 Phosphorus 106423 p-Xylenes
85449 Phthalic anhydride Antimony Compounds
1336363 Polychlorinated biphenyls (Aroclors)	Ars ic	 Compounds 	 (inorganic 	 including. 	 .
1120714 1,3-Propane sultone Beryllium Compounds
57578 beta-Propiolactone Cadmium Compounds
123386 Propionaldehyde Chromium Compounds
114261 Propoxur (Baygon) Cobalt Compounds
78875 Propylene dichloride (1,2-Dichloropropane) Coke Oven Emissions
75569 Propylene oxide Cyanide Compoundsl
75558 1,2-Propylenimine (2-Methyl aziridine) Glycol ethers2
91225 Quinoline Lead Compounds
106514 Quinone Manganese Compounds
100425 Styrene Mercury Compounds
96093 Styrene oxide Fine mineral fibers3
1746016 2,3,7,8-Tetrachlorodibenzo-p-dioxin Nickel Compounds
79345 1,1,2,2-Tetrachloroethane Polycylic Organic Matter4
127184 Tetrachloroethylene (Perchloroethylene) Radionuclides (including radon)5
7550450 Titanium tetrachloride Selenium Compounds
APPENDIX B
SOURCE INFORMATION FOR ALL FACILITIES
The information provided in this appendix is presented by source facility in the order
shown below. Information is provided on the point emissions sources, the fugitive
emissions sources, and the mass emission rates.
Facility City County
1. Firmenich Inc. Newark Essex
2. Hoechst Celanese Corporation Newark Essex
3. Hoffmann-La Roche Inc. Nutley Essex
4. Penick Corporation Newark Essex
5. Sun Chemical Corporation Newark Essex
6. Troy Chemical Corporation Newark Essex
7. Amerchol Corporation Edison Middlesex
8. Private Formulations Inc. Edison Middlesex
9. RBH Dispersions, Inc. Bound Brook Middlesex
10. Rhodia Inc. New Brunswick Middlesex
11. Staflex Products, Inc. Carteret Middlesex
12. Union Carbide Corporation Piscataway Middlesex
13. Ciba-Geigy Corp. Summit Union
14. Exxon Corp. Linden Union
15. Merck & Co. Inc. Rahway Union
16. Schering Corporation Kenilworth Union
17. Schering Corporation Union Union
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The emissions statement data were supplied by the NJDEP as Microsoft® Office Excel
spreadsheets. Separate spreadsheets were obtained for all 17 source facilities. Within
each spreadsheet there were seven individual worksheets labeled Al, A2, Bl, Cl, D1,
El, and Fl. The worksheets contained the following information:
■ Al — plant level data
■ A2 — process identification data for sources on record with the NJDEP
■ B1 — process and emission information for fuel combustion
■ Cl — process and emission information for VOC storage tanks
■ D1 — process emission information for batch operations
■ El — process and VOC emission information for surface coating operations
■ Fl — process and emission information for other process types and pollutants
The descriptions of the field headers for worksheet Al are listed below. All the
information for each facility was obtained from the NJDEP facility emissions statements
unless otherwise specified.
PLANT ID	 NJDEP identifier for a facility.
PLANT NAME
	 Facility name.
LOCATION	 Facility address.
PLANT CITY	 City in which facility is located.
SIC	 SIC code on record with the NJDEP.
SECOND SIC	 Secondary SIC code(s) on record with the NJDEP.
PRIN PROD
	 General and brief description of facility's activities.
VOC_TON_YR	 Tons per year of VOCs emitted.
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The descriptions of the field headers for worksheets A2 and D2, for the point emission
sources, are listed below. All the information for each facility was obtained from the
NJDEP facility emissions statements unless otherwise specified.
MODEL ID	 Unique identifier assigned to all point emission sources modeled in
this study.
STACK_ID	 NJDEP identifier for a point source.
SR DESCR	 Brief description of the source.
HEIGHT	 Stack height above ground level in units of feet.
DIAMETER	 Average diameter of the stack in units of inches.
TEMP	 Average temperature of the exhaust gas in units of degrees
Fahrenheit.
VOLUME	 Average exhaust flow rate in units of actual cubic feet per minute.
CHEM NAME	 Name of the chemical emitted.
TPY_HC
	
Tons per year of a chemical emitted.
g/s
FULL ID
Grams per second of a chemical emitted. The grams per second
were calculated from the TPY_HC field. Refer to Equation 3.1 in
Section 3.2.1 (Hazard Identification).
Unique identifier for each emission. The FULL_ID is a
concatenation of the PLANT ID ("P"), the STACK_ID ("T"), and
the SOURCE _ID ("0"). The FULL_ID is a 10 digit number in the
form PPPPPTTTOO.
EFFICIENCY
	 The combined overall efficiency (%) of all control devices present
on the source.
The descriptions of the field headers for the fugitive emission sources are listed below.
All the information for each facility was obtained from the USEPA and State of NJ TRI
databases unless specified otherwise.
CHEM NAME	 Name of the chemical emitted.
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REL EST AMT 	 Estimated amount of chemical released in pounds per year.
g/s 	 Field for the grams per second of a chemical emitted. The grams
per second were calculated from the REL_EST_AMT field. Refer
to Equation 3.2 in Section 3.2.1 (Hazard Identification).
REL CODE 	 Description of the basis for estimating the release.
TRI_FAC_ID 	 TRI Facility Identification code.
Table B.1 Source Facility: Firmenich, Inc.
PLANT_ID 	 06242
PLANT NAME 	 Firmenich, Inc.
LOCATION 	 928-964 Doremus Avenue
PLANT CITY
	 Newark
SIC 	 2869
SECOND SIC 	 -
PRIN_PROD 	 Fragrance raw materials
VOC_TON_YR 	 15.8
TRIF ID 	 07114CHMFL92896
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
E_FM_01 001 REACTOR 50 2 95 1
E_FM_02 002 DISTILLATION SYSTEM 50 2 70 1
E_FM_03 038 REACTOR 55 2 50 1
E_FM_04 053 REACTORS 55 3 86 3
E_FM_05 071 DISTILLATION SYSTEM 55 10 85 3
E_FM_06 074 DISTILLATION SYSTEM 55 10 85 2
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
E_FM_V01 	 21.9	 2.79 	 3
Table B.1 Source Facility: Firmenich, Inc. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL _ID EFFICIENCY
EFM01 001 BENZALDEHYDE 1.4E-05 0624200101 0
EFM01 001 METHANOL 9.0E-04 0624200101 0
E_FM_02 002 BENZALDEHYDE 3.1E-04 0624200201 0
E_FM_03 038 PENTANAL 3.8E-04 0624203801 0
EFM04 053 METHANOL 1.3E-01 0624205303 0
E_FM_05 071 NONANAL 7.0E-04 0624207101 0
E_FM_05 071 XYLENE 1.2E-06 0624207101 0
E_FM_06 074 BENZALDEHYDE 1.2E-03 0624207401 0
E_FM_06 074 XYLENE 2.9E-06 0624207401 0
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID CHEM_NAME g/s REL_CODE
E_FM_V01 DIMETHYL SULFATE 7.2E-05 Other Approaches
E_FM_V01 FORMALDEHYDE 7.2E-05 Other Approaches
E_FM_V01 METHANOL 3.6E-03 Other Approaches
E_FM_VO1 PHOSPHORIC ACID 7.2E-05 Other Approaches
E_FM_VO1 STYRENE OXIDE 7.2E-05 N/A
E_FM_V01 XYLENE (MIXED ISOMERS) 3.9E-02 Other Approaches
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Table B.2 Source Facility: Hoechst Celanese, Inc.
PLANT_ID 	 05131
PLANT NAME 	 Hoechst Celanese Chemical Group, Inc.
LOCATION 	 354 Doremus Avenue
PLANT CITY
	 Newark
SIC 	 2869
SECOND SIC 	 -
PRIN_PROD
	 Formaldehyde solutions
VOC_TON_YR 	 745.9
TRIF ID 	 07105HCHST354D0
POINT SOURCE
MODEL _ID STACK ID SR_DESCR
	 HEIGHT DIAMETER TEMP VOLUME
EHC_01
	 051 	 LIQUID TRANSFER 	 37 	 13 	 60 	 3000
E_HC_02
	 052 	 LIQUID TRANSFER 	 37 	 13 	 60 	 3000
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Table B.2 Source Facility: Hoechst Celanese, Inc. (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME gls FULL ID EFFICIENCY
EHC01 051 ACETONE 4.2E-03 0513105101 90
EHC_01 051 ACRYLIC ACID 1.0E-04 0513105101 90
E_HC_01 051 BUTANOL 4.4E-04 0513105101 90
EHC_01 051 BUTYL ACETATE 1.7E-03 0513105101 90
EHCO1 051 ETHYL ACRYLATE 4.5E-03 0513105101 90
E_HCO1 051 FORMALDEHYDE 4.0E-05 0513105101 0
E_HCO1 051 ISOBUTYL ALCOHOL 4.8E-04 0513105101 90
E_HCO1 051 MEK 9.3E-03 0513105101 90
E_HCO1 051 METHANOL 1.1E-02 0513105101 90
EHC_01 051 METHYL ACRYLATE 5.3E-03 0513105101 90
EHC_01 051 N-BUTYL ACRYLATE 4.2E-04 0513105101 90
E_HCO1 051 N-PROPYL ACETATE 1.2E-03 0513105101 90
EHCO1 051 VINYL ACETATE 4.1E-02 0513105101 90
EHCO2 052 ACETIC ACID 1.8E-03 0513105201 90
EHCO2 052 BUTANOL 5.9E-04 0513105201 90
E_HCO2 052 ETHYL ACETATE 9.4E-03 0513105201 90
E_HCO2 052 FORMALDEHYDE 2.6E-02 0513105201 90
E_HCO2 052 FORMIC ACID 4.6E-04 0513105201 90
E_HC_02 052 ISOPROPAL ALCOHOL 1.1E-03 0513105201 90
E_HCO2 052 METHANOL 3.8E-04 0513105201 0
E_HC_02 052 PROPIONIC ACID 7.2E-06 0513105201 90
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
E_HC_V01 	 23.2 	 2.79 	 3
Table B.2 Source Facility: Hoechst Celanese, Inc. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
E_HC_VO1 ACETONE 3.73E-03 Other Approaches
E_HC_VO1 BUTYL ACRYLATE 6.08E-03 Other Approaches
E_HC_VO1 ETHYL ACRYLATE 8.77E-03 Other Approaches
E_HC_V01 ETHYLENE GLYCOL 2.70E-02 Other Approaches
E_HC_V01 FORMALDEHYDE 5.01E-02 Other Approaches
E_HC_VO1 METHANOL 6.28E-02 Other Approaches
E_HC_VO1 METHYL ACRYLATE 8.67E-03 Other Approaches
E_HC_VO1 METHYL ETHYL KETONE 4.20E-03 Other Approaches
E_HC_VO1 METHYL ISOBUTYL KETONE 3.82E-03 Other Approaches
E_HC_VO1 N-BUTYL ALCOHOL 1.77E-02 Other Approaches
E_HC_V01 VINYL ACETATE 1.04E-01 Other Approaches
Note: butyl and ethyl acrylate were summed together for modeling
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Table B.3 Source Facility: Hoffman LaRoche, Inc.
PLANT_ID 	 30374
PLANT NAME 	 Hoffman LaRoche, Inc.
LOCATION	 RTE. 3 (also 340 Kingsland Street)
PLANT CITY 	 Clifton (also Nutley)
SIC 	 2834
SECOND SIC
	 -
PRIN_PROD 	 Pharmaceuticals
VOC_TON_YR 	 820.5
TRIF ID 	 07110HFFMN340KI
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
E_HR_Ol 008 REACTOR 65 1 81 4
E_HR 02 009 REACTORS 65 2 104 7
E_HR03 456 REACTORS 10 80 70 1300
E_HR 04 457 REACTORS 120 80 70 3000
E_HR_05 458 SEPARATOR 45 1 47 11
E_HR_06
460, 465,
UNKNOWN
SOURCES
STRIPPER 20 40 70 100
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Table B.3 Source Facility: Hoffman LaRoche, Inc. (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME Ws FULL _ID EFFICIENCY
EHR 01 008 TETRAHYDROFURAN 1.4E-03 3037400802 0
E_HR 01 008 TOLUENE 3.7E-04 3037400801 0
E_HR 02 009 ISOPROPYL ALCOHOL 2.5E-03 3037400907 95
E_HR 02 009 METHANOL 9.0E-05 3037400904 93
E_HR 02 009 METHYL BROMIDE 2.1E-02 3037400906 99
E_HR02 009 TOLUENE 1.8E-04 3037400905 0
EHR 03 456 ETHANOL 3.9E-03 3037445615 0
E_HR 03 456 METHANOL 1.9E-02 3037445615 88
E_HR 03 456 TOLUENE 1.9E-02 3037445615 85
E_HR 04 457 ACETONE 6.5E-03 3037445710 95.4
E_HR 04 457 METHANOL 2.7E-03 3037445710 95.4
E_HR 04 457 TOLUENE 6.5E-03 3037445710 95.4
E_HR 05 458 ETHANOL 3.0E-05 3037445801 0
EHR 05 458 METHANOL 6.0E-05 3037445801 0
E_HR_05 458 TOLUENE 2.2E-05 3037445801 0
E_HR_06 718 ACETIC ACID 5.9E-02 0500471803 0
E_HR06 893 ACETIC ANHYDRIDE 8.3E-02 0500489302 0
E_HR_06 A15 ACETONE 1.5E+00 30374A1521 0
E_HR 06 514 ACETONITRILE 2.5E-03 3037451401 0
E_HR 06 113 BENZENE 4.3E-05 3037411304 0
E_HR 06 349 BUTANOL 6.1E-04 3037434901 62.5
E_HR 06 A13 CHLOROFORM 6.3E-02 30374A1381 0
EHR 06 A04 CYCLOHEXANE 5.7E-02 30374A0482 0
E_HR 06 A27 DIMETHYL FORMAMIDE 9.1E-03 30374A2712 0
E_HR 06 928 ETHANOL 6.3E-02 0500492801 0
E_HR 06 501 ETHYL CHLOROFORMATE 1.2E-03 3037450105 95
E_HR 06 465 ETHYL ETHER 1.4E-02 3037446502 37
E_HR 06 115 ETHYLENE GLYCOL 1.1E-02 0500411501 0
E_HR 06 626 FORMALDEHYDE 3.0E-03 0500462602 90
EHR 06 A05 ISOPROPYL ALCOHOL 4.4E-01 30374A0511 0
EHR 06 A14 METHANOL 1.0E+00 30374A1431 20
EHR 06 A03 METHYL ETHYL KETONE 2.2E-02 30374A0332 0
E_HR_06 283 METHYL FORMATE 6.5E-04 3037428301 0
E_HR_06 898 METHYLHYDRAZINE 1.2E-04 0500489801 33.33
E_HR_06 855 N-HEPTANE 1.3E+00 0500485501 99
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
E_HR V01 	 62 	 2.79 	 3
Table B.3 Source Facility: Hoffman LaRoche, Inc. (Continued)
MODEL ID STACK ID CHEM_NAME g/s FULL _ID EFFICIENCY
EHR_06 A05 N-HEXANE 1.2E+00 30374A0501 89
E_HR 06 868 PHENOL 4.6E-06 3037486807 0
EHR_06 928 PYRIDINE 3.4E-02 0500492801 0
E_HR_06 222 TERT-BUTYL CHLORIDE 6.1E-04 0500422201 90.38
EHR06 725 TETRAHYDROFURAN 1.7E-01 0500472501 0
E_HR_06 A27 TOLUENE 7.0E+00 30374A2712 0
E_HR_06 725 TRIETHYLAMINE 1.1E-03 0500472501 0
E_HR_06 330 OIL 8.8E-03 0500433001 90
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID CHEM_NAME g/s REL_CODE
E_HR_VO1 ACETONE 2.9E-01 Other Approaches
E_HR_VO1 CHLOROFORM 3.6E-03 Other Approaches
E_HR_VO1 DICHLOROMETHANE 1.8E-01 Other Approaches
E_HR_VO1 METHANOL 2.4E-01 Other Approaches
EHRvol_	 _ NAPHTHALENE 7.2E-05 Published EmissionFactors
E_HR_VO1 TOLUENE 1.9E-01 Other Approaches
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Table B.4 Source Facility: Penick Corp.
PLANT_ID 	 06265
PLANT NAME 	 Penick Corporation
LOCATION 	 158 Mount Olivet Avenue
PLANT CITY 	 Newark
SIC 	 2833
SECOND SIC 	 -
PRIN_PROD
	 Bulk pharmaceuticals
VOC_TON_YR 	 53.6
TRIF ID 	 07114PNCKC158MT
POINT SOURCES
MODEL ID STACK ID SR DESCR HEIGHT DIAMETER TEMP VOLUME
E_PK_Ol
016, 013,
014, 015, SOLVENT RECOVERY 50 2 70 5
019 SYSTEM
E_PICO2 020 CONCENTRATOR 60 2 86 1
022, 02,
E_PK_03 026, 027, DRYER, TANK 24 2 70 1
028
E PK 04 029, 005,007,018
REACTOR, DRYER,
TANK 30 2 80 2
E_PK_05 041 REACTOR 60 5 70 1
E_PK 06 042, 047 REACTOR 60 5 70 3
E PK 07 049, 052,057, 058 TANKS 12 3 60 2
E_PK_08 070 REACTOR 60 1 70 40
EPK09 072 REACTOR 60 5 80 3
76, 075,
E_PK_10 77, 078, CRYSTALLIZER 50 3 70 4
079, 080
E PK 11 082 , 083,Ogg' 60 3 90 1
087, 094,
E_PK_12 095, 096, TANKS 25 2 70 3
101
E_PK_13 102 CENTRIFUGE 15 3 70 5
E PK 14— 	 —
103, 105,
109, 110
BUILDING
VENTILATION 60 20 70 2000
E_PK_15 111, 113 TANK 60 2 70 3
171
Table B.4 Source Facility: Penick Corp. (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
EPKOl 019 METHANOL 1.2E-02 0626501902 0
E_PKO2 020 BUTANOL 8.0E-03 0626502001 0
EPKO3 028 BUTANOL 1.2E-03 0626502801 0
E_PKO4 029 ETHANOL 1.8E-02 0626502901 0
EPKO5 041 TOLUENE 3.8E-01 0626504111 0
EPK06 047 BUTANOL 5.4E-03 0626504701 0
E_PK_07 058 METHANOL 4.7E-03 0626505801 0
E_PK_08 070 ETHANOL 5.6E-04 0626507009 0
E_PK_08 070 TOLUENE 1.3E-02 0626507009 0
E_PK_09 072 BUTANOL 3.9E-03 0626507212 0
E_PK_10 080 METHANOL 1.6E-01 0626508001 0
E_PK11 084 ETHANOL 1.7E-04 0626508401 0
E_PK_11 084 METHANOL 2.3E-03 0626508401 0
EPK11 084 TOLUENE 1.3E-03 0626508401 0
E_PK_12 096 BUTANOL 4.2E-03 0626509601 0
E_PK_12 096 ETHANOL 3.1E-03 0626509601 0
E_PK 12 087 ISOPROPANOL 4.2E-03 0626508701 0
EPK 12 101 TOLUENE 2.2E-02 0626510101 0
E_PK 13 102 ISOPROPANOL 6.7E-04 0626510201 0
E_PK_13 102 TOLUENE 1.6E-03 0626510201 0
E_PK_14 110 BUTANOL 9.4E-04 0626511002 0
E_PK_14 109 ETHANOL 9.7E-04 0626510901 0
E_PK_14 109 ISOPROPANOL 9.0E-05 0626510901 0
E_PK 14 109 METHANOL 3.9E-04 0626510901 0
E_PK_14 109 TOLUENE 1.5E-03 0626510901 0
E_PK_15 113 ETHANOL 7.2E-04 0626511301 0
E_PK_15 113 METHANOL 2.5E-04 0626511301 0
E_PK_15 113 TOLUENE 2.0E-03 0626511301 0
172
Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL ID
E_PK_VO1	 11.4	 2.79	 3
Table B.4 Source Facility: Penick Corp. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL CODE
EPKVO1_	 _ AMMONIA 9.4E-02 Published EmissionFactors
EPKVO1_	 _ HYDROCHLORIC ACID 7.2E-05 Published EmissionFactors
EPKVO1_	 _ METHANOL 4.2E-01 Published EmissionFactors
EPKVO1_	 _ N-BUTYL ALCOHOL 4.2E-01 Published EmissionFactors
E_PK_VO1 PHOSPHORIC ACID 7.2E-05 N/A
EPKVO1
—	 —
TOLUENE 4.2E-01 Published EmissionFactors
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Table B.5 Source Facility: Sun Chemical Corp.
PLANT_ID 	 06262
PLANT NAME 	 Sun Chemical Corporation - Pigments Division
LOCATION 	 185 Foundry Street
PLANT_CITY 	 Newark
SIC 	 2819
SECOND SIC 	 -
PRIN_PROD 	 Manufacturers of synthetic organic chemicals
VOC_TON_YR 	 65.7
TRIF ID 	 07105SNCHM185F0
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
E_SC_01 001 REACTOR 35 2 120 15
E_SC_02 003 DRYER VENT OVENS 40 17 321 6488
E_SC_03 004 FILTER PRESS 8 30 100 2000
E_SC_04 005 REACTOR 6 30 100 6000
E_SC_05 006 FILTER PRESS 20 20 80 2077
E_SC_06 011 EXHAUST FAN 12 10 70 6329 (')
Note: (1) Volume in table exceeded AERMOD's range of acceptable values. Default volume of 5000 used in study.
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
ESC 01 001 METHANOL 5.9E-02 0626200101 0
ESC 02 003 METHANOL 7.5E-02 0626200302 95
ESC 02 003 NAPHTA 5.5E-02 0626200302 0
ESC 03 004 METHANOL 8.6E-02 0626200403 0
E_SC_04 A02 METHANOL 4.1E-01 06262A0201 0
E_SC_05 006 METHANOL 2.2E-01 0626200601 0
E_SC_05 006 NAPHTA 3.9E-02 0626200601 0
E_SC_06 011 METHANOL 3.3E-02 0626201101 0
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
E SC VO1 	 14.9 	 2.79 	 3
Table B.5 Source Facility: Sun Chemical Corp. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID 	 CHEM_NAME
	 g/s 	 REL_CODE
E_SC_VO1 	 METHANOL
	 6.2E-01 	 Other Approaches
E_SC_VO1 	 PHOSPHORIC ACID 	 7.2E-05
	 Other Approaches
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Table B.6 Source Facility: Troy Chemical Corp.
PLANT_ID 	 05459
PLANT NAME 	 Troy Chemical Corp.
LOCATION 	 One Avenue L
PLANT CITY
	 Newark
SIC 	 2851
SECOND SIC
	 -
PRIN_PROD 	 Specialty chemicals
VOC_TON_YR 	 15.3
TRIF ID 	 07105TRYCHONEAV
POINT SOURCES
MODEL ID STACK ID SR DESCR HEIGHT DIAMETER TEMP VOLUME
ETC 01 017 REACTOR 20 8 70 600
E_TC_02 034 METHANOL RECOVERYSYSTEM 30 1 70 3
E_TC_03 036 REACTOR 40 2 70 100 (1)
E_TC_04 058 REACTOR 18 2 175 40
E_TC_05 060 TANK 25 2 70 3
E_TC_06 062 TANK 22 2 70 3
E_TC_07 068 REACTOR 20 5 100 300
ETC 08 069 REACTOR 25 15 120 100
ETC 09 070 REACTOR 25 2 70 3
ETC 10 071 TANK 30 2 50 10
ETC 11 074, 073 TANK 20 2 70 7
E_TC_12 077 METHANOL RECOVERYSYSTEM 30 2 90 3
Note: (1) Volume in table exceeded AERMOD's range of acceptable values. Default volume of 5000 used in study.
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL ID
ETC V01	 20.5	 2.79	 3
Table B.6 Source Facility: Troy Chemical Corp. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL _ID EFFICIENCY
ETC 01 017 METHANOL 6.7E-02 0545901702 99
E_TC_02 034 METHANOL 1.6E-02 0545903401 95
E_TC_03 036 DIETHYLENE TRIAMINE 1.3E-03 0545903601 99
E_TC_03 036 NAPTHA 3.6E-03 0545903601 99
ETC04 058 NAPHTHA 1.4E-02 0545905801 50
E_TC_05 060 METHANOL 6.4E-03 0545906001 50
E_TC_06 062 METHANOL 6.6E-03 0545906201 50
E_TC_07 068 PROPARGYL ALCOHOL 3.5E-03 0545906802 90
E_TC_08 069 METHANOL 5.6E-04 0545906902 90
E_TC_08 069 PROPARGYL ALCOHOL 5.2E-04 0545906901 90
E_TC_09 070 METHANOL 1.7E-01 0545907001 20
E_TC_10 086 METHANOL 3.5E-02 0545908601 0
E_TC_11 073 METHANOL 9.0E-02 0545907301 99
E_TC_11 074 NAPHTHA 6.6E-04 0545907401 20
ETC 12 077 METHANOL 1.5E-03 0545907701 99
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
E_TC_VO1 1 2 4-TRIMETHYLBENZENE 3.6E-03 Other Approaches
E_TC_V01 METHANOL 2.7E-01 Other Approaches
E_TC_V01 STYRENE 7.2E-05 Other Approaches
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Table B.7 Source Facility: Amerchol Corp.
PLANT ID 	 15343
PLANT NAME 	 Amerchol Corp.
LOCATION 	 136 Talmadge Road
PLANT CITY 	 Edison
SIC 	 2843
SECOND SIC 	 -
PRIN_PROD
	 Cosmetic intermediates
VOC_TON_YR 	 76.8
TRIF ID 	 08818MRCHL136TA
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
MAMEROl 13, 16 REACTOR 25 2 180 1
M_AMER02 15 REACTOR 27 2 295 11
M_AMER03 18 TANK 22 1 70 1
M_AMER04 19, 20, 28 TANK & TANK VENTS 25 2 188 1
M_AMER_05 29 REACTOR 25 2 180 1
M_AMER_06 31 REACTOR 25 2 221 1
M_AMER_07 32 REACTOR 25 1 194 2
M_AMER 08 33 REACTOR 25 2 140 1
M_AMER 09 38, 39, 46 SETTLING TANK 26 2 70 7
M_AMER_10
41,42, 43,
44, 45, 47,
51
TANK VENT 28 1 130 1
M_AMER_11 54 REACTOR 27 2 70 250
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL _ID
M_AMERVO1 	 22.8 	 2.79 	 3
Table B.7 Source Facility: Amerchol Corp. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM NAME_ g/s FULL ID EFFICIENCY
MAMEROl 016 ISOPROPANOL 0.182429 1534301601 95
M_AMER_02 015 METHANOL 130.720443 1534301501 99.9
M_AMER03 018 ACETIC ACID 0.007123 1534301801 0
MAMER 03 018 ACETIC ANHYDRIDE 0.000980 1534301801 0
M_AMER03 018 HEPTANE 0.015401 1534301801 95
M_AMER_04 020 MINERAL SPIRITS 0.003788 1534302001 0
M_AMER04 028 TOLUENE 0.883737 1534302801 95
M_AMER_05 029 ISOPROPANOL 0.091215 1534302901 95
M_AMER_06 031 ACETIC ACID 0.007107 1534303101 0
M_AMER_06 031 ACETIC ANHYDRIDE 0.000980 1534303101 0
M_AMER_07 032 MINERAL SPIRITS 0.001894 1534303201 0
M_AMER07 032 TOLUENE 0.404139 1534303201 95
M_AMER 08 033 ACETIC ACID 0.000016 1534303301 0
M_AMER08 033 HEPTANE 0.015401 1534303301 95
MAMER 09 046 MINERAL SPIRITS 0.011747 1534304601 0
M_AMER 10 051 MINERAL SPIRITS 0.013258 1534305101 0
M_AMER10 051 TOLUENE 2.828972 1534305101 95
M_AMER_11 054 METHANOL 130.720443 1534305401 99.9
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
M_AMER_VO1 ETHYLENE OXIDE 2.3E-03 Other Approaches
M_AMER_VO1 METHANOL 7.8E-02 Other Approaches
M_AMER_VO1 PROPYLENE OXIDE 1.0E-01 Other Approaches
M_AMER V01 TOLUENE 5.4E-01 Other Approaches
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
M_RRFMVO1 	 45.4 	 2.79 	 3
Table B.8 Source Facility: Private Formulations, Inc.
PLANT_ID 	 15579
PLANT NAME
	 Private Formulations, Inc.
LOCATION 	 460 Plainfield Avenue
PLANT CITY 	 Edison
SIC 	 2834
SECOND_SIC
PRIN_PROD 	 Over the counter pharmaceuticals
VOC_TON_YR 	 22.2
TRIF ID 	 08818PRVTF460PL
POINT SOURCES
MODEL ID STACK ID SR_DESCR
	 HEIGHT DIAMETER TEMP 	 VOLUME
MPRFM01 1
	 DRYING 	 30 	 20 	 100 	 7500
M_PRFM_02 17 	 MIXING TANK
	 30 	 10 	 70 	 7600
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME
	 g/s 	 FULL ID EFFICIENCY
MPRFM01 001
	 METHANOL 	 4.9E-02 	 1557900101 	 99
M_PRFM_02 A01
	 METHANOL
	 3.7E-01 	 15579A0101 	 0
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID 	 CHEM_NAME 	 g/s 	 REL_CODE
M_RRFM_V01
	 METHANOL 	 3.6E-03 	 Other Approaches
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Table B.9 Source Facility: RBH Dispersions, Inc.
PLANT ID
	 15678
PLANT NAME 	 RBH Dispersions, Inc.
LOCATION	 L-5 Factory Lane
PLANT CITY 	 Middlesex
SIC 	 2899
SECOND_SIC 	 2851
PRIN_PROD
	 Pigment dispersions
VOC_TON_YR 	 32.4
TRIF ID 	 08805RBHDSL5FAC
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
M RBH 01— 	 —
10, 14, 15,
16,18,22,
25, 32, 33, MILL (Average) 28 14 71.5 3000
34, 35
M_RBH02 26, 27, 28 MIXING TANK (Average) 17 20 75 3000
M_RBH_03 002 STORAGE TANK 17 2 70 57
MRBH04 017 MIXING TANK 17 20 75 3000
M_RBH_05 020 BLDG. 17 10 80 5000
M_RBH_06 030 COWLES 30 6 70 1600
M_RBH_07 031 TANK 25 20 70 7200
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Table B.9 Source Facility: RBH Dispersions, Inc. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME Ws FULL ID EFFICIENCY
M_RBH01 034 ACETONE 0.008004 1567803401 0
M_RBH01 018 BUTANOL 0.002541 1567801804 0
M_RBHOl 034 BUTYL ACETATE 0.009390 1567803404 0
M_RBHOl 018 CYCLOHEXANONE 0.000345 1567801804 0
M_RBH01 034 ETHYL ACETATE 0.007545 1567803404 0
M_RBH01 034 ETHYL ALCOHOL 0.005438 1567803404 0
M_RBHOl 018 ISPOROPYL ALCOHOL 0.339136 1567801801 0
MRBH01 036 METHOXY 2 PROPANOL 0.001254 1567803601 0
MRBH01 036 METHYL ETHYL KETONE 0.068463 1567803601 0
M_RBH_Ol 034 METHYL ISOBUTYLKETONE 0.008628 1567803401 0
MRBHOl_ 	 _ 018 METHYLMETHACRYLATE 0.001216 1567801804 0 
M_RBHOl 036 PROPANOL 0.003419 1567803601 0
M_RBHO1 018 SOLVESSO 100 0.000583 1567801804 0
M_RBI-101 036 TOLUENE 0.022657 1567803601 0
M_RBH_01 018 XYLENE 0.003803 1567801804 0
M_RBH02 026 ACETONE 0.000003 1567802602 0
M_RBH_02 028 BUTANOL 0.000051 1567802801 0
M_RBH02 026 BUTYL ACETATE 0.000003 1567802602 0
M_RBH_02 026 ISOPROPYL ALCOHOL 0.000270 1567802603 0
M_RBH_02 026 METHOXY 2 PROPANOL 0.000002 1567802602 0
M_RBH02 028 METHYL ETHYL KETONE 0.002098 1567802801 0
M_RBH_02 026 METHYL ISOBUTYLKETONE 0.000003 1567802602 0
M_RBH02 026 PROPANOL 0.000018 1567802602 0
M_RBH_02 027 SOLVESSO 100 0.000144 1567802701 0
M_RBH_02 028 TOLUENE 0.000104 1567802801 0
M_RBH_02 028 XYLENE 0.000076 1567802801 0
M_RBH_03 002 METHOXY 2 PROPANOL 0.000029 1567800201 0
M_RBH_03 002 METHYL ETHYL KETONE 0.000173 1567800201 0
M_RBH03 002 PROPANOL 0.000288 1567800201 0
M_RBH_03 002 TOLUENE 0.000058 1567800201 0
M_RBH04 017 BUTANOL 0.000211 1567801702 0
M_RBH04 017 BUTYL ACETATE 0.000235 1567801702 0
M_RBH04 017 CYCLOHEXANONE 0.000006 1567801702 0
M_RBH_04 017 ETHYL ACETATE 0.000705 1567801702 0
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Table B.9 Source Facility: RBH Dispersions, Inc. (Continued)
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
M_RBH04 017 ETHYL ALCOHOL 0.000362 1567801702 0
M_RBH04 017 ISOPROPYL ALCOHOL 0.000352 1567801702 0
M_RBH04 017 METHOXY 2 PROPANOL 0.000176 1567801702 0
M_RBH04 017 METHYL ETHYL KETONE 0.000622 1567801702 0
M_RBH04 017 METHYL ISOBUTYLKETONE 0.000006 1567801702 0
MRBH04_ 017 METHYLMETHACRYLATE 0.000235 1567801702 0 
M_RBH04 017 SOLVESSO 100 0.000110 1567801702 0
M_RBH_04 017 TOLUENE 0.001533 1567801702 0
M_RBH04 017 XYLENE 0.000369 1567801702 0
M_RBH05 020 BUTANOL 0.000511 1567802001 0
M_RBH_05 020 BUTYL ACETATE 0.000365 1567802001 0
M_RBH_05 020 CYCLOHEXANONE 0.000009 1567802001 0
M_RBI-105 020 ETHYL ACETATE 0.001094 1567802001 0
M_RBH_05 020 ETHYL ALCOHOL 0.000802 1567802001 0
M_RBH05 020 ISOPROPYL ALCOHOL 0.000438 1567802001 0
M_RBH05 020 METHYL ETHYL KETONE 0.000967 1567802001 0
M_RBH_05 020 METHYL ISOBUTYLKETONE 0.000009 1567802001 0
M_RBH_05 020 METHYOXY 2 PROPANOL 0.000274 1567802001 0
M_RBH05 020 SOLVESSO 100 0.000171 1567802001 0
M_RBH05 020 TOLUENE 0.002198 1567802001 0
M_RBH05 020 XYLENE 0.000937 1567802001 0
M_RBH_06 030 BUTYL ACETATE 0.000396 1567803003 0
M_RBH_06 030 CYCLOHEXANONE 0.000317 1567803003 0
M_RBH_06 030 ETHYL ACETATE 0.001189 1567803003 0
M_RBH_06 030 ETHYL ALCOHOL 0.001114 1567803004 0
M_RBH06 030 ISOPROPYL ALCOHOL 0.000476 1567803003 0
M_RBH06 030 METHYL ETHYL KETONE 0.004435 1567803003 0
M_RBH_06 030 METHY ISOBUTYLKETONE 0.000317 1567803003 0
MRBH06 030 TOLUENE 0.002768 1567803004 0
M_RBH_07 031 BUTYL ALCOHOL 0.002073 1567803101 0
M_RBH07 031 BUTYL ACETATE 0.021260 1567803103 0
M_RBH_07 031 ETHYL ACETATE 0.070000 1567803103 0
M_RBH07 031 ETHYL ALCOHOL 0.051334 1567803103 0
MRBH07 031 ISOPROPYL ALCOHOL 0.028000 1567803103 0
M_RBH07 031 TOLUENE 0.060667 1567803103 0
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
M_RBH_VO1	 10.6	 2.79	 3
Table B.9 Source Facility: RBH Dispersions, Inc. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
MRBHVO1_	 _ METHYL ETHYL KETONE 7.2E-02 Published EmissionFactors
M_RBH_VO1 METHYL METHACRYLATE 3.6E-03 Other Approaches
MRBHVO1_	 _ TOLUENE 3.5E-02 Published EmissionFactors
M_RBH_V01 XYLENE (MIXED ISOMERS) 2.5E-02 Published EmissionFactors
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Table B.10 Source Facility: Rhone-Poulenc, LP.
PLANT_ID 	 15101
PLANT NAME 	 Rhone-Poulenc Specialty Chemicals, LP.
LOCATION 	 298 Jersey Avenue
PLANT CITY 	 New Brunswick
SIC 	 2869
SECOND_SIC
PRIN_PROD 	 Industrial organic chemicals
VOC_TON_YR 	 19.8
TRIF ID 	 08901RHNPL298JE
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
M_RHOD_Ol 006 REACTOR 41 2 120 3
M_RHOD_02 007 REACTOR 42 3 120 25
M_RHOD_03 010 SCRUBBER 45 13 70 2520
M_RHOD_04 044 TANK 41 2 70 4
M_RHOD_05 045 TANK 40 2 105 25
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
MRHODOl 006 FORMALDEHYDE 3.60E-04 1510100601 0
M_RHODOl 006 PHENOL 3.60E-04 1510100601 0
M_RHOD_02 007 FORMALDEHYDE 3.60E-04 1510100701 0
M_RHOD02 007 PHENOL 3.60E-04 1510100701 0
M_RHOD_03 010 METHANOL 1.01E-02 1510101001 90
M_RHOD_04 044 FORMALDEHYDE 3.17E-04 1510104401 0
M_RHOD_04 044 PHENOL 3.17E-04 1510104401 0
M_RHOD_05 045 FORMALDEHYDE 0.00E+00 1510104501 0
M_RHOD05 045 PHENOL 0.00E+00 1510104501 0
M_RHOD_05 055 TOLUENE 7.92E-04 1510105501 0
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
M_RHOD_V01
	 10.2 	 2.79	 3
Table B.10 Source Facility: Rhone-Poulenc, LP. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID CHEM NAME_ g/s REL_CODE
M_RHODVO1 METHANOL 3.0E-01 Published EmissionFactors
MRHODVO1_ 	 _ PHENOL 3.6E-03 Published EmissionFactors
M_RHODVO1 TOLUENE 1.6E-01 Published EmissionFactors
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Table B.11 Source Facility: Staflex, Inc.
PLANT_ID 	 15074
PLANT NAME 	 Staflex Specialty Esters, Inc.
LOCATION 	 Middlesex Avenue
PLANTSITY 	 Carterte
SIC 	 2869
SECOND_SIC
PRIN_PROD
	 Esters
VOC_TON_YR 	 32.8
TRIF ID 	 07008STFLXMIDDL
POINT SOURCES
MODEL _ID STACK ID SR_DESCR
	 HEIGHT DIAMETER TEMP 	 VOLUME
M_SF_01
	 150 	 REACTOR 	 20 	 3 	 70 	 19
M_SF_02 	 151 	 REACTOR VENT 	 20 	 2 	 70 	 8
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL JD EFFICIENCY
MSF01 150 BUTANOL 1.8E-04 1507415001 0
M_SF_01 150 ISOPROPYL ALCOHOL 1.0E-03 1507415001 0
MSF_02 151 BUTANOL 9.4E-04 1507415101 0
M_SF_02 151 BUTYL ACETATE 1.4E-04 1507415101 0
MSF02 151 METHANOL 1.1E-04 1507415101 0
M_SF_02 151 METHYL AMYLALCOHOL 3.5E-04 1507415101 0
M_SF_02 151 TRIDECYL ALCOHOL 5.7E-05 1507415101 0
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL ID
M_SF_VO1 	 53.5 	 2.79 	 3
Table B.11 Source Facility: Staflex, Inc. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
M_SF_VO1 BIS(2-ETHYLHEXYL) ADIPATE 4.2E-04 Other Approaches
M_SF_VO1 CERTAIN GLYCOL ETHERS 1.2E-03 Other Approaches
M_SF_VO1 DI(2-ETHYLHEXYL) PHTHALATE 4.4E-03 Other Approaches
M_SF_VO1 DIBUTYL PHTHALATE 2.3E-04 Other Approaches
M_SF_VO1 MALEIC ANHYDRIDE 1.7E-04 Other Approaches
M_SF_VO1 METHANOL 8.6E-04 Other Approaches
M_SF_VO1 N-BUTYL ALCOHOL 2.4E-02 Other Approaches
M_SF_VO1 PHTHALIC ANHYDRIDE 7.2E-05 Other Approaches
188
Table B.12 Source Facility: Union Carbide Corp.
PLANT_ID 	 15031
PLANT NAME
	 Union Carbide Chemicals & Plastics Corporation
LOCATION 	 One River Road
PLANT CITY
	 Bound Brook
SIC 	 2833
SECOND_SIC
PRIN_PROD 	 Polyethylene
VOC_TON_YR 	 559.7
TRIF ID 	 08854NNCRB1RIVE
POINT SOURCES
MODEL ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
M_UC_01 016 REACTOR 40 10 77 10
M_UC_02 069 REACTOR 15 15 160 125
M_UC_03 125 EVAPORATOR 50 3 125 1
M_UC_04 138 REACTOR 38 60 70 1
M_UC_05 139 MIX TANK 25 10 80 20
M_UC_06 147 REACTOR 30 3 1500 2
M_UC_07 171 REACTOR & TANK 20 3 70 5
M_UC_08 181 VACUUM DRYER 35 2 77 65
M_UC_09 184 CONFIDENTIAL 30 3 80 5
M_UC_10 198 DRYING UNIT 4 2 70 2
M_UC_11 218 EXTRUDER 35 20 1500 85
M_UC_12 223 FLUID BED DRYER 37 10 140 2500
M_UC_13 226, 227, 228 SEPARATOR & SIEVE 50 2 70 0
M UC 14_ 	 _ 229 DRYING OVEN 30 12 158 1456
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Table B.12 Source Facility: Union Carbide Corp. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
M_UCO1 016 ACETONE 1.2E-04 1503101601 60.00
M_UCO1 016 N-BUTANOL 6.1E-04 1503101601 99.90
MUC01 016 TOLUENE 3.1E-04 1503101601 97.00
M_UCO1 016 TRIETHYLAMINE 1.2E-05 1503101601 99.00
M_UCO2 069 ACETONE 4.0E-03 1503106901 99.90
M_UCO2 069 VINYL ACETATE 8.5E-04 1503106901 99.90
M_UCO2 069 VINYL CHLORIDE 8.0E-02 1503106901 99.90
M_UC_03 125 BUTANOL 1.1E+01 1503112501 99.90
M_UCO3 A01 ETHANOL 3.1E-01 15031A0101 99.90
MUC_03 A01 TOLUENE 2.1E+01 15031A0101 99.90
M_UC_03 A01 VINYL METHYL ETHER 4.2E-01 15031A0101 99.90
M_UCO4 138 BUTANOL 2.1E-02 1503113801 99.00
M_UCO4 138 EPICHLOROHYDRIN 1.4E-02 1503113801 99.00
M_UC_04 138 TOLUENE 1.6E-01 1503113801 99.00
M_UCO5 139 BUTANOL 1.1E-03 1503113901 99.00
M_UCO5 139 ETHANOL 1.1E-03 1503113901 99.00
M_UCO5 139 HEPTANE 6.1E-03 1503113901 99.00
M_UCO5 139 HEXANE 1.1E-03 1503113901 99.00
MUCO5 139 ISOPENTANE 1.1E-03 1503113901 99.00
M_UCO5 139 PROPANOL 1.1E-03 1503113901 99.00
M_UCO5 139 TETRAHYDROFURAN 1.1E-03 1503113901 99.00
M_UC_05 139 XYLENE 6.1E-03 1503113901 99.00
M_UC_06 147 PROPANE 9.6E-02 1503114701 99.00
M_UC_07 171 METHYLENE CHLORIDE 1.7E-02 1503117101 99.90
M_UCO8 181 ACETONE 2.4E-04 1503118101 99.00
MUCO9 184 ACETONE 3.5E-04 1503118401 99.90
M_UC_09 184 DIETHYLENE GLYCOL 1.7E-03 1503118401 99.90
M_UC_09 184 ETHYL ACRYLATE 1.7E-03 1503118401 99.90
M_UC_10 198 BUTANOL 5.2E-06 1503119801 0.00
MUC10 198 TOLUENE 4.1E-05 1503119801 0.00
M_UC_11 218 PROPANE 7.6E-03 1503121803 99.00
MUC12 223 ACETONE 4.3E-04 1503122301 0.00
M_UC_12 223 ISOPROPANOL 1.7E-05 1503122301 0.00
M_UC_12 223 METHANOL 8.6E-05 1503122301 0.00
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL JD
M_UC_V01 	 49 	 2.79 	 3
Table B.12 Source Facility: Union Carbide Corp. (Continued)
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
M_UC_12 223 METHYL ACETATE 3.5E-04 1503122301 0.00
M_UC_12 223 VINYL ACETATE 4.3E-05 1503122301 0.00
MUC13 228 METHYLENECHLORIDE 6.0E-03 1503122801 0.00
MUC14 229 METHYLENE CHLORIDE 2.5E-01 1503122901 0.00
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID CHEM_NAME g/s REL_CODE
M_UC_V01 ACETONE 2.0E-02 Other Approaches
M_UC_VO1 CERTAIN GLYCOL ETHERS 7.4E-02 Other Approaches
M_UC_V01 DICHLOROMETHANE 5.9E-02 Other Approaches
M_UC_V01 EPICHLOROHYDRIN 1.2E-04 Other Approaches
M_UC_V01 FORMALDEHYDE 4.0E-02 Other Approaches
M_UC_V01 N-BUTYL ALCOHOL 3.7E-02 Other Approaches
M_UC_V01 PHENOL 1.0E-01 Other Approaches
M_UC_V01 PHOSPHORIC ACID 1.9E-03 Other Approaches
M_UC_VO1 TOLUENE 3.1E-02 Other Approaches
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Table B.13 Source Facility: Ciba-Geigy Corp.
PLANT_ID 	 40017
PLANT_NAME 	 Ciba-Geigy Corporation
LOCATION 	 556 Morris Avenue
PLANT CITY	 Summit
SIC 	 2834
SECOND_SIC
	 2833
PRIN PROD 	 Pharmaceuticals
VOC_TON_YR 	 244.8
TRIP ID 	 07901CBGGY556M0
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Table B.13 Source Facility: Ciba-Geigy Corp. (Continued)
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
U_CG_01 058 REACTOR AND SCRUBBER 30 40 50 15
UCG_02 069, 015 REACTOR 30 2 70 5
100, 030,
U_CG_03 101, 104, REACTORS 30 2 70 15
105, 106, 107
U_CG_04 119 REACTORS 30 1 70 5
121, 122,
U_CG_05 123,125,
124,
126, REACTORS 30 2 70 3
127, 129, 130
U_CG_06 132 EVAPORATOR, DEGREASERS, TANKS 20 3 70 483 (1)
U_CG_07 133 REACTOR 35 2 100 5
U_CG_08 136 REACTOR 30 2 70 3
U_CG_09 137 MIXER 25 8 75 750
U_CG_10 138 CENTRIFUGE 30 2 60 15
U_CG_11 140 REACTORS 30 1 32 1
U_CG_12 141 REACTORS 30 2 70 30
U_CG_13 142 REACTORS 20 5 450 15
U_CG_14 144 REACTOR 25 2 70 1
U_CG_15 146 GENERAL EXHAUST VENT 42 20 70 7200
U_CG_16 147 REACTORS EXHAUST VENT 34 25 70 3680
U_CG_17 148 GENERAL EXHAUST VENT 42 20 70 7200
U_CG_18 152,154,
153,
155, 167 REACTOR 30 2 70 1
U_CG_19 176 TANK VENT 40 3 70 483 (2)
U_CG_20 180 TANK VENT 25 4 70 500
Notes:
(1) Volume adjusted from 600 ACFM to 483 ACFM so Velocity would be <= 50 m/s
(2) Volume adjusted from 680 ACFM to 483 ACFM so Velocity would be <= 50 m/s
Table B.13 Source Facility: Ciba-Geigy Corp. (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME Ws FULL ID EFFICIENCY
U_CGO1 058 ETHANOL 8.4E-04 4001705808 83
U_CG_01 058 DIOXANE 4.0E-06 4001705808 0
U_CG_01 058 ISOPROPANOL 1.8E-03 4001705808 75
U_CG_01 058 METHYLENE CHLORIDE 1.6E-03 4001705808 0
U_CGO1 058 HEXANE 1.5E-03 4001705808 66
U_CGO1 058 TOLUENE 1.4E-04 4001705808 50
U_CG_02 069 ACETIC ACID GLACIAL 8.9E-05 4001706901
U_CG_02 069 BUTANOL 1.8E-05 4001706901 90
U_CG_02 069 HEXANE 8.9E-03 4001706901 66
U_CG_03 167 ACETONE 4.2E-01 4001716701 60
U_CG_03 107 ETHANOL 4.1E-03 4001710703 83
U_CG_03 167 ISOPROPYLAMINE 2.3E+00 4001716701 98
U_CG_03 105 METHANOL 1.3E-04 4001710501 57
U_CG_03 107 TOLUENE 1.1E-02 4001710703 79
U_CGO4 119 ACETIC ACID GLACIAL 4.3E-04 4001711902 0
U_CG_04 119 ETHANOL 1.9E-03 4001711902 83
U_CG_04 119 DIOXANE 8.1E-06 4001711902 0
U_CGO4 119 ISOPROPYL ALCOHOL 5.8E-07 4001711902 75
U_CGO4 119 METHANOL 1.2E-06 4001711902 83
U_CG_04 119 METHYLENE CHLORIDE 4.1E-03 4001711902 0
U_CG_05 130 ACETONE 4.5E-03 4001713001 80
U_CG_05 123 ETHANOL 1.2E-04 4001712302
U_CG_05 130 ETHYL ACETATE 4.6E-03 4001713001 80
U_CG_05 123 DIMETHYLFORMAMIDE 3.5E-03 4001712301
U_CG_05 123 TOLUENE 3.3E-03 4001712302
U_CG_06 132 TOLUENE 8.0E-03 4001713207 0
U_CG_07 133 METHANOL 1.3E-04 4001713301 83
U_CG_07 133 METHYL CYCLOHEXANE 1.0E-03 4001713301 81
U_CGO7 133 TOLUENE 1.3E-03 4001713301 0
U_CG_08 136 ACETIC ACID GLACIAL 4.3E-04 4001713602 0
U_CG_08 136 ETHANOL 1.9E-03 4001713602 83
U_CG_08 136 DIOXANE 8.1E-06 4001713602 0
U_CG_08 136 ISOPROPYL ALCOHOL 2.9E-07 4001713601 75
U_CG_08 136 METHANOL 5.8E-07 4001713601 83
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Table B.13 Source Facility: Ciba-Geigy Corp. (Continued)
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
U_CG_08 136 METHYLENE CHLORIDE 4.1E-03 4001713602 0
U_CG_09 137 ETHANOL 8.5E-03 4001713701 95
U_CG_10 138 ACETONE 3.8E-02 4001713801 60
U_CG_10 138 ETHANOL 5.9E-04 4001713801 83
U_CG_10 138 ISOPROPYLAMINE 2.1E-01 4001713801 98
U_CG_10 138 METHANOL 1.3E-04 4001713801 57
U_CG_10 138 TOLUENE 1.6E-03 4001713801 79
U_CG_11 140 DIMETHYLAMINE 3.6E-03 4001714002
U_CG_11 140 METHANOL 7.4E-03 4001714002
U_CG_12 141 ACETONE 7.6E-02 4001714102 60
U_CG_12 141 ISOPROPYL ALCOHOL 3.6E-03 4001714102 75
U_CG_12 141 ISOPROPYLAMINE 4.2E-01 4001714102 98
U_CG_13 142 DIMETHYLFORMAMIDE 1.4E-05 4001714201
UCG14 144 ETHANOL 1.3E-04 4001714402 83
U_CG_14 144 ETHYL ACETATE 3.1E-04 4001714402 95
UCG15 146 ACETONE 1.1E+00 4001714628 60
U_CG_15 146 ETHANOL 1.4E-02 4001714624 83
U_CG_15 146 DIMETHYLAMINE 5.0E-02 4001714628
U_CG_15 146 ISOPROPYLAMINE 5.9E+00 4001714628 98
U_CG_15 146 METHANOL 1.0E-01 4001714628
U_CG_15 146 TOLUENE 3.8E-02 4001714624 79
U_CG_16 147 ACETONE 8.9E-02 4001714741 80
U_CG_16 147 ETHANOL 1.7E-03 4001714741
U_CG_16 147 ETHYL ACETATE 5.7E-02 4001714741 80
U_CG_16 147 DIMETHYLFORMAMIDE 4.8E-02 4001714741
U_CG_16 147 TOLUENE 6.3E-02 4001714741
UCG17 A03 ACETIC ACID GLACIAL 4.1E-03 40017A0301 0
U_CG_17 A04 ACETONE 3.8E-02 40017A0401 60
U_CG_17 A04 ETHANOL 1.5E-02 40017A0401 83
U_CG_17 148 DIOXANE 6.0E-05 4001714815 0
U_CG_17 A02 ISOPROPYL ALCOHOL 3.2E-02 40017A0202 75
U_CG_17 A04 ISOPROPYLAMINE 2.1E-01 40017A0401 98
U_CG_17 A01 METHANOL 4.2E-03 40017A0102 83
U_CG_17 A01 METHYL CYCLOHEXANE 1.8E-02 40017A0102 81
U_CG_17 148 METHYLENE CHLORIDE 3.1E-02 4001714815 0
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Table B.13 Source Facility: Ciba-Geigy Corp. (Continued)
MODEL _ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
U_CG17 148 BUTANOL 1.3E-04 4001714815 90
U_CG_17 A02 HEXANE 9.2E-02 40017A0202 66
UCG17 A04 TOLUENE 3.5E-02 40017A0401 79
U_CG_18 155 METHANOL 1.8E-04 4001715501
U_CG_18 155 METHYLENE CHLORIDE 9.9E-03 4001715501
U_CG_19 176 ETHANOL 1.2E-06 4001717601
U_CG_19 176 ISOPROPYL ALCOHOL 1.2E-06 4001717601
U_CG_19 176 METHANOL 1.1E-05 4001717601
U_CG_19 176 METHYLENE CHLORIDE 9.5E-05 4001717601
U_CG_20 180 ETHANOL 1.7E-06 4001718001
U_CG_20 180 ISOPROPYL ALCOHOL 1.7E-06 4001718001
U_CG_20 180 METHANOL 1.7E-05 4001718001
U_CG_20 180 METHYLENE CHLORIDE 1.5E-04 4001718001
FUGITIVE SOURCE
No fugitive emissions were reported in the TRI for 1990.
FUGITIVE SOURCE EMISSIONS
No fugitive emissions were reported in the TRI for 1990.
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Table B.14 Source Facility: Exxon Corp.
PLANT ID 	 40064, 40003, 40276
PLANT NAME 	 Exxon — Bayway Chemical Plant / Bayway Refinery,
LOCATION
	 1400 Park Avenue
PLANT CITY
	 Linden
SIC 	 2869
SECOND_SIC 	 2911,8731
PRIM PROD 	 Petrochemicals
VOC_TONYR
	 2303.4
TRIF ID 	 07036XXNCH1400P
POINT SOURCES
MODEL _ID STACK ID SR_DESCR HEIGHT DIAMETER TEMP VOLUME
UBW_01 084 REACTOR 60 25 1600 3400
U_BW02 256 REACTOR 40 2 115 8
U_BW_03 299 REACTOR 70 3 100 55
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME g/s FULL _ID EFFICIENCY
UBW01 084 ACETIC ACID 2.0E+00 4006408402 99.9
UBW01 A02 HEXANE 7.0E+00 40276A0201 10
U_BW01 084 PHENOL 1.8E+00 4006408401 99.9
U_BW_02 256 HEXANE 4.6E+00 4006425601 99.9
U_BW02 256 PHENOL 1.8E+00 4006425601 99.9
U_BW_03 299 ACETIC ACID 2.0E+00 4006429901 99.9
U_BW_03 299 HEXANE 2.0E+00 4006429901 99.9
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL ID
U_BW_V01 	 110 	 2.79 	 3
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Table B.14 Source Facility: Exxon Corp. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL _ID CHEM_NAME g/s REL_CODE
U_BW_VO1 AMMONIA 1.3E+00 Other Approaches
U_BW_VO1 CHLORINE 1.4E-03 Other Approaches
U_BW_VO1 CYCLOHEXANE 1.7E-02 Other Approaches
U_BW_VO1 ETHYLENE GLYCOL 3.6E-03 Other Approaches
U_BW_V01 HYDROCHLORIC ACID 1.1E-01 Other Approaches
U_BW_VO1 MALEIC ANHYDRIDE 1.4E-03 Other Approaches
U_BW_VO1 NAPHTHALENE 1.4E-05 Other Approaches
U_BW_VO1 PHENOL 1.7E-03 Other Approaches
U_BW_VO1 SEC-BUTYL ALCOHOL 4.3E-03 Other Approaches
U_BW_VO1 TOLUENE 1.4E-05 Other Approaches
U_BW_VO1 XYLENE (MIXED ISOMERS) 1.7E-04 Other Approaches
Table B.15 Source Facility: Merck & Co., Inc.
PLANT_ID 	 40009
PLANT NAME 	 Merck & Co., Inc.
LOCATION
	
126 East Lincoln Avenue
PLANTSITY 	 Rahway
SIC 	 2833
SECOND SIC 	 Pharmaceuticals
PRIN_PROD
VOC_TON_YR 	 1188
07065MRCKC126EL
POINT SOURCES
MODEL _ID STACK ID SR_DESCR 	 HEIGHT DIAMETER TEMP 	 VOLUME
U_MK_Ol 	 899 	 REACTORS 	 55	 20 	 70 	 3000
U_MK_02 	 919 	 UNKNOWN SOURCES 	 94 	 15 	 104 	 6000
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Table B.15 Source Facility: Merck & Co., Inc. (Continued)
POINT SOURCE EMISSIONS
MODEL _ID STACK ID CHEM_NAME g/s FULL _ID EFFICIENCY
UMKOl A01 ACETIC ACID 1.6E-03 40009A0180 0
UMKOl 899 ACETIC ANHYDRIDE 1.2E-03 4000989918 0
U_MK_O 1 A01 ACETONE 9.8E-01 40009A0189 0
UMKOl A01 CHLOROBENZENE 1.8E-01 40009A0174 0
UMKOl A01 DIMETHYLFORMAMIDE 2.7E-02 40009A0180 0
UMK 01 A01 ETHANOL 1.9E-01 40009A0179 78.2
UMKOl A01 ETHYL ACETATE 1.5E+00 40009A0185 10.4
UMK 01 A01 FORMALDEHYDE 5.6E-04 40009A0180 0
UMK 01 A01 HEXANE 3.7E-01 40009A0197 3.2
UMKOl A01 ISOPROPANOL 3.0E-01 40009A0179 92.5
UMKOl A01 MEK 7.6E-02 40009A0179 0
UMK_Ol A10 METHANOL 5.9E+00 40009A1062 0
UMK_Ol A01 TETRAHYDROFURAN 8.7E-01 40009A0195 0
U_MK 01 A01 TOLUENE 2.7E-01 40009A0197 77
U_MK_02 919 ACETIC ANHYDRIDE 1.7E-05 4000991908 0
UMK02 919 ACETONE 5.7E+00 4000991967 0
U_MK_02 919 CHLOROFORM 2.8E-03 4000991935 99
UMK02 919 ETHANOL 2.9E-03 4000991931 69.9
U_MK_02 919 ISOPENTYL ALCOHOL 6.0E-01 4000991954 0
U_MK_02 919 ISOPROPANOL 1.1E+00 4000991967 0
U_MK_02 919 METHANOL 7.8E-01 4000991967 0
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL ID
U_MK_V01	 108	 2.79	 3
Table B.15 Source Facility: Merck & Co., Inc. (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID CHEM_NAME g/s REL_ CODE
UMKVO1_	 _ 1 1 2 2-TETRACHLOROETHANE 2.4E-04 Data Monitoring OrMeasurements
UMKVO1_	 _ 1 2-DICHLOROBENZENE 1.9E-02 Published EmissionFactors
UMKVO1_	 _ ACETONE 1.9E-01 Data Monitoring OrMeasurements
UMKVO1_	 _ ACETONITRILE 1.1E-01 Published EmissionFactors
UMKVO1_	 _ AMMONIA 1.9E-01 Published EmissionFactors
UMKVO1_	 _ BENZENE 7.8E-02 Data Monitoring OrMeasurements
UMKVO1_	 _ CARBON DISULFIDE 1.3E-01 Published EmissionFactors
UMKVO1_	 _ CHLOROFORM 2.7E-02 Published EmissionFactors
UMKVO1_	 _ DICHLOROMETHANE 2.0E-01 Data Monitoring OrMeasurements
UMKVO1_	 _ HYDROCHLORIC ACID 3 .5E-01 Published EmissionFactors
UMKVO1_	 _ METHANOL 7.9E-01 Data Monitoring OrMeasurements
UMKVO1_	 _ METHYL ETHYL KETONE 3.5E-03 Published EmissionFactors
UMKVO1_	 _ TOLUENE 1.7E-01 Published EmissionFactors
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Table B.16 Source Facility: Schering Corp. (Kenilworth)
PLANT_ID 	 40384
PLANT NAME 	 Schering Corporation
LOCATION 	 2000 Galloping Hill Road
PLANT CITY 	 Kenilworth
SIC 	 2834
SECOND SIC 	 Pharmaceuticals
PRIN_PROD
VOC_TON_YR 	 2775.3
TRIF ID 	 07033SCHRN2000G
POINT SOURCE
MODEL _ID STACK ID SR DESCR HEIGHT DIAMETER TEMP VOLUME
U_SPK_Ol 006 COATING PANS 26 30 80 9999
U_SPK_02 009 DRYER 29 9 195 3300
U_SPK_03 028 TANK 22 10 72 800
029, 030,
U_SPK04_ 031, 032 '033, 034, DRYER 66 34 113 9000 
A01
USPK_05 041, 042 DRYER 26 13 120 2000
USPK_06 047, 048 DRYER 80 10 175 4800
U_SPK_07 051 MIXER 64 36 70 9999
U_SPK_08 052, 060 AEROSOL FILLING MACHINE 84 6 70 350
Table B.16 Source Facility: Schering Corp. (Kenilworth) (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME g/s FULL ID EFFICIENCY
USPKO 1 006 ETHANOL 1.8E-02 4038400608 0
USPKO1 006 ISOPROPANOL 1.9E-04 4038400608 0
U_SPK_O 1 006 METHANOL 7.6E-04 4038400608 0
U_SPK_02 009 ETHANOL 1.3E-02 4038400901 95
USPK_02 009 METHANOL 6.9E-04 4038400901 95
U_SPKO3 028 ETHANOL 1.7E-02 4038402802 0
USPK03 028 HEXANE 7.4E-04 4038402802 0
U_SPK_03 028 METHANOL 9.3E-04 4038402802 0
USPKO3 028 NAP THA 1.9E-04 4038402802 0
USPK04 A01 ETHANOL 6.6E-01 40384A0103 95
USPK04 A01 METHANOL 3.5E-02 40384A0103 95
USPK_05 042 ETHANOL 3.6E-02 4038404201 0
USPKO5 042 ISOPROPANOL 3.8E-04 4038404201 0
U_SPKO5 042 METHANOL 1.5E-03 4038404201 0
USPK_06 048 ETHANOL 4.8E-02 4038404801 0
U_SPKO6 048 METHANOL 2.5E-03 4038404801 0
USPK_07 051 ETHANOL 4.4E-02 4038405105 0
USPK_07 051 METHANOL 2.3E-03 4038405105 0
U_SPK_08 060 ISOBUTANE 5.5E-03 4038406001 0
USPKO8 060 N-BUTANE 3.7E-04 4038406001 0
U_SPK_08 060 PROPANE 1.5E-03 4038406001 0
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Table B.17 Source Facility: Schering Corp. (Union)
PLANT_ID 	 40084
PLANT NAME 	 Schering Corporation
LOCATION 	 1011 Morris Avenue
PLANT CITY 	 Union
SIC 	 2834
SECOND SIC 	 Pharmaceuticals
PRIN_PROD
VOC_TON_YR 	 183.7
TRIF ID 	 07083SCHRN1011M
POINT SOURCES
MODEL ID STACK ID SR DESCR HEIGHT DIAMETER TEMP VOLUME
U_SPU_01 069 REACTOR 50 3 100 150
U_SPU_02 076 REACTOR 40 30 70 7000
USPUO3 082 REACTOR 25 3 70 1
U_SPU_04 083 TANK 41 10 70 1400
U_SPU_05 086 TANK 5 25 40 1
USPU06_ 	 _ 094, 095 '096, 107 DRYER 32 10 200 1500 
U_SPU_07 145 DRYER 52 8 190 1250
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Table B.17 Source Facility: Schering Corp. (Union) (Continued)
POINT SOURCE EMISSIONS
MODEL ID STACK ID CHEM_NAME Ws FULL ID EFFICIENCY
U_SPU_01 069 ACETONE 2.6E-06 4008406902 95
U_SPU_01 069 METHANOL 1.8E-05 4008406902 95
U_SPU_01 069 TOLUENE 1.3E-05 4008406902 95
U_SPUO1 069 TRIMETHYL BORATE 2.6E-06 4008406902 95
U_SPUO2 076 ACETIC ACID 9.9E-05 4008407617 0
U_SPUO2 076 BENZONITRILE 2.2E-05 4008407621 0
U_SPUO2 A02 BUTANOL 3.7E-02 40084A0201 0
U_SPUO2 A01 ETHYL ACETATE 3.0E-02 40084A0101 0
U_SPUO2 076 ETHYLENE GLYCOL 9.0E-05 4008407621 0
U_SPU_02 076 GYLCERINE 9.2E-05 4008407607 0
U_SPUO2 A01 HEPTANE 2.9E-02 40084A0103 0
USPUO2 A01 ISOPROPANOL 7.3E-02 40084A0103 0
U_SPU_02 076 METHANOL 2.5E-03 4008407615 0
U_SPUO2 A02 TOLUENE 5.0E-02 40084A0201 0
USPUO3 082 BUTANOL 7.2E-04 4008408201 0
USPUO3 082 METHANOL 7.2E-06 4008408201 0
U_SPUO4 083 TICHLOROACETIC ACID 2.0E-06 4008408301 0
USPU05 086 ETHANOL 6.9E-05 4008408601 0
USPUO6 107 BUTANOL 1.3E-02 4008410701 0
U_SPUO6 107 HEPTANE 2.8E-02 4008410701 0
U_SPU_06 096 ISOPROPANOL 3.5E-02 4008409601 0
U_SPU_06 107 METHANOL 2.3E-03 4008410701 0
U_SPUO6 107 TOLUENE 2.1E-02 4008410701 0
USPUO7 145 ACETONE 2.6E-06 4008414501 95
U_SPU_07 145 BUTANOL 8.8E-05 4008414501 95
U_SPUO7 145 METHANOL 1.8E-05 4008414501 95
USPU_07 145 TOLUENE 1.3E-05 4008414501 95
U_SPUO7 145 TRIMETHYL BORATE 2.6E-06 4008414501 95
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Table B.17 Source Facility: Schering Corp. (Union) (Continued)
FUGITIVE SOURCE
No fugitive emissions were reported in the TRI for 1990
FUGITIVE SOURCE EMISSIONS
No fugitive emissions were reported in the TRI for 1990
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Initial Lateral
Dimension (meters)
Initial Vertical
Dimension (meters)
Release Height
(meters)MODEL_ID
U_SPK_VO1 	 25.6 	 2.79 	 3
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Table B.16 Source Facility: Schering Corp. (Kenilworth) (Continued)
FUGITIVE SOURCE
FUGITIVE SOURCE EMISSIONS
MODEL ID 	 CHEM NAME 	 g/s 	 REL CODE 	 TRI FAC ID
U_SPK_VO1 	 1 1 1-TRICHLOROETHANE 	 2.0E-02 	 Other Approaches 	 07033SCHRN2000G
APPENDIX C
CHRONIC TOXICITY CRITERIA
Table C.1 lists the chronic toxicity values selected for use in this study. The chronic
toxicity values used in this study were obtained from the sources listed below and in
priority order. Details on the sources can be found in Section 3.2.2 (Toxicity
Assessment).
■ USEPA Office of Air Quality Planning and Standards (OAQPS) Dose-Response
Assessment Tables, February 28, 2005 Version (USEPA, 2005b).
■ USEPA Integrated Risk Information System (IRIS) computer database (USEPA,
2005a).
■ USEPA Health Effects Assessment Summary Table (HEAST), July 31, 1997
Edition (USEPA, 1997b).
■ USEPA Region III Risk Based Concentration (RBC) Table, October 2005 Edition
(USEPA, 2005c).
■ New Jersey Department of Environmental Protection (NJDEP) Air Quality
Permitting Program Table of Reference Concentrations for Inhalation and the
Table of Unit Risk Factors for Inhalation, September 2005 Versions (NJDEP,
2005).
■ California EPA (Cal EPA) Toxicity Criteria Database (Cal EPA, 2005c) and the
Cal EPA Air Resources Board (ARB) Consolidated Table of OEHHA/ARB
Approved Risk Assessment Health Values, April 25, 2005 Edition (Cal EPA,
2005a).
■ Texas Commission on Environmental Quality (TCEQ) Effects Screening Levels
(ESLs) Table, October 01, 2003 Version (TCEQ, 2003).
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Table C.1 Chronic Toxicity Criteria
Sources:
ASTDR ATSDR chronic Minimum Risk Levels (MRLs).
CAL California EPA value.
Com Oral. Value converted from an oral toxicity value.
EPA-P USEPA provisional peer-reviewed values.
EPA-NCEA-P USEPA National Center for Exposure Assessment (NCEA) provisional values.
ESL-LT Effects Screening Levels (ESLs) — Long Term.
HEAST Health Effects Assessment Summary Table.
HEAST-ALT Health Effects Assessment Summary Table, Alternate table.
IRIS USEPA Integrated Risk Information System (IRIS) on-line database.
P-CAL California EPA provisional value.
References:
OAQPS USEPA Office of Air Quality Planning and Standards (OAQPS), Prioritized Chronic Dose-Response Values tables.
IRIS USEPA Integrated Risk Information System (IRIS) on-line database.
R3RBC USEPA Region 3 Risk Based Concentrations (RBC) table.
TCEQ Texas Commission on Environmental Quality (TCEQ), Effects Screening Levels (ESLs) table.
Chemical of Concern CAS No. HAP RfC(mg/m Source Reference (P91m3) 	
UR
3r
Source Reference
Acetic acid 64-19-7 N 2.50E-01 ESL-LT TCEQ -- -- —
Acetic anhydride 108-24-7 N 2.00E-01 ESL-LT TCEQ -- -- —
Acetone 67-64-1 N 3.15E+00 Corm Oral ,IRIS R3 RBC -- -- —
Acetonitrile 75-05-8 Y 6.00E-02 IRIS OAQPS -- — —
Acrylic acid 79-10-7 Y 1.00E-03 IRIS OAQPS -- — —
Acrylic momoner 79-06-1 Y 7.00E-04 P-CAL EPA OAQPS 1.30E-03 IRIS OAQPS
Ammonia 7664-41-7 N 1.00E-01 IRIS R3 RBC -- — —
Benzaldehyde 100-52-7 N 3.50E-01 Corm Oral
,
IRIS R3 RBC -- — —
Benzene 71-43-2 Y 3.00E-02 IRIS OAQPS 7.80E-06 IRIS OAQPS
Benzonitrile 100-47-0 N 5.00E-01 ESL-LT TCEQ — — —
Bis(2-
ethylhexyl)adipate
103-23-1 N 2.10E4)0 Corm Oral
,
IRIS R3 RBC 3.43E-07
Cony. Oral ,
IRIS R3 RBC
Butane 106-97-8 N 1.90E+01 ESL-LT TCEQ -- — —
Butanol 71-36-3 N 3.50E-01 Cony. Oral ,IRIS R3 RBC -- — —
Butyl acetate 123-86-4 N 1.85E+00 ESL-LT TCEQ -- — —
Carbon disulfide 75-15-0 Y 7.00E-01 IRIS OAQPS — — —
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Table C.1 Chronic Toxicity Criteria (Continued)
Chemical of Concern CAS No. HAP RfC 
3)(mg/m Source Reference Wini
R 
3Y1
Source Reference
Chlorine 7782-50-5 Y 2.00E-04 CAL OAQPS -- -- -
Chlorobenzene 108-90-7 Y 1.00E+00 CAL EPA OAQPS -- -- --
Chloroform 67-66-3 Y 9.80E-02 ATSDR OAQPS - -- -
Cyclohexane 110-82-7 N 6.00E+00 IRIS IRIS - -- -
Cyclohexanone 108-94-1 N 1.75E+01
Cony. Oral ,
IRIS R3 RBC - -- --
Di(2-
ethylhexyl)phthalate
117-81-7 Y 1.00E-02 P-CAL OAQPS 2.40E-06 CAL OAQPS
Diacetone alcohol 123-42-2 N 1.33E+00 ESL-LT TCEQ - - --
Dibutyl phthalate 84-74-2 Y 3.50E-01
Cony. Oral 'IRIS R3 RBC - - --
Dichlorobenzene 95-50-1 N 1.40E-01 HEAST R3 RBC - - --
Diethylene glycol 111-46-6 N 2.20E+00 ESL-LT TCEQ - - -
Diethylene triamine 111-40-0 N 4.00E-02 ESL-LT TCEQ -- - -
Dimethyl carbamoyl
chloride
79-44-7 Y - -- - 3.70E-03 TCD CAL EPA
Dimethyl sulfate 77-78-1 Y 5.00E-03 ESL-LT TCEQ - - -
Dimethylamine 124-40-3 N 4.00E-02 ESL-LT TCEQ -- - -
Dimethylformamide 68-12-2 Y 3.00E-02 IRIS OAQPS -- - -
Dioxane 123-91-1 Y 3.60E+00 D-ATSDR OAQPS 3.10E-06 Cony. Oral OAQPS
Epichlorohydrin 106-89-8 Y 1.00E-03 IRIS OAQPS 1.20E-06 IRIS OAQPS
Ethanol 64-17-5 N 1.80E+01 ESL-LT TCEQ - -- --
Ethyl acetate 141-78-6 N 3.15E+00
Cony. Oral 'IRIS R3 RBC - -- -
Ethyl acrylate 140-88-5 Y - -- -- 1.40E-05 Cony. Oral OAQPS
Ethyl chloroformate 541-41-3 N 5.00E-03 ESL-LT TCEQ -- -- -
Ethyl ether 60-29-7 N 7.00E-01 Cony. Oral
,
IRIS R3 RBC -- -- -
Ethylene dichloride 107-06-2 Y 2.40E+00 ATSDR OAQPS 2.60E-05 IRIS OAQPS
Ethylene glycol 107-21-1 Y 4.00E-01 CAL EPA OAQPS -- - --
Ethylene oxide 75-21-8 Y 3.00E-02 CAL OAQPS 8.80E-05 CAL OAQPS
Formaldehyde 50-00-0 Y 9.80E-03 ATSDR OAQPS 5.50E-09 OAQPS OAQPS
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Table C.1 Chronic Toxicity Criteria (Continued)
Chemical of Concern CAS No. HAP RfC 
3)(mg/m 1113
Source Reference
419/
UR
P
Source Reference
Formic acid 64-18-6 N 9.00E-02 ESL-LT TCEQ -- -- -
Glycerine 56-81-5 N 5.00E-02 ESL-LT TCEQ - -- --
Heptane 142-82-5 N 3.50E+00 ESL-LT TCEQ - -- --
Hexane 110-54-3 Y 2.00E-01 IRIS OAQPS -- -- -
Hydrazine 302-01-2 Y 2.00E-04 CAL EPA OAQPS 4.90E-03 IRIS OAQPS
Hydrochloric acid 7647-01-0 Y 2.00E-02 IRIS OAQPS -- -- -
Hydroquinone 123-31-9 Y -011.40E- Cony. 	P-Oral,,EPA R3 RBC 1.60E-05
Oral P-Cony. ral,
EPA
R3 RBC
Isobutane 75-28-5 N 4.80E+00 ESL-LT TCEQ -- -- -
Isobutyl alcohol 78-83-1 N 1.05E+00
Cony. Oral ,
IRIS R3 RBC -- -- -
Isopentane 78-78-4 N 3.50E+00 ESL-LT TCEQ -- -- -
Isopentyl alcohol 123-51-3 N 1.50E-01 ESL-LT TCEQ - -- -
Isopropanol 67-63-0 N 7.85E+00 ESL-LT TCEQ - -- -
Isopropylamine 75-31-0 N 1.20E-01 ESL-LT TCEQ - -- -
Maleic anhydride 108-31-6 Y 7.00E-04 CAL OAQPS - -- -
Methanol 67-56-1 Y 4.00E+00 CAL EPA OAQPS - -- -
Methyl acetate 79-20-9 N 3.50E+00
Cony. Oral ,
HEAST R3 RBC -- -- --
Methyl acrylate 96-33-3 N 1.05E-01
Cony. Oral 'HEAST-Alt R3 RBC -- -- -
Methyl amyl alcohol 108-11-2 N 2.90E-01 ESL-LT TCEQ -- -- -
Methyl bromide 74-83-9 Y 5.00E-03 IRIS OAQPS -- -- --
Methyl cyclohexane 108-87-2 N 3.01E+00 HEAST R3 RBC -- - -
Methyl ethyl ketone 78-93-3 Y 5.00E+00 IRIS OAQPS -- - -
Methyl formate 107-31-3 N 2.50E+00 ESL-LT TCEQ -- -- --
Methyl hydrazine 60-34-4 Y 2.00E-04 CAL EPA OAQPS 4.90E-03 IRIS OAQPS
Methyl isobutyl ketone 108-10-1 Y 3.00E+00 IRIS OAQPS -- - -
Methyl methacrylate 80-62-6 Y 7.00E-01 IRIS OAQPS -- -- -
Methylene chloride 75-09-2 Y 1.00E+00 ATSDR OAQPS 4.70E-07 IRIS OAQPS
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Table C.1 Chronic Toxicity Criteria (Continued)
Chemical of Concern CAS No. HAP RfC(mg1m Source Reference (pgim3) 	
UR
3)-1 Source Reference
Naphtha
64742-95-
6 N 1.25E+00 ESL-LT TCEQ — -- —
n-butyl acrylate 141-32-2 N 1.80E-01 ESL-LT TCEQ — -- --
Nonanal 124-19-6 N 1.50E+00 ESL-LT TCEQ — — --
n-propyl acetate 109-60-4 N 6.30E-01 ESL-LT TCEQ -- — --
Oil 8012-95-1 N 5.00E-02 ESL-LT TCEQ — — --
Pelargonic acid 112-05-0 N 5.00E-03 ESL-LT TCEQ — — --
Pentanal 110-62-3 N 1.00E-01 ESL-LT TCEQ — — --
Phenol 108-95-2 Y 2.00E-01 CAL EPA OAQPS — — --
Phosphoric acid 7664-38-2 N 1.00E-02 IRIS R3 RBC — — --
Phthalic anhydride 85-44-9 Y 2.00E-02 CAL OAQPS — — --
Propane 74-98-6 N 1.80E+01 ESL-LT TCEQ -- — —
Propanol 71-23-8 N 4.90E+00 ESL-LT TCEQ -- — —
Propargyl alcohol 107-19-7 N 2.00E-02 ESL-LT TCEQ -- — —
Propionic acid 79-09-4 N 1.00E-01 ESL-LT TCEQ -- — —
Propylene glycol,
methyl ester
107-98-2 N 2.00E+00 IRIS R3 RBC -- — —
Propylene oxide 75-56-9 Y 3.00E-02 IRIS OAQPS 3.70E-06 IRIS OAQPS
Pyridine 110-86-1 N 7.00E-02 ESL-LT TCEQ -- — —
Styrene 100-42-5 Y 1.00E+00 IRIS OAQPS -- — —
Styrene oxide 96-09-3 Y 6.00E-03 P-CAL OAQPS -- — —
tert-Butanol 75-65-0 N 6.20E-01 ESL-LT TCEQ -- — --
tert-Butyl chloride 507-20-0 N 4.40E+00 ESL-LT TCEQ -- -- —
Tetrachloroethane 79-34-5 Y -- — -- 5.80E-05 IRIS OAQPS
Tetrahydrofuran 109-99-9 N 3.01E-01 EPA-NCEA-P R3 RBC 1.94E-06 EPA-NCEA-P R3 RBC
Toluene 108-88-3 Y 4.00E-01 IRIS OAQPS -- -- —
Trichloroacetic acid 76-03-9 N 7.00E-02 ESL-LT TCEQ -- -- —
Trichloroethane 71-55-6 Y 1.00E+00 CAL OAQPS -- -- --
213
Table C.1 Chronic Toxicity Criteria (Continued)
Chemical of Concern CAS No. HAP RfC(mg1m Source Reference oigin3) 	 URvy Source Reference
Tridecyl alcohol 112-70-9 N 2.70E+00 ESL-LT TCEQ — -- —
Triethylamine 121-44-8 Y 7.00E-03 IRIS OAQPS — — --
Triethylene glycol 112-27-6 N 1.00E-01 ESL-LT TCEQ — — --
Trimethyl benzene 95-63-6 N 5.95E-03 EPA-P R3 RBC — — --
Trimethyl borate 121-43-7 N 1.30E-02 ESL-LT TCEQ — — --
Vinyl acetate 108-05-4 Y 2.00E-01 IRIS OAQPS — — --
Vinyl chloride 75-01-4 Y 1.00E-01 IRIS OAQPS 8.80E-06 IRIS OAQPS
Vinyl methyl ether 107-25-5 N 9.70E+00 ESL-LT TCEQ — — --
Xylene 1330-20-7 Y 1.00E-01 IRIS OAQPS — — --
APPENDIX D
AERMET INPUT FILE AND SUMMARY FILE
Appendix D contains the input file to and summary file from AERMET. The
meteorological data processed through AERMET was imported into the air dispersion
modeling software and used in all modeling runs.
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DJ AERMET Input File
** BREEZE AERMET v4.0.7 - C:\Documents and
Settings\SILVERMK\Desktop\KCS\Dissertation\MetData\EWR91-95.amt
** Trinity Consultants, Dallas, TX
JOB
MESSAGES C:\DOCUME-1\SILVERMK\Desktop\KCS\DISSER-4\MetData\EWR91-95.MSG
REPORT C:\DOCUME-1\SILVERMK\Desktop\KCS\DISSER-4\MetData\EWR91-95.RPT
CHK_SYNTAX
METPREP
DATA C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.MRG
MODEL AERMOD
LOCATION FACILITY 40.43N 74.1W 5
NWS HGT WIND 9.1
XDATTS 	 91/01/01 95/12/31
METHOD WIND DIR RANDOM
METHOD REFLEVEL SUBNWS
FREQ_SECT SEASONAL 1
SECTOR
	 1 0 360
SITE_CHAR 1 1 	 0.35 1.75 1.00
SITE_CHAR 2 	 1 	 0.14 1.00 1.00
SITE_CHAR 3 	 1 	 0.16 2.00 1.00
SITE_ CHAR 4 	 1 	 0.18 2.00 1.00
OUTPUT C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.SFC
PROFILE C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.PFL
**BREEZE
** 	 TYPE 4
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Process Scheme Description
I).2 AERMET Summary File
********************************************************************************
*** Stage 3 - Estimate Boundary Layer Parameters
********************************************************************************
AERMET, A Meteorological Processor for the AERMOD Dispersion Model
Version 03273
Data Processed on 2-JUL-05 at 23:24:19
********************************************************
*** AERMET Setup Finished Successfully ***
********************************************************
1. Input/Output Files
C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.RPT
OPENED SUCCESSFULLY
C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.MSG
OPENED SUCCESSFULLY
C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.MRG
OPENED SUCCESSFULLY
C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.SFC
OPENED SUCCESSFULLY
C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-95.PFL
OPENED SUCCESSFULLY
2. Dispersion Model for which Data Are Processed
AERMOD
3. Processing Options
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WIND DIRECTION RANDOM 	 NWS wind directions are RANDOMIZED
SBL PROCESSING UCALST 	 The default (Holtslag method is used)
REFERENCE LEVEL SUBNWS 	 NWS data ARE SUBSTITUTED for on-site data
4. Locations of Meteorological Data
Data 	 Site 	 Longitude Latitude
Pathway 	 ID 	 (degrees) 	 (degrees)
UPPERAIR 	 00093755 	 74.67W 	 39.75N
SURFACE 	 14734 	 74.17W 	 40.7N
ONSITE 	 0
*****************************************
* Longitude and Latitude for Processing *
* 74.10 40.43 *
*****************************************
5. Surface
Month
Characteristics
Wind Sector
Start 	 End Albedo
Bowen
Ratio
Roughness
Length (m)
1 0. 360. 0.3500 1.7500 1.0000
2 0. 360. 0.3500 1.7500 1.0000
3 0. 360. 0.1400 1.0000 1.0000
4 0. 360. 0.1400 1.0000 1.0000
5 0. 360. 0.1400 1.0000 1.0000
6 0. 360. 0.1600 2.0000 1.0000
7 0. 360. 0.1600 2.0000 1.0000
8 0. 360. 0.1600 2.0000 1.0000
9 0. 360. 0.1800 2.0000 1.0000
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10 0. 360. 0.1800 2.0000 1.0000
11 0. 360. 0.1800 2.0000 1.0000
12 0. 360. 0.3500 1.7500 1.0000
6. Input File(s) for AERMOD
Surface Meteorology: C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-
95.SFC
Profile Data 	 : C:\DOCUME-1\SILVERMK\DESKTOP\KCS\DISSER-4\METDATA\EWR91-
95.PFL
The number of calms encountered is: 	 935
APPENDIX E
AERMOD INPUT FILES
The air dispersion model (AERMOD) was run four times, one time for each of the four
receptor grids in the study (North Essex, East Union, West Union, and South Middlesex).
Each model run simultaneously modeled all of the emission sources, located on all the
source facilities, within the boundaries of the respective receptor grid. The AERMOD-
MSP option in the BREEZE® software automatically created a batch file that ran each of
the four modeling runs 102 times, one time for each of the COCs. The final number of
modeling runs done for this study was 408 runs (i.e., 4 receptor grids x 102 COCs). The
total number of receptors modeled were 4,900 in both the North Essex and West Union
grids; 7,742 in the East Union grid; and 4,140 in the Lower Middlesex grid. This
appendix contains abbreviated versions of all four AERMOD input files (i.e.,
NE_Runl.dat, EU_Runl.dat, WU_Runl.dat, SM_Runl.dat). To abbreviate the original
input file, the 'X' and 'Y' coordinates of the individual receptors were omitted.
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APPENDIX F
EXAMPLE OF AERMOD OUTPUT FILES
The modeling runs generated 408 output files (i.e., 4 receptor grids x 102 COCs). All air
dispersion modeling output was collected in standard text format files that contained
geographical coordinates ('X' and 'Y') for every receptor as well as a modeled air
concentration for every COC at that receptor. The height for all modeled receptors was
ground level (i.e., 'Z' = 0). The modeled air concentrations were expressed as
micrograms/cubic meter (.1g/m3). This Appendix contains abbreviated versions of the
AERMOD output files for several COCs (benzene, formaldehyde, methylene chloride,
methyl hydrazine, and tetrahydrofuran) emitted from the Hoffman LaRoche source
facility. To abbreviate the original output file, pages 5 through 125 were omitted. These
pages contained the 'X' and 'Y' coordinates for all the receptors modeled as well as the
predicted concentration of the COC at each receptor.
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